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Effective food and feed control systems are essential to protect the health of consumers. 
Serious food and feed safety incidents during the last decades urged the European 
Commission and other countries across the world to review their food safety systems and to 
look for improved strategies to protect consumers against unsafe food.  
One of the food safety issues includes the presence of trace levels of natural chemical 
contaminants including marine biotoxins and mycotoxins. Mycotoxins are secondary 
metabolites produced by a wide range of fungi on agricultural commodities in the field or 
during storage under specific environmental conditions. Despite extensive efforts during crop 
growth, harvesting or storage, it is not possible to completely avoid mycotoxin contamination. 
To understand the awareness of the Flemish population (including food consumers and 
producers) concerning mycotoxin contamination of food and feed, a questionnaire was 
developed and distributed online at the Agriflanders Fair for and by Flemish agriculture 
(2013). 
Fusarium toxins called trichothecenes form the most commonly found mycotoxin group in 
Europe, among them deoxynivalenol occurs at highest rate. The mycotoxin deoxynivalenol, 
also known as DON or vomitoxin, is one of over 150 related compounds of trichothecenes 
and is of particular relevance to the wheat crop.  
Analytical methods for mycotoxin detection and quantitation in grain cereals consists of a 
sampling, sample preparation and chromatographic or immunochemical detection step. The 
sampling step is considered as the most significant source of uncertainty of the test result. 
Mycotoxins are heterogeneously distributed in a cereal bulk lot, leading to the difficulty of 
selecting a representative test sample. To overcome the problem of heterogeneous distribution 
of mycotoxins in food and feed, the European MycoHunt project (FP7/2007-2013, grant 
agreement n°243633) suggested the testing of grain dust which is created when tons of bulk 
grains are moved and transported through closed systems e.g. (un)loading of a truck. Grain 
dust can be considered as a representative sample as it is continuously generated and sampled 
through the entire grain movement process.  
The sampling of dust is not a novel technique. Tangni and Pussemier (2006) analysed settled 
grain dust for ochratoxin A and citrinin content and assessed the impact of the grain dust for 
its direct contribution as contaminant and inoculum in stored wheat. Krysinska-Traczyk et al. 
(2001) described and compared the sampling of grain and settled grain dust for the 
determination of Fusaria and fusariotoxin levels. As notable quantities of Fusaria and 
fusariotoxins were found in both grain and grain dust, the authors expressed their concern 
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regarding the risk of mycotoxicoses to agricultural workers exposed to grain dust. The 
inhalation of dust contaminated with mould spores and/or mycotoxins have been reported as 
the cause of acute and chronic respiratory diseases and certain infection diseases and cancer 
due to long-term inhalation [Halstensen et al., 2004].  
The purpose of the MycoHunt project was the combination of the grain (i.e. wheat) dust 
sampling technique with a fast and DON specific detection technique. For the detection, an 
amperometric immunoassay technology was selected. Immunoassays are based on antigen-
antibody reaction and therefore anti-DON monoclonal antibodies were needed. All of the 
commercially available anti-DON antibodies show high cross-reactivity (> 100%) against one 
of the acetylated DON derivatives, 3-acetyldeoxynivalenol (3-ADON) and 15-
acetyldeoxynivalenol (15-ADON). Current legislation does not include maximum or guidance 
levels for both 3-ADON and 15-ADON, even though they are of toxicological importance. To 
comply with the legislation, specific anti-DON monoclonal antibodies were aimed for. During 
this research, an immunogen synthesis strategy was developed using different procedures. 
Also, different linkers with varying length and chemical structure between DON and the 
carrier protein were synthesized to be able to lower cross-reactivity of the monoclonal 
antibodies. Balb/C female mice (ethical approval according to ECD 10/08) were subjected to 
an injection with the different DON immunogens and monoclonal antibodies were developed 
using the hybridoma technology. 
To even lower the cross-reactivity of the derived monoclonal antibodies, recombinant 
antibody technology was used. Using the gene sequence of the derived single-chain variable 
fragment (scFv) antibodies and the target DON chemical structure, modeling and docking 
studies were performed. These studies were able to visualize the amino acid importance 
within the complementary determining region (CDR) responsible for the specific target 
interaction. 
As at the moment, no regulatory limits exist for mycotoxins in grain dust, a correlation was 
needed between the DON level in wheat dust versus the DON level in the corresponding 
wheat. First of all, a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method 
was developed and validated for the determination of DON in wheat dust. Using this method, 
the DON content of different wheat dust samples was measured and together with the DON 
levels of the corresponding wheat samples determined by the LC-MS/MS method described 
by De Boevre et al. (2012b), a correlation curve was prepared. As in the MycoHunt system, 
an immunoassay technology was developed, the suitability of the generated anti-DON 
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monoclonal antibodies was tested. Therefore an aqueous sample extraction and enzyme-
linked immunosorbent assay (ELISA) method was developed and validated for the wheat and 
wheat dust matrix. The obtained ELISA results were compared to the LC-MS/MS results for 
DON determination in wheat and wheat dust and a general conclusion was made. 
To summarize, the PhD research focused on the following objectives: 
- To develop an alternative sampling method for wheat grain (Chapter 2); 
- To synthesize different immunogens with varying length and chemical structure 
between DON and the carrier protein (Chapter 3); 
- To develop monoclonal anti-DON antibodies using hybridoma technology (Chapter 3); 
- To improve the specificity of the monoclonal anti-DON antibodies by using 
recombinant technology (Chapter 5); 
- To make a correlation between the DON content in wheat dust versus wheat grain by 
the use of a developed and validated LC-MS/MS (Chapter 2) and ELISA method 
(Chapter 4). 
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CHAPTER 1: GENERAL INTRODUCTION AND PRINCIPLES 
 
1.1 MYCOTOXINS: AN OVERVIEW 
Mycotoxins are naturally occurring secondary metabolites produced by a wide range of fungi 
including Aspergillus spp., Penicillium spp., and Fusarium spp.. All of them are known to be 
invisible or cannot be detected by smell or taste [Binder, 2007]. They are produced by the 
specific fungus under optimal environmental conditions as high temperature and humidity. 
Furthermore, mycotoxin production occurs at different stages. Fusarium mycotoxins for 
example are produced on the field whereas Aspergillus and Penicillium mycotoxins are 
formed during storage [Savi et al., 2013]. 
An obvious structural diversity can be seen over the five hundred different mycotoxins which 
have been discovered so far. This results in different chemical and physicochemical properties 
and as a consequence different biological effects. The toxic effects induced by mycotoxins 
depend on several factors, namely toxin-related (type of mycotoxin consumed, level of intake 
and duration of exposure, mechanism of action and metabolism) and animal-related factors 
(animal species, sex, age, breed, general health and immune status) [Bennett and Klich, 2003; 
Koppen et al., 2010; Krska et al., 2001; Binder, 2007]. In Table 1.1 an overview is given of 
different food and feed commodities together with the possible mycotoxin contaminants, the 
affected animal species and the most commonly found clinical effects on humans and animals. 
Since many plant and animal products are commonly used for the production of fish feed, 
water living animals also discover harm related to mycotoxin exposure. A decrease in growth, 
organ lesions and immunosuppression are symptoms commonly found in fishes exposed to 
subchronic levels of mycotoxins, whereas fish liver tumours are induced by chronic aflatoxin 
exposure. The co-occurrence of diverse mycotoxins can lead to antagonistic, additive or 
synergistic effects [Binder, 2007; Speijers and Speijers, 2004; Caruso et al., 2013]. 
Mycotoxicoses, caused by the direct contamination of agricultural commodities and by a 
“carry-over” of mycotoxins and their metabolites into animal tissue after feeding with 
contaminated cereals, can be induced by either mycotoxin ingestion, inhalation or skin-
contact [Stepien et al., 2007; Koppen et al., 2010; Krska et al., 2001]. Through occurrence of 
outbreaks that affected animals and humans in the past centuries, it was possible to discover 
the presence of mycotoxins. From the 8
th
 to 16
th
 century there were epidemics of “Saint 
Anthony’s fire”, which were the result of eating rye contaminated with ergot alkaloids 
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produced by the mould Claviceps purpurea. The symptoms of Saint Anthony’s fire include 
gangrene, burning sensations and hallucinations. Around 150 years ago, fumonisins were 
considered as a cause of disease and death of horses by consumption of maize which was 
contaminated with Fusarium species. Aflatoxins were discovered in the United Kingdom in 
1960 just prior to Christmas. Hundred thousands of turkeys and other birds were found death 
after the consumption of contaminated groundnuts. This outbreak was called “Turkey X 
disease” [Bennett and Klich, 2003; Koppen et al., 2010; Krska et al., 2001]. In the mid 1980s 
conjugated or masked mycotoxins were discovered. Due to metabolism, plants are capable of 
transforming mycotoxins into conjugated forms such as zearalenone and deoxynivalenol 
glucosides. These masked forms are not detected during routine analysis, but are possibly 
hydrolysed during digestion which may contribute to cases of mycotoxicoses [Berthiller et al., 
2005; Binder, 2007]. 
 
Table 1.1  Summary of different food and feed commodities together with the possible mycotoxin 
contaminants, the most affected animals and the corresponding clinical effects 
Mycotoxin Food and feed 
commodities 
Animals 
affected 
Clinical effects 
Aflatoxins Maize, peanuts, 
tree nuts, dairy 
products 
Swine, dogs, 
cats, cattle, 
sheep, young 
birds, humans 
Liver damage, intestinal bleeding, 
carcinogenic and teratogenic effects 
Ergot alkaloids Rye, sorghum, 
pasture grasses 
Cattle, sheep, 
humans 
Nervous or gangrenous syndromes  
Fumonisins Maize, silage Horses, swine, 
humans 
Pulmonary oedema, 
leukoencephalomalacia, oesophageal 
cancer, neural tube defects, liver 
damage 
Ochratoxins Cereal grains, 
coffee, grapes 
Swine, 
humans 
Kidney and liver damage, cancer 
Trichothecenes Wheat, barley, 
oats, maize 
Swine, dairy 
cattle, poultry, 
horses, 
humans 
Immunological effects, inhibition 
protein synthesis, DNA damage, 
haematological changes, feed refusal, 
diarrhoea, vomiting, skin disorders 
Zearalenone Maize, hay Swine, dairy 
cattle 
Estrogenic effects, abortion, 
malformation of testicles and ovaries 
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Certain food processes enhance the cultivation of mycotoxin-producing fungi [Hazel and 
Patel, 2004]. Fusarium moulds are capable of growing and producing mycotoxins during the 
beer production process. Nowadays three reduction methods for mould growth during malting 
can be considered, namely irradiation, chemical and biological methods. However, their effect 
on malt quality and mycotoxin production of the surviving mould still needs to be evaluated 
in detail [Wolf-Hall and Schwarz, 2002]. During the lengthy process of winemaking, the skin 
of the grape fruit and juice are in close contact for more than 10 days. This contact gives the 
mycotoxin-producing fungi the opportunity to grow and secrete mycotoxins into the 
fermentation source. The coincidence of mycotoxins and mouldy fruits has been proved, 
however introducing mycotoxins into the winemaking process via intact fruits has not been 
previously reported [Jiang et al., 2013; Serra et al., 2005]. 
Besides fruit, also vegetables can be attacked by mycotoxigenic fungi. If consumers process a 
rotten fruit or vegetable, this form can still be a significant source of mycotoxins as most 
fungi survive food processing [Barkai-Golan and Paster, 2008; Monbaliu et al., 2009a]. Due 
to the heat resistance of these fungi, they can even appear in coffee or tea. Their appearance in 
coffee can be the consequence of their presence during harvesting, preparation, transport or 
storage of coffee cherries and beans. Also herb tea or medicinal plants contain a number of 
micro-organisms, mainly originating from the flora of the plant [Halt, 1998; Batista et al., 
2003]. Dairy products can be contaminated with mycotoxins as well, due to the presence of 
fungal growth for fermentation or unintentional fungal growth. Although moulds are 
intentionally grown on cheese for the production of French Roquefort and Camembert, these 
fungi are not able to produce mycotoxins, but the presence of toxigenic strains due to 
environmental contamination could result in mycotoxin appearance [Prandini et al., 2009]. 
Meat and fish can contain traces of fungi in a post-slaughter condition due to the contact with 
contaminated air, water, processing facilities or by addition of food ingredients [Hashem and 
Mohamed, 2011; Cook, 1995]. 
At the moment, the most common known source of mycotoxigenic fungi are cereals. Poor 
post-harvest management of grain cereals entering storage facilities can lead to rapid 
deterioration in grain quality, severely decreasing germinability and nutritional value of stored 
grains. The presence of fungal activity can contribute to previously mentioned effects and can 
result in contamination with mycotoxins [Magan et al., 2003]. As these mycotoxins are very 
stable during food processing, they can be found in cereal end products such as bread or other 
bakery products [Molinie et al., 2005; De Boevre et al., 2012a]. 
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The control of mycotoxin contamination starts with the implementation of good agricultural 
practices (GAPs) to prevent infection with the corresponding moulds. Preventive strategies 
should be implemented from pre- through post-harvest. Measures at the pre-harvest level 
include good planting and growing conditions e.g. soil treatment, crop rotation, irrigation. 
During the process of harvesting, functional harvest equipment and dry collection and 
transportation equipment would lower infection probability. Postharvest measures include the 
drying of the cereals and appropriate storage conditions [Magan et al., 2003; Murphy et al., 
2006]. 
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1.2 THE AWARENESS ABOUT MYCOTOXIN CONTAMINATION OF FOOD AND 
FEED: A SURVEY IN THE FLEMISH POPULATION 
Knowledge of food and feed safety among consumers has various dimensions. A quantitative 
survey (n = 520) was set up to determine the awareness of the risks of mycotoxin 
contaminated food and feed throughout the Flemish population. In subchapter 1.2.2, all 
answers and considerations are presented and discussed.  
 
1.2.1 Materials and methods 
1.2.1.1 Objective and participants 
To understand the awareness of the Flemish population concerning mycotoxin contamination 
of food and feed, a questionnaire was developed by the Centre of Excellence Food2know 
within Ghent University in cooperation with the Laboratory of Food Analysis. The 
questionnaire was distributed online at the Agriflanders Fair for and by Flemish agriculture 
from the 10
th
 – 13th of January 2013. Of the in total 520 participants, 55% were women 
whereas 45% were men with the year of birth between 1924 and 1998. Young persons as well 
as elderly people participated in this survey. Most of the participants were married or lived 
together (67%) and 59% had children. Furthermore, the people included in the survey had 
different education levels, different jobs and were working in various sectors. In figure 1.1 an 
overview is given of the different working sectors of the participants and their profession.  
 
 
140 (27%) 
81 (16%) 
78 (15%) 
55 (11%) 
54 (10%) 
33 (6%) 
29 
(6%) 
22 (4%) 
16 (3%) 8 (2%) 
4 (1%) 
Agriculture
Other
Education
Medical sector
Government
None
Food
Construction sector
Technological sector
Chemical sector
ICT
A 
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1.2.1.2 Questionnaire 
The complete questionnaire which was generated by using the online Qualtrics Survey 
Software, is displayed in Appendix A.  
Overall, seven questions concerning food and feed safety in general and more specific 
concerning moulds and mycotoxins were posed. The first two questions dealt with the 
possibilities in which case a certain food or feed product can become unsuitable or dangerous 
to eat. A third question investigated the knowledge of the participants regarding mycotoxins. 
Furthermore, several food products were listed and the occurrence of mould growth was 
questioned. Consequently, participants were asked which actions they would take if a certain 
product is mouldy. Finally, two questions were stated to assess who is responsible according 
to the Flemish population to guard the safety of food and feed with respect to moulds and 
mycotoxins.  
In addition to the above mentioned questions, some more general ones were addressed as well, 
including gender, year of birth, highest obtained degree, profession, working sector, marital 
status and number of children.  
 
1.2.1.3 Statistics  
All calculations were performed and processed using Microsoft Office Excel 2010 and IBM 
SPSS 22.  
171 (33 %) 
116 (22 %) 
50 (10 %) 
46 (9 %) 
42 (8 %) 
39 (8 %) 
22 (4 %) 
19 (4 %) 
10 (2 %) 
5 ( 1 %) 
Employee
Self-employed/free profession
Student
Teacher
Other
Labourer
Executive
(Early) Retiree
Housewife/-husband
Job seeker
Figure 1.1 An overview of the different working sectors of the participants (A) and their profession (B) 
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1.2.2 Results and discussion 
To start the questionnaire, people were asked in the first two questions in which cases food 
(question 1) or feed (question 2) cannot be eaten anymore or is even dangerous to eat. It was 
noticed that 444 of the 520 participants (85.4%) answered that food cannot be eaten when it is 
infected by moulds such as Aspergillus species. Therefore, it can be concluded that most 
people were aware of the presence and negative effects of the mould species. In addition, 110 
of the 140 people (78.6%) who were working in the agricultural field stated that it is not 
trustworthy to eat mouldy food. Consequently, 21.4% of these people were not aware of the 
consequences of mould growth and correlating mycotoxin production. Regarding feed as a 
source of mould growth, a total of 411 of the 520 people (79.0%) answered that mouldy feed 
can be dangerous to animals and therefore should not be consumed anymore. In accordance 
with the answers concerning food, 111 of the 140 people (79.3%) working in the agricultural 
field did not trust mouldy feed. Compared to the results of the food matrix by the use of a 
Chi-squared test, in total a significantly higher number of people (2 = 7.487, degree of 
freedom = 2, p-value = 0.025) would still feed the animals with a meal containing moulds. 
Comparing the above described results with those concerning bacteria by the use of a Chi-
squared test, shows that significantly (2 = 62.600, degree of freedom = 2, p-value < 0.001) 
more people were aware of the potential negative effects of bacteria compared to moulds. In 
total 511 of 520 participants (98.3%) said it is possible for bacteria to cause these negative 
effects on food. Moreover, 134 of 140 people (95.7%) working in the agricultural field 
recognized these potential effects of bacteria. Furthermore, the presence and effects of 
bacteria in feed were found possible by 458 of 520 persons (88.1%) and 129 of 140 persons 
working in the agricultural field (92.1%). In conclusion one can state that the Flemish 
population is more aware of the negative effects of bacteria in food and feed then those 
concerning moulds. 
In question 3, people were asked about the source of mycotoxin production. An overview of 
the answers is illustrated in Figure 1.2. A significantly (2 = 581.191, degree of freedom = 6, 
p-value < 0.001) larger number of people (59.6%) picked out moulds as mycotoxin source 
compared to toxic plants (12.9%), bacteria (15.0%) and viruses (8.5%). But still in each 
category, the number of people who did not know the source of mycotoxin production was 
high, namely 38.3%. Between 29.3 and 39.3% of the people working in the agricultural sector 
did not know if toxic plants, bacteria, moulds or viruses are producers of mycotoxins, which 
is really a matter of concern. 
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Figure 1.2 Percentage of people who found toxic plants, bacteria, moulds and viruses a source of 
mycotoxin production 
 
In the second part of question 3, people were asked if mycotoxins could be harmful for 
humans and/or animals. The largest group of people, namely 376 of the 520 people (72.3%) 
and 369 of 520 people (71.0%), answered that mycotoxins could lead to respectively human 
and animal toxicity. But still 26.5% of the participants did not have an idea about toxicity of 
mycotoxins and 22% of these “not knowing” people were working in the agricultural field. 
People were also asked about the toxicity towards plants. It has been noticed by different 
researchers that the infection of plants can lead to plant cell death due to oxidative stress by 
the induction of increased reactive oxygen species (ROS) levels. Transcriptomic studies have 
identified genes encoding ROS scavenging enzymes for example peroxidases, that were up-
regulated in plants in response to certain mycotoxins e.g. trichothecenes [Foroud et al., 2012; 
Arunachalam and Doohan, 2013]. Based on the answers of the population, 73.3% of the 
people and 28.3% of persons working in the agricultural field did not have an idea about 
possible toxic plant effects or thought there are no toxic effects on plants. Also, the answers 
on possible toxicity towards water living animals are a matter of concern. The majority of the 
participants (57.5%) were not aware that mycotoxins are toxic towards fish. Hence, it is 
advisable to raise the knowledge of the Flemish population with regards to the harmful effects 
of mycotoxins. 
As previously mentioned, mycotoxicoses can be induced by ingestion, inhalation or skin 
contact of mycotoxin contaminated food or feed. People were asked during this questionnaire 
about the possibility of mycotoxin exposure by inhalation. Of a total of 520 people, 354 
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persons (68.1%) did not know the answer or answered that this kind of exposure does not lead 
to mycotoxin toxicity. In all working fields, even in the agricultural sector, food sector and in 
education, the majority of the people were not aware of this exposure pathway. 
The objective of question 4 was to check for consumers awareness of mould growth in food 
and feed. Figure 1.3 depicts the results of this question. The possible presence of moulds in 
fresh vegetables or fruits (85.2%), in dairy products (94%) and bread or other bakery products 
(93.8%) and animal feed (79.6%) was well known. The questionnaire showed that 48.8% of 
the people were not aware of the possible presence of moulds in beer or wine. First of all, 
during the malting process in beer production and during the fermentation process in 
winemaking, mould growth and mycotoxin production occur and even despite the existence of 
eradication processes, it is difficult to eliminate the mould growth [Jiang et al., 2013; Serra et 
al., 2005; Wolf-Hall and Schwarz, 2002]. Other sources of mould growth the population 
showed not being informed of, are coffee and tea (56.5%). The other food products mentioned 
in question 4 and Figure 1.3 are of less importance as they contain no or only traces of mould 
growth under normal storage conditions and will therefore not be discussed [Sulyok et al., 
2010]. 
In the following question, people were asked how to deal with mouldy products. The possible 
answers were: removal of the mouldy part so the remainder can still be consumed; moulds are 
not harmful so you can just eat it; after washing the product it can be consumed; after 
warming the product it can be consumed; you need to throw away the product. The results are 
illustrated in Figure 1.4. It has been shown that the removal of the fungal mycelium in fruits 
or vegetables, does not consequently lead to the elimination or reduction of the mycotoxin 
contamination. Careful selection, washing and sorting of fruits is the most important action in 
reducing the mycotoxin content of food products, but this still does not lead to a complete 
removal [Barkai-Golan and Paster, 2011; Drusch and Ragab, 2003]. As seen in Figure 1.4, 
57.8% of the people thought it is not good to remove only the mouldy part of the food product, 
while throwing away the whole product was considered by 58.9% of the Flemish population. 
The majority of the people (86.6%) were aware of the harmful and toxic effects of moulds, 
which is an important consideration. The fact that mycotoxins can not be totally eliminated by 
washing or warming up the mouldy food product was known to respectively, 83.7% and    
88.5% of the population. In general, it can be concluded that still more information should be 
distributed on how to handle mouldy food and feed products and which measures could be 
taken to eliminate or reduce mycotoxin exposure. 
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The last two questions focused on who could be considered responsible for food and feed 
safety related to mycotoxins. It is quite obvious that producers of food and feed products are 
primarily responsible. If they observe mould growth during harvest, measures should be taken, 
for example analysis of mycotoxins, and if this leads to a positive result, the total lot should 
be eliminated. As some unprocessed food and feed products escape this first control point or 
mycotoxin production occurs during the processing of food, grocers and even consumers 
should take extra precautions. Out of the last question, it became clear that the majority of the 
people wanted to have food or feed products tested for mould presence and mycotoxin 
contamination (84.8% and 79.6%, respectively). A total of 63.5% of the people knew that it is 
not possible to see mycotoxin contamination by eye and only 42.7% of the population thought 
it is possible to notice mould growth. For the final product, which is tested on mycotoxin 
presence, 51.7% of the participants did not mind to pay more for it. 
 
 
Figure 1.3 Consumers awareness of mould growth in food and feed 
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Figure 1.4 Frequency distribution of how people deal with mouldy products 
 
1.2.3 Conclusion 
The questionnaire which was distributed at the Agriflanders Fair for and by Flemish 
agriculture in January 2013, indicated some points of interest that should be considered in the 
future. In general, people were aware of the negative effects of moulds to cause unsuitable or 
harmful food or feed. However, these potential effects were better known for bacteria than for 
moulds. Although 59.4% of all participants stated that moulds are mycotoxin producers, still a 
large part, including people from the agricultural field, did not know by which organisms 
mycotoxins are produced. When it comes to addressing the toxic effects of mycotoxins, fewer 
persons were aware of these effects on plants and water living animals than for humans and 
other animals. In all cases, the toxic effects were not sufficiently recognized. Furthermore, the 
exposure pathways of mycotoxins, more specifically through inhalation, were not generally 
known. The participants were also not appropriately aware of the possible mould growth and 
presence of mycotoxins in beer, wine, coffee, tea and cereal derived products.  
In addition, it can be concluded that consumers do not always take the correct measures when 
they come into contact with a mouldy food. Surprisingly, although 82.2% (average) of the 
participants preferred to have their food or feed tested for the presence of moulds and 
mycotoxins, only 51.7% was willing to pay more for it.   
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In summary, one can state that more awareness concerning mould growth, production of 
mycotoxins by moulds, their toxic effects on organisms, exposure pathways and how to deal 
with mouldy food is of high value and importance for the Flemish population. More 
information should be provided to increase the awareness of mycotoxin contamination of food 
and feed. 
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1.3 DEOXYNIVALENOL AND MASKED FORMS 
1.3.1 Fusarium head blight 
Trichothecenes are the most commonly found mycotoxin group in Europe produced by 
Fusarium species. Among the 150 related trichothecenes, deoxynivalenol (DON) also called 
vomitoxin, occurs at highest rate. Especially wheat, triticale and maize are vulnerable for 
Fusarium infection and are, therefore, frequently higher contaminated with DON compared to 
other cereals [Maragos et al., 2006; Döll and Dänicke, 2011; Lancova et al., 2008a; Krska et 
al., 2001; Beyer et al., 2006; Murphy et al., 2006].  
The infection of small grain cereals (e.g. wheat, barley, oats) by Fusarium species during 
anthesis causes Fusarium head blight (FHB). Until now, 17 species of Fusarium have been 
described to be potentially associated with FHB symptoms [Leonard and Bushnell, 2003]. In 
Europe, F. graminearum and F. culmorum are known as the most important FHB pathogens 
of wheat because of their high pathogenic character in comparison with other species and 
their high mycotoxin production level, in particular DON. As mentioned by Hooker et al. 
(2002), weather conditions during flowering are the main factors contributing to the variation 
in DON content. Rainfall and warm temperatures during wheat anthesis promote the FHB 
incidence [Edwards, 2004; Beyer et al., 2006; Blandino et al., 2012]. In addition, weather 
conditions during the vegetative growth of wheat during autumn and winter influence the 
FHB infection pressure [Landschoot et al., 2012]. Besides weather conditions, good 
agricultural practices contribute to minimize the FHB problem.  
FHB infection can be controlled by a combination of the following methods: crop rotation, 
tillage, choice of the wheat variety, and use of fungicides. Besides wheat, Fusarium species 
infect maize and after harvest crop debris provides an excellent source for the survival of 
pathogens. Therefore, including maize in crop rotation systems will increase the risk of FHB 
epidemics and DON contamination. Another method to control FHB infection is tillage (i.e. 
ploughing). No tillage and minimal tillage leave all or part of the crop residue on the soil 
surface after harvest and therefore favour FHB infection due to the capacity of Fusarium spp. 
to survive saprophytically on these crop residues. Ploughing decreases the inoculum level 
since Fusarium spp. are aerobic, and as such leads to a reduction in DON content. A third 
method which can be considered in order to reduce the FHB incidence is the wheat variety. At 
the moment, no complete FHB-resistant crop is known, even though the susceptibility of 
commercial wheat varieties to FHB pathogens and their DON content differs. The lack of an 
absolute type of resistance originates from the multigenic nature of FHB resistance encoded 
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by quantitative trait loci which are scattered throughout the genome. Consequently, cultivated 
wheat varieties display a continuous variation in resistance depending on the country of origin 
due to differences in the genetic pool within each country’s breeding program and the 
different environmental and agronomic conditions in which crops are cultivated [Edwards, 
2004; Miller et al., 1998; Beyer et al., 2006; Lori et al., 2009; De Boevre et al., 2012a]. The 
improvement of host genetic resistance is therefore seen as essential to achieve meaningful 
control although advances in this research are hampered by the multigenic nature of the 
resistance [Gilbert and Haber, 2013]. Besides crop rotation and variety choice, fungicides 
remain an indispensable measure to tackle the FHB problem. Research trials conducted in the 
nineties showed the effectiveness of the triazoles prothioconazole, metconazole and 
tebuconazole plus prothioconazole in suppressing FHB disease and controlling mycotoxins. 
The best control of the disease can be achieved with fungicide applications at wheat anthesis 
and the efficacy declines rapidly with time after and before the plant growth stage [Beyer et 
al., 2006; Gilbert and Haber, 2013]. Although the impact of fungicides on fungal biomass is a 
straightforward reduction, the implication of fungicide application with regard to toxin 
production is a story that has not been fully elucidated and several research groups report on 
increased toxin production upon fungicide application or a selection towards specific 
chemotypes of the fungus [Audenaert et al., 2010; Zhang et al., 2013]. 
 
1.3.2 Chemistry 
As illustrated in Figure 1.5A, trichothecene mycotoxins consist of a tetracyclic 
sesquiterpenoid structure, an epoxide ring structure at C12-C13 and a double bond at C9-C10. 
Therefore they are called 12,13-epoxytrichothec-9-enes. Trichothecene mycotoxins are 
divided into 4 groups (A, B, C and D) based on the extra functional groups. Due to the 
presence of a carbonyl function at C8, which is of importance for toxicological and 
immunological activity, DON (Figure 1.5B/C) belongs to group B trichothecenes. Next to the 
epoxy and the carbonyl function, the DON molecule consists of 3 extra reactive sites, namely 
the hydroxyl groups on C3, C7 and C15 of which the C3 and C15 hydroxyl groups are 
considered as most chemical reactive [Li et al., 2012; Maragos and McCormick, 2000]. 
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Figure 1.5 General structure of trichothecene mycotoxins (A) and stereochemical configuration (B) versus 
three-dimensional structure (C) of DON  
 
1.3.3 Toxicity 
Acute exposure to DON can lead to reduced food or feed consumption, abdominal distress, 
increased salivation, malaise, diarrhoea, leucopoenia, haemorrhage, shock and death in 
extremely high DON doses. The most common effects of prolonged dietary exposure to DON 
are decreased weight gain, anorexia, altered nutritional efficiency, immune function 
(enhancement and suppression) and reproductive effects (reduced litter size) [Pestka, 2007; 
Maragos and McCormick, 2000; Pestka and Smolinski, 2005]. 
The affection of the immune system with either immune suppressive or immune stimulative 
effects is depending on dose, exposure frequency and timing. A low DON dose leads to the 
transcriptional and post-transcriptional upregulation of the expression of cytokines, 
chemokines and inflammatory genes with concurrent immune stimulation. High DON dose 
exposure promotes leukocyte apoptosis and therefore can lead to immune suppression 
[Dänicke et al., 2006; Krska et al., 2001; Rocha et al., 2005; Murphy et al., 2006; Dietrich et 
al., 2012; De Boevre et al., 2012a; De Boevre et al., 2012b; Zhou et al., 2003]. The 
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response”. Due to the binding of DON to the eukaryotic 60s ribosomal subunit, mitogen-
activated protein kinases (MAPKs) are phosphorylated and subsequently induced. This leads 
to an increase in transcription, messenger ribonucleic acid (mRNA) stability and cell 
apoptosis. Leukocytes, macrophages, B- and T-cells are especially sensitive to trichothecenes, 
like DON. In Figure 1.6, an overview is given of the trichothecene-induced toxicity [Zhou et 
al., 2003; Casteel et al., 2010; Pinton et al., 2012; Pestka et al., 2004]. 
The binding of DON to the eukaryotic 60s ribosomal subunit leads as well to interference of 
the activity of peptidyl transferase and subsequent inhibition of the initiation, elongation and 
termination of protein synthesis. DON is also known to induce DNA damage and cell death 
due to oxidative stress and an increase in ROS levels [Arunachalam and Doohan, 2013]. 
Equal DON toxicity was found within all evaluated animal species, although sensitivity was 
different due to differences in metabolism, absorption, distribution and elimination. The 
susceptibility of animals to DON follows this order: pigs ! mice ! rats ! poultry ≈ ruminants 
[Pestka, 2007].  
Trichothecene dose/duration 
 
Ribosomal/receptor binding ? 
 
                              MAPK activation               p53 
 
Transcriptional activation ↑     mRNA stability ↑      Leukocyte apoptosis ↑ 
 
      Anorexia, reduced weight gain                       Proinflammatory genes↑            Immune suppression 
 
    Immune stimulation/autoimmune effects                          Tissue injury 
Figure 1.6 Mechanisms involved in trichothecene-induced toxicity [Pestka et al., 2004] 
 
1.3.4 Masked forms 
Masked mycotoxins are mycotoxin forms which are undetectable by conventional analytical 
techniques due to their structure change and therefore lead to an underestimation of the 
mycotoxin content. Two types of masked mycotoxins can be distinguished, namely the 
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extractable, conjugated and non-extractable, bound varieties. The extractable conjugated 
mycotoxins can be detected by appropriate analytical techniques when their structure is 
known and analytical standards are available. Bound mycotoxins first need to be liberated 
from the matrix by chemical or enzymatic treatment prior to chemical analysis. The 
conjugation of mycotoxins occurs during metabolic processes in fungi, living plants and 
mammals or during food processing [Berthiller et al., 2009a; Berthiller et al., 2013]. Further 
explanation will be given in relation to the masked DON forms. 
DON derivatives produced during fungal metabolization processes are known as 3-
acetyldeoxynivalenol (3-ADON) and 15-acetyldeoxynivalenol (15-ADON). These DON 
derivatives are originating from 3,15-diacetyl deoxynivalenol and have been reported to occur 
together with DON in many Fusarium-contaminated cereals, but at lower levels [Pestka, 
2010]. The structures of these DON derivatives are presented in Figure 1.7. In 2010 the Joint 
FAO/WHO Expert Committee on Food Additives (JECFA) considered the toxicity of the 
acetylated derivatives equal to that of DON, but a recent study suggested the higher toxicity 
of 15-ADON should be taken into account [Pinton et al., 2012; Berthiller et al., 2009b; Joint 
FAO/WHO Expert Committee on Food Additives (JECFA), 2011]. 
                      
 
Figure 1.7 Chemical structure of 3-ADON (A) and 15-ADON (B) 
 
Plants can protect themselves against mycotoxins, such as DON, by converting them to more 
polar metabolites and therefore inactivate and detoxify the mycotoxins. Miller et al. (1983) 
was among the first speculating increased DON levels due to an enzymatic conversion of an 
unknown precursor (conjugate). Later it was shown that deoxynivalenol-3--glucopyranoside 
(DON-3G) (Figure 1.8) could be formed from DON in maize cell suspension cultures and by 
Arabidopsis thaliana due to the presence of a gene encoding an UDP glucosyltransferase. The 
DON-3G formation is part of phase II reactions occurring in plants. During these reactions, 
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involvement of the specific enzymes glucosyl- and glutathion-S-transferase, respectively. 
Phase II conjugates can be incorporated into the insoluble fraction of the plant cell wall or 
converted into a soluble form and transferred into the plant cell vacuoles (phase III 
metabolism) [Berthiller et al., 2011; Berthiller et al., 2009a; Poppenberger et al., 2003].  
 
Figure 1.8 Chemical structure of DON-3G 
 
Food processing can lead to an enormous increase in the production of masked DON 
conjugates. Lancova et al. (2008b) described a dramatic increase of DON-3G during malting 
and brewing experiments. Compared to the DON-3G content in input barley and malt, an 
increase of maximum 880% was observed. The presence of DON oligoglucosides, like di- and 
triglucosides in malts, beers and bakery products was described by Zachariasova et al. (2012). 
The nature of this increase in conjugated mycotoxins is still not completely known. A first 
explanation could be the production of extra mycotoxins which are efficiently conjugated by 
the metabolically highly active germling. Another possibility is the enzymatic release of 
bound mycotoxins present in the cell wall polymer fraction during the malting process. 
There is concern that the masked DON-3G may be metabolised in the gastro-intestinal tract 
by mammals to DON and thus may contribute to the overall exposure to DON. This could 
increase the risk of exposure to DON levels above the tolerable daily intake (TDI) set by the 
Scientific Committee for Food (SCF) and mentioned in Commission Regulation 
1881/2006/EC [Sasanya, 2008]. 
The mycotoxin conjugates that arise from mammalian metabolism, are not regarded as 
masked mycotoxins as they do not occur in food or feed. Mycotoxins are conjugated by 
mammals during their metabolization in the liver and are further excreted in urine. The 
described DON conjugates found in urine include DON-3-glucuronide and DON-4-sulfate. 
These conjugates can be used as biomarkers of exposure and via this way the total exposure 
of individuals towards certain mycotoxins regardless of their source and form of intake, can 
be monitored. Recently, a study was conducted to evaluate mycotoxin exposure through 
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different age and gender groups and different seasons and years within the Flemish population 
via the use of biomarkers [Heyndrickx et al., 2014]. 
 
1.3.5 Legislation 
In 2000 the European Union launched its “White Paper on Food Safety” as a legal basis for 
appropriate food and feed production and food safety control. This was followed by the 
introduction of the general Food Law in 2002 laying down general principles, procedures and 
requirements to assure and protect the human health in matters of food safety (178/2002/EC). 
One year later, in 2003, the European Food Safety Authority (EFSA) was set up to focus on 
risk assessment and scientific advice in the field of food safety questions. 
In order to decrease the presence of DON in food and feed, the European Commission has set 
maximum levels and guidance levels for mycotoxins in products, respectively intended for 
human consumption (Commission Regulation 1881/2006/EC) and for animal feed 
(Commission Recommendation 2006/576/EC). An overview of the current DON maximum 
levels and guidance values for respectively food and feed is presented in Table 1.2.  
Results from national monitoring programs on the presence of DON in food and feed are to be 
reported on a regular basis at the European level. In 2010, EFSA received a mandate from the 
European Commission to collect and analyse, on a continuous basis, all available data on 
DON in food and feed. The report analysing these data mentions the lack of data on DON-3G, 
3-ADON and 15-ADON in order to characterize their potential contribution to the total DON 
exposure in a more efficient way. However, the EFSA CONTAM expert group on Fusarium 
mycotoxins is currently evaluating the DON masked forms.  
In 2002, the SCF has set a provisional TDI for DON at 1 µg/kg body weight per day. The TDI 
was extended in 2010 by JECFA to the group of DON and its acetyl derivatives 3-ADON and 
15-ADON and laid down an acute reference dose (ARfD) at 8 µg/kg body weight. The 
exposure assessments conducted to date at national or European level concluded that a high 
number of consumers and young children were exposed to DON at levels close to or even 
higher than the TDI [Joint FAO/WHO Expert Committee on Food Additives (JECFA), 2011]. 
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Table 1.2 Overview of the current DON maximum levels for food and guidance values for feed based on 
1881/2006 (EC) and 2006/576 (EC), respectively 
Foodstuffs: maximum levels µg/kg 
- Unprocessed cereals other than durum wheat, oats and maize 1 250 
- Unprocessed durum wheat and oats 1 750 
- Unprocessed maize 1 750 
- Cereals intended for direct human consumption, cereal flour (including 
maize flour, maize meal and maize grits), bran as end products 
marketed for direct human consumption and germ, with the exception 
of foodstuffs listed in 
†
 
750 
- Pasta (dry) 750 
- Bread (including small bakery wares), pastries, biscuits, cereal snacks 
and breakfast cereals 
500 
- † Processed cereal-based foods and baby foods for infants and young 
children 
200 
 
Feed: guidance values relative to a feeding stuff with a moister content of 12% µg/kg 
Feed materials  
- Cereals and cereal products with the exception of maize by-products 8 000 
- Maize by-products 12 000 
Complementary and complete feeding stuffs with the exception of: 5 000 
- Complementary and complete feeding stuffs for pigs 900 
- Complementary and complete feeding stuffs for calves (< 4 months), 
lambs and kids 
2 000 
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1.4 ANALYTICAL METHODS FOR THE DETECTION OF DEOXYNIVALENOL 
AND ITS MASKED FORMS 
Regarding food and feed safety, it is necessary to determine the mycotoxin content in 
different matrices. However, analysing grain samples for the presence of mycotoxins is not 
easy. A good sampling plan, which consists of sampling, sample preparation and analysis, is a 
prerequisite for correct classification of cereal lots. Because of the inevitable errors associated 
with each analysis step, the results should always be reported with an estimate of uncertainty. 
Precision and accuracy are the most important parameters related to the uncertainty. The 
variance (V), standard deviation (SD) and coefficient of variation (CV) are used as a measure 
to determine precision. Accuracy is associated with a bias, which is an influence that causes 
the deviation of the measured value from the true value. The final sample and analysis 
procedure needs to be selected to obtain high precision and high accuracy [Koch, 2004; 
Whitaker and Slate, 2012]. 
 
1.4.1 Sampling 
A first step in the sampling plan is the sample selection. Heterogeneity remains the largest 
problem in mycotoxin analysis and the sampling step is generally considered as the most 
significant source of uncertainty. To overcome the problem of heterogeneous distribution of 
mycotoxins in food and feed, the sample taken for analysis should be an accumulation of 
many small portions (i.e. incremental samples). 
The collection of laboratory samples out of a bulk lot can be performed in two different ways: 
dynamic or static collection. Dynamic sampling is the movement of the lot on a conveyor 
belt; sampling is performed by collecting the increments on different places at a fixed time-
schedule. Static storage in containers, silos, load docks and cargo ships is more frequently 
used. Sampling is more difficult as several increments of all the layers of the bulk need to be 
charged. The mycotoxin concentration of the sample is determined as an estimation of the true 
mycotoxin concentration in the bulk lot or as a comparison to a defined accept/reject limit 
(ARL) that is usually equal to a maximum level or regulatory legal limit. 
To obtain a homogeneous test sample, the different incremental samples need to be blended 
thoroughly. According to IUPAC, the degree of heterogeneity (i.e. opposite of homogeneity) 
is the determining factor of sampling error. Other sources of error and consequently 
uncertainty during the sampling step can be e.g. cross-contamination and the instability of 
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samples. By increasing the size of the sample and reducing the particle size followed by 
efficient mixing, the bias can also be reduced. Other measures to reduce the problem of 
heterogeneity together with sampling protocols are included in European Commission 
Regulation (EC) No. 401/2006 [Maestroni and Cannavan, 2011; Campbell et al., 1986; 
Whitaker and Slate, 2005; Whitaker and Slate, 2012]. 
The relationship between the probability of accepting a lot with a specific mycotoxin 
concentration and the mycotoxin concentration of the bulk lot, is illustrated by the operating 
characteristic (OC) curve (Figure 1.9) [Whitaker and Slate, 2005]. The areas limited by the 
ARL and the OC curve describe the economic risk (Seller’s risk) and the consumer risk 
(Buyer’s risk). The Seller’s risk is the risk of rejecting good lots (false positives) and the 
Buyer’s risk is the risk of accepting bad lots (false negatives). The slope of the OC curve has a 
high economic and health relevance. When designing a sampling plan it is crucial to 
maximize the slope of the OC in order to reduce consumer and producer risks and minimize 
the risk of lot misclassification. The shape of the OC curve is defined by the sample size, 
degree of grinding, subsample size, the number of analysis and the ARL. Therefore these 
parameters can be used to reduce the Buyer’s and Seller’s risks associated with a sampling 
plan [Whitaker and Slate, 2005; Maestroni and Cannavan, 2011]. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.9 Operating characteristic curve for the acceptance probability of mycotoxin sampling in a bulk 
lot, defined with possible outcomes when lots are classified as accepted or rejected (Whitaker and Slate, 
2005). 
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1.4.2 Sample preparation 
The major goal of sample preparation is the elimination of matrix compounds and is a 
challenging process as a diversity of sample matrices can be contaminated with mycotoxins. 
Each sample matrix requires its own optimized sample preparation to generate accurate and 
consistent analytical results. Different conventional and modern sample pretreatment methods 
are currently used in different laboratories. Sample preparation normally includes two steps, 
namely extraction and clean-up. As DON is a polar mycotoxin, it can easily be extracted from 
food and feed matrices by shaking or blending with pure water or mixtures of water with 
other polar solvents such as acetonitrile or methanol. Trenholm et al. (1985) evaluated several 
extraction solvents for DON extraction such as methanol-water (50/50, v/v) or acetonitrile-
water (84/16, v/v) for wheat and maize matrices and acetonitrile was found to lower matrix 
interferences.  
Analyte enrichment is the next critical step after sample extraction. The most important 
procedures employed for clean-up of DON contaminated samples are liquid-liquid extraction 
(LLE), solid-phase extraction (SPE) and use of immunoaffinity columns (IAC). LLE is 
performed by shaking the sample extract with an immiscible solvent and therefore merging 
the analyte to its preferable solvent. SPE can either be used for analyte enrichment or matrix 
elimination. It can be applied as a reversed phase or a normal phase separation. Reversed 
phase SPE is characterized by a polar or moderately polar mobile phase and a non-polar 
stationary phase. In normal phase SPE the stationary phase is polar, while the mobile phase is 
non-polar. Retention of the polar DON analyte in the column takes place due to the 
interaction between its functional groups and the surface of the sorbent.  
When the aqueous sample extract is applied to an IAC, the analyte molecules are bound to the 
antibodies which are linked to an organic carrier material. Subsequent to a washing step the 
toxins can be eluted due to the denaturation of the antibodies by the use of pure organic 
solvents [Krska et al., 2001; Razzazi-Fazeli and Reiter, 2011]. 
 
1.4.3 Chromatographic methods 
Because of the economic importance and from a food safety point of view a variety of 
analytical techniques have been developed for the separation and detection of DON in food 
and feed. Most commonly used chromatographic techniques include thin-layer 
chromatography (TLC), gas chromatography (GC) and liquid chromatography (LC).  
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TLC was the first chromatographic method to be applied for DON determination and is still in 
use in many laboratories. Reagents such as sulphuric acid or para-anisaldehyde are necessary 
to visualize the non-fluorescent and short wavelength (λmax 220 nm)-absorbing DON. In 
addition to the spray reagents which are specific to the 12,13-epoxy group, AlCl3 is the most 
useful visualisation reagent for DON and other type B trichothecenes. TLC is a fast and low 
cost method, but due to low selectivity it is not sufficient for quantitative determination 
[Shephard, 2008; Trucksess et al., 1984; Krska et al., 2001]. Currently used quantitative 
methods for DON analysis include GC or LC based systems coupled to diverse detectors. The 
limitation of a GC method is the necessity of derivatization. Common derivatization reactions 
at the hydroxyl moieties of DON involve the formation of trimethylsilyl (TMS) ethers, or 
trifluoroacetyl, pentafluoropropionyl and heptafluorobutyryl ester derivatives. Methods were 
described using TMS ethers or fluoro acyl derivatives coupled to electron capture detection 
(ECD) [Eskola et al., 2000; Radova et al., 1998; Tacke and Casper, 1996] or mass 
spectrometric detection [Rodrigues-Fo et al., 2002; Black et al., 1987; Mirocha et al., 1998]. 
When using ECD for DON detection a higher background signal and less sensitive results 
were obtained especially in complex samples, compared to MS detection. LC-analysis can be 
performed with fluorescence, ultraviolet (UV) (214-229 nm) or MS detection. For 
fluorescence detection a pre- or post-column derivatization is required, which makes this type 
of detection time-consuming. The use of UV detection is often limited by lack of specificity 
because of the need to use low wavelengths [Sano et al., 1987].  
Over the last few years, LC and GC techniques coupled to mass spectrometric detectors have 
been developed and established. Several of these developed chromatographic methods have 
been recognized as official as they have been interlaboratory validated in terms of 
repeatability, reproducibility, limit of detection (LOD) and limit of quantitation (LOQ). A 
number of international bodies such as Association of Official Analytical Chemists (AOAC), 
the European Committee for standardization (CEN) or the European Commission are 
involved in the validation procedures.   
LC is a dynamic separation technique based on the difference in affinity between the mobile 
phase and the stationary phase. As DON is a small and polar compound, it will be ideally 
separated by the use of reversed-phase LC which is based on the separation of molecules up 
on their interaction with a hydrophobic stationary phase. Mostly, the hydrophobic stationary 
phase consists of silica particles with a diameter of 5 µm or less which surface is modified 
with a hydrophobic layer such as octadecyl (C18) moieties. The DON containing extract is 
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applied on the LC-column in a polar mobile phase. Decreasing the mobile phase polarity by 
adding more organic solvent reduces the hydrophobic interaction between DON and the solid 
support resulting in desorption. The more hydrophobic the molecule, the more time it will 
spend on the solid support and the higher the concentration of organic solvent that is required 
to promote desorption. Therefore DON will be separated from other interfering components 
based on the difference in hydrophobicity [Shephard, 2011]. In recent years, hydrophilic 
interaction liquid chromatography (HILIC) has been successfully applied for the separation of 
various polar components including mycotoxins [Sorensen et al., 2007; Pereira et al., 2009]. 
In HILIC mode, a high concentration (> 70%) organic phase is used as water will not retain 
the polar components on the stationairy phase. Increasing the amount of water will elute 
molecules in order of polarity.  
Mass spectrometry (MS) provides a high detection selectivity owing to the ability to separate 
or filter ions according to their mass-to-charge ratios (m/z). MS includes ionization which 
implies a conversion of molecules into ions in the gas phase. Ionization methods used, are 
electrospray ionization (ESI) and atmospheric pressure chemical ionization (APCI). During 
ESI, the sample is dissolved in a polar solvent and pumped through a stainless steel capillary 
which caries between 2 000 and 4 000 V. The liquid aerosolizes at the exit of the capillary 
where ions leave the desolvating droplets and flow into the MS due to a combination of 
electrostatic attraction and vacuum. APCI differs from ESI as neutral analytes are transferred 
into the gas phase by vaporizing the introduced liquid in a heated gas stream. Both ESI and 
APCI methods were developed for DON identification and quantitation [Monbaliu et al., 
2009b; De Boevre et al., 2012b; Toth et al., 2011]. Literature data also switch between the 
positive and negative ionization mode. Lagana et al. (2003) reported data were the negative 
mode was preferred for type B trichothecenes such as DON, in contrast Bily et al. (2004) and 
Pallaroni et al. (2002) both preferred the use of positive ion mode for DON. 
Prior to detection, the ions are separated based on their m/z value. During this research, a 
Quattro Premier XE MS/MS (Waters, Milford, MA, USA) was applied, consisting of two 
mass analysers or quadrupoles and a T-wave collision cell. Using selected reaction monitoring 
(SRM) a specific precursor ion is selected in the first quadrupole followed by destruction in 
the collision cell. Out of the fragment ions, a specific ion is detected in the second quadrupole. 
Based on the high accuracy and sensitivity of the liquid chromatography-tandem mass 
spectrometry (LC-MS/MS) method in addition to the ability to use internal standards (e.g. 
deepoxy deoxynivalenol (DOM), 
13
C-isotope-labelled internal standard) to correct losses of 
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DON during sample preparation and ion suppression effects in the mass spectrometer, this 
analytical method can be referred as a state-of-art technique for the measurement of DON 
[Langseth and Rundberget, 1998; Neuhof et al., 2009]. Further advantages of LC-MS/MS 
include no need of derivatization prior to analysis, low detection limits, the ability to generate 
structural information of the analytes and the requirement of minimal sample pretreatment 
[Berthiller et al., 2007; Spanjer, 2011]. 
 
1.4.4 Immunochemical methods 
Immunochemical methods occupy a leading place in the screening group of methods for the 
determination of mycotoxins. They offer the advantage of selectivity, sensitivity, simplicity 
and rapidity, which are of importance for routine and on-site testing of mycotoxins. Moreover, 
these methods require simple instruments as most of them are based on photometric, 
fluorimetric, luminescence or electrochemical detection [Maragos and McCormick, 2000; 
Maragos et al., 2006; Maragos et al., 2002; Koppen et al., 2010]. Common disadvantages are 
possible non-specific binding of components and cross-reaction with related compounds 
which can lead to an overestimation of DON-levels (false positive results) in comparison with 
chromatographic methods [Goryacheva and De Saeger, 2011]. Described immunochemical 
methods include enzyme-linked immunosorbent assay (ELISA), membrane-based 
immunoassay such as flow-through assay and lateral flow test, gel-based tests and 
fluorescence polarization. 
 
1.4.4.1 Interaction principle 
The interaction of an antibody with an antigen forms the basis of all immunochemical 
reactions. An IgG antibody, which is the type of antibody mostly used in immunochemical 
reactions, has a typical Y-shape (Figure 1.10) and contains two symmetrical parts each 
consisting of two polypeptide chains, namely a light and a heavy chain connected to each 
other via disulphide bridges between two cysteines. The light and heavy chain have a 
molecular weight of 25 and 55 kDa, respectively, and each chain contains a carboxy-terminal 
and amino-terminal end group. The amino groups of the variable heavy (VH) and light (VL) 
chain form the antigen binding site. The amino acids from the antigen binding site correspond 
to the amino acids of the hypervariable regions, also known as complementarity determining 
regions (CDRs).  
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Figure 1.10 Structure of an IgG antibody 
 
Interactions between the epitopes of the antigen and the CDRs of the antibody take place 
through physical non-covalent bonds, namely Coulombic bonds, Van Der Waals forces, Ca
+2
-
bridges and/or hydrogen bonds. An important property of antigen-antibody interaction is the 
affinity, which is the strength of the binding between the antigen and the antibody. As seen in 
the equilibrium reaction below, the affinity can be measured by the equilibrium constant (Keq) 
or dissociation constant (KD), which represents a measure of stability. At the beginning of an 
antigen-antibody binding, the reaction proceeds predominantly in one direction, but the 
reverse rate progressively increases until the forward and reverse speeds are equal. At this 
point, the reaction is said to have reached its equilibrium. At equilibrium, the ratio between 
the concentrations of the antigen-antibody complex and free antigen and antibody is constant 
and is characterized by Keq (Equation 1.1), which typically assumes a value around 10
8
 and 
10
10
 and is the ratio of the dissociation (kd) and association (ka) rate constants. The constant 
Keq is related to the change in free energy via Equation 1.2. In order for a reaction to proceed 
spontaneously, the free energy change must be negative. Therefore the higher the Keq, the 
more negative the free energy change and the more preferable the antibody-antigen complex 
formation will be. Parameters that may be modulated to influence the affinity are: the surface 
tension, pH, ionic strength, dielectric constant and temperature.  
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Equilibrium reaction 1.1 Antibody   Antigen      
  Antibody-Antigen complex 
 
Equation 1.1  
[Complex]
[Antigen][Antibody]
   
ka
kd
   e    
 
 D
 
 ka is the association constant, kd is the dissociation constant and Keq is the equilibrium constant 
Equation 1.2  ln ( e )   - 
  
R   T
 
Keq is the equilibrium constant, G is the free energy change, R is the universal gas constant (= 8.314472 J K
-1
 
mol
-1
) and T is the temperature (310 K at 37 °C) 
 
Another important property in the antigen-antibody interaction is the specificity, which is a 
measure of the selectivity of the interaction between the antigen determinant and antibody-
active sites compared to other chemically similar molecules. The ability of an antibody to 
react with similar antigenic sites on different substances is called cross-reactivity [Harlow and 
Lane, 1988; Reverberi and Reverberi, 2007; Vanoss et al., 1986].  
 
1.4.4.2 Enzyme-linked immunosorbent assay 
In ELISA, the antigen-antibody interaction procedure is performed in 96-well polystyrene 
plates, where one of the immunoreagents is usually immobilized on the bottom and walls of 
the wells for separation of bound and free reagents. There are two main forms of ELISA, 
namely the direct and indirect form and each of them can be performed in a competitive or 
non-competitive way. The term competition describes an assay in which measurement 
involves the quantification of a substance by its ability to interfere with an established 
concentration of standard antigen [Goryacheva and De Saeger, 2011]. The principle of the 
different ELISA formats specific for DON screening is further explained.  
For DON measurement using direct ELISA (Figure 1.11A), secondary antibody is coated to 
microtitre plates followed by the addition of primary anti-DON antibody. After DON is 
extracted from a ground sample with solvent, a portion of sample extract and an enzyme-
coupled DON conjugate are added to the plate. Any DON in the sample extract or control 
standard is allowed to compete with the enzyme-conjugated DON for the antibody binding 
sites. A blue colour is developed in the plate when adding an enzyme substrate and the 
intensity of the colour is inversely proportional to the concentration of DON in the sample or 
standard. After stopping the enzyme reaction, the colour is optically measured using an 
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ELISA reader at a wavelength of 450 nm. The optical density (OD) is determined and 
compared to the ODs of the standards. For the indirect ELISA (Figure 1.11B), DON extracted 
samples or DON standard is added together with the primary anti-DON antibody to a 
microtitre plate coated with DON-protein conjugate. This reaction is followed by the addition 
of enzyme-coupled secondary antibody. The colour development and measurement occurs in 
the same way as for direct ELISA [Zheng et al., 2006; Goryacheva et al., 2009].  
Currently, commercial ELISA test kits are available for the determination of DON 
contamination in several cereal target commodities (cereals, food, feed and beer). An 
overview of different commercially available ELISA test kits, namely RIDASCREEN
®
 DON 
(r-Biopharm, Darmstadt, Germany), Deoxynivalenol EIA (Eurodiagnostica, Arnhem, The 
Netherlands), Veratox
®
 5/5 quantitative DON test (Neogen, Anderlecht, Belgium) and 
AgraQuant
® 
DON (Romer Labs, Tulln, Austria) is shown with its major characteristics in 
Table 1.3. As seen, all of them are characterized by cross-reactivities towards the masked 
mycotoxins 3-ADON, 15-ADON and/or DON-3G. Even though these masked forms are not 
mentioned in current legislation (Commission Regulation 1881/2006/EC for food and 
Commission Recommendation 2006/576/EC for feed), based on the available toxicity data, it 
is important to measure their occurrence in food and feed [Goryacheva et al., 2009; 
Zachariasova et al., 2008]. ELISA test kits were validated for DON detection in several target 
commodities by several authors as mentioned in Table 1.3 [Lupo et al., 2010; Yoshizawa et 
al., 2004; Papadopoulou-Bouraoui et al., 2004; Zachariasova et al., 2008]. Validation 
generally includes the evaluation of the analytical range, detection limit, sensitivity, accuracy 
and precision as enforced by the AOAC. 
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Figure 1.11 Competitive direct (A) and indirect ELISA (B) using anti-DON antibody 
    A 
    B 
 
Chapter 1: General introduction and principles 
39 
 
Table 1.3 Overview of commercial ELISA test kits for DON determination [Zachariasova et al., 2008] 
ELISA kit Linear range 
(ng/mL) 
Cross-reactivity (%) Target commodities 
  DON 3-ADON 15-ADON DON-3G  
RIDASCREEN
® 
DON 
 
3.7-100 100 >100 19 n.a. cereals, malt, feed 
and beer  
Deoxynivalenol EIA 
 
0.313-10 100 230 <0.1 115 cereals, food, feed, 
beer and silage 
Veratox
®
 5/5-
quantitative DON 
test 
25-200 100 40 0 157 wheat, barley, maize, 
malted barley, oats 
and rice  
AgraQuant
®
 DON 
assay 0.25/5.0 
12.5-250 100 770 2 52 wheat, barley, maize, 
oats, malted barley, 
rice and wheat flour  
 
1.4.4.3 Membrane-based immunoassay 
The flow-through assay and lateral flow test are the two most popular types of membrane-
based immunoassay. The flow-through assay (immunofiltration test or immunofiltration assay 
or enzyme-linked immunofiltration assay) is based on the direct competitive ELISA principle 
with an anti-DON antibody-coated membrane surface. In contrast, the lateral flow test (strip 
test or dipstick test) is a membrane-based immunoassay format which consists of one step and 
does not require special instrumentation or reagents.  
The procedure specific for DON screening by lateral flow test is the following. Firstly, a 
sample extract is added by dipping the strip test into the test sample or by dropping the sample 
onto the sample pad. Any DON present will bind to the anti-DON antibody colloidal gold 
particles present in the conjugate pad and as a complex they migrate along the membrane. 
When they pass the test zone containing DON-protein conjugate, free anti-DON antibody 
gold particles can be captured allowing coloured particles to concentrate and form a visible 
line. For negative samples (DON level lower than cut-off level) a colour will be developed. 
No coloured line will appear in the test zone for positive samples (DON level higher than cut-
off level). Further on, a control zone is present which contains secondary antibody, which will 
be visible due to the anti-DON antibody gold particle-secondary antibody complex. 
Chapter 1: General introduction and principles 
40 
 
Confirmation of DON contamination can be performed by chromatographic analytical 
methods.  
Several strip tests for DON determination have been developed and commercialized. 
Kolosova et al. (2008) describes the development of a lateral-flow colloidal gold-based 
immunoassay for DON determination using two different indicator ranges, namely 250-500 
and 1 000-2 000 µg/kg. A multiplex dipstick was developed by Lattanzio et al. (2012) for the 
simultaneous determination of zearalenone, T-2/HT-2 toxin, DON and fumonisins in wheat, 
oats and maize. Cut-off levels for DON were set at 1 400 µg/kg for all different food 
commodities [Zheng et al., 2006; Goryacheva and De Saeger, 2011]. Commercially available 
lateral flow test strips include RIDA
®
QUICK DON (r-Biopharm, Darmstadt, Germany) with a 
cut-off value of 0.5 mg/kg and validated for wheat, triticale and maize samples. The same cut-
off level is mentioned for the AgraStrip
® 
Quantitative DON test (Romer Labs, Tulln, Austria) 
using wheat samples. For maize samples a lower cut-off value of 0.2 mg/kg is described. 
Other commercial strip tests (DONCheck
TM
, Cereal tester, Fleurus, Belgium and 
Deoxynivalenol test stip, Abraxis, Warminster, UK) have a higher cut-off value of 1 mg/kg. 
Until now, only the use of colloidal gold particles was described for DON detection. Usleber 
et al. (1993) described the use of enzymes instead of colloidal gold as a label for the detection 
of 15-ADON. This could increase the sensitivity of the strip test to a detection limit of 5 
ng/mL, even though extra steps were necessary during the measurement such as a washing 
and substrate addition step [Goryacheva and De Saeger, 2011].  
 
1.4.4.4 Gel-based tests 
The carrier membrane of a membrane-based immunoassay can be replaced by a sepharose gel 
to reduce matrix effects and increase assay sensitivity. The sepharose gel contains the 
immobilized anti-DON antibodies and is present in a small plastic cartridge as for SPE. When 
applying a sample extract on the column, the DON present in the extract binds to the antibody. 
Similar to the membrane-based assay, competition for binding with the antibody will be 
induced by adding DON-enzyme conjugate. A chromogenic substrate will induce colour 
development. Next to DON determination, the gel-based column can be used as an 
immunoaffinity column taking care of separation and preconcentration of DON analyte 
[Goryacheva and De Saeger, 2011; Schneider et al., 2004; Zheng et al., 2006]. 
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Immunoaffinity columns are just like ELISA test kits and membrane-based immunoassays 
commercially available and validated for several food and feed matrices.  
 
1.4.4.5 Fluorescent polarization 
In the fluorescence polarization immunoassay format, DON present in the sample extract and 
DON labelled with fluorophore compete for anti-DON antibody binding sites. When DON-
fluorophore binds to the antibody, the rotation of the tracer molecule is affected and therefore 
changes the orientation of fluorescence. Subsequently, polarization is determined and is 
inversely proportional to the amount of DON present in the sample. The differences with 
ELISA are that no enzyme reaction is involved and no separation of bound and free 
compounds is needed. Maragos and Plattner (2002) compared the use of fluorescent 
polarization with LC-UV for the determination of DON in wheat samples. Recoveries of   
71.2% were determined when using fluorescent polarization immunoassay and a linear 
correlation between DON measured with fluorescent polarization and with LC-UV was found 
according to the correlation coefficient r (0.967), proving the working of fluorescent 
polarization for the screening of DON in wheat samples [Zheng et al., 2006; Schneider et al., 
2004; Maragos et al., 2002].  
 
1.4.4.6 Other emerging technologies 
In the last 20 years, the development of biosensors increased significantly due to the high 
demand for rapid and accurate methods to detect mycotoxins. Biosensors involve biological 
recognition elements such as enzymes, antibodies, nucleic acids or artificial receptors coupled 
to a transducer to translate a biochemical signal into a quantifiable electronic signal. 
Depending on the type of transducer, four groups of biosensors are mostly used for DON 
detection: colorimetric, surface plasmon resonance (SPR) sensors, mass-sensitive quartz-
crystal microbalance (QCM) sensors and electrochemical sensors using amperometric, 
potentiometric or conductometric detection. During this research SPR was applied and will 
therefore be discussed in detail. 
The use of an affinity-based SPR sensor system with less demanding sample clean-up steps as 
for other analytical methods, might be a useful alternative for screening and cost effective 
quantitative determination. SPR has been successfully used for many years in biochemical 
research, but is a quite new technique in food and feed analysis.  
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SPR is based on the measurement of interaction of light with the captured biomolecule on the 
sensor surface (Figure 1.12). The sensor glass surface consists of a thin gold film, where 
dextran molecules are attached to to be able to bind molecules and to make the surface 
hydrophilic. Biacore
®
 technology is based on the SPR principle and the most versatile sensor 
chip used herein is the CM5 chip (GE Life Sciences, Diegem, Belgium), which consists of 
carboxymethylated dextran where molecules can be covalently coupled via amine, thiol, 
aldehyde or carboxyl groups.  
At the interface between the two transparent media of different refractive indices, namely 
glass (high refractive index) and aqueous buffer (low refractive index), light coming from the 
side of higher refractive index is partly reflected and partly refracted. At a certain incident 
angle of polarized light, known as resonance or SPR angle, light is adsorbed by electrons 
(plasmons) in the metal film of the sensor chip, causing them to resonate. This results in a 
decrease in the reflected light intensity, which can be seen as a dark band that is displayed as a 
dip (angle shift) in the SPR reflection intensity curve. The shape and position of the registered 
dip provides information about the sensor surface. When an antigen-antibody interaction 
occurs at the sensor surface, the resonance angle position of the dark band changes due to a 
change in refractive index of the buffer solution, causing a shift in the SPR intensity curve. 
The resonance angle change is proportional to the amount of bound antigen-antibody. A 
sensorgram is built up out of the continuous monitoring of the resonance angle plotted as 
response units (RU) in function of time and delivers kinetic information of the antibody (i.e. 
affinity, selectivity) [Zheng et al., 2006; Schneider et al., 2004; Teeparuksapun, 2013; 
Schnerr et al., 2002; Vidal et al., 2013].  
Research in using SPR technology for DON analysis by using anti-DON antibodies has been 
conducted and some results are quite promising. Schnerr et al. (2002) reports the use of a 
DON-biotin conjugate immobilized on a streptavidin coated SPR sensor surface. Wheat 
extracts were mixed with polyclonal anti-DON antibody and injected over the sensor surface 
of the Biacore
®
 device. An LOD value of 2.5 pg/µL (corresponds to 7.5 µg/kg in naturally 
contaminated wheat samples) and an half-maximal inhibitory concentration (IC50) value (i.e. 
measure for sensitivity) of 0.72 µg/mL was determined. The assay had a working range 
between 0.13 and 10 µg/mL, equivalent to 390 and 3 000 µg/kg of DON in wheat samples. 
Regeneration of the sensor surface to remove polyclonal antibody was performed using 6 M 
guanidinechloride in 10 mM glycine (pH 2.9). In Tudos et al. (2003), the use of a DON-
casein sensor with monoclonal anti-DON antibody is described. An SPR system with an even 
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lower working range of 2.5 – 30 ng/mL was established, making it possible to quantify very 
low DON contamination levels. This was also done by Kadota et al. (2010) using a DON-
BSA immobilised SPR sensor chip, obtaining an IC50 value of 14.9 ng/mL. A linear 
correlation (r = 0.98) was even found between the DON determined by LC-MS and SPR for 
several matrices, namely durum wheat, wheat-based breakfast cereals, maize, maize-based 
baby food and oats [Meneely et al., 2010].  
 
                   
Figure 1.12 (A) Polarized light is applied on the surface of the sensor chip and is reflected. The intensity of 
the reflected light is reduced at a certain incident angle, the resonance or SPR angle. (B) Interacting 
substances near the surface of the sensor chip increase the refractive index, which alters the SPR angle. (C) 
A sensorgram is built up out of the continuous monitoring of the resonance angle plotted as response units 
(RU) in function of time. 
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Molecular imprinted polymers (MIPS) are alternative biomimetic receptors currently being 
researched. A MIP is a polymer in which monomers are polymerized in the presence of a 
template molecule. After removal of the template, binding sites or cavities containing 
functional groups remain which show an enhanced affinity for the chosen template molecule. 
MIPS are not only used for SPE of mycotoxins, but also in detection systems such as the 
described biosensors. Choi et al. (2011) describe the use of MIP technology for the detection 
of DON using an SPR transducer. As a result, DON was able to be detected between 0.1 and 
100 ng/mL. The selectivity or specificity of the MIPS is improved compared to antibodies, 
but still not optimal as cross-reactivities were determined against 3-ADON and 15-ADON of 
respectively 19% and 44% [Goryacheva and De Saeger, 2011; Zheng et al., 2006]. The 
commercially available AFFINIMIP
®
 Deoxynivalenol (Polyintell, Val-de-Reuil, France) was 
recently developed for SPE applications in wheat, maize and oats matrices.  
Another alternative for antibodies are aptamers. Aptamers are single-stranded 
oligonucleotides selected in vitro to bind to molecular targets ranging from large proteins to 
small molecules such as mycotoxins. The selection process used is the systematic evolution of 
ligands by exponential enrichment (SELEX). While antibodies have been the standard for 
several decades, aptamers have emerged owing to inherent advantages with respect to 
antibodies: immunization of animals is not required, they are more chemically and thermally 
stable, they are particularly useful in presence of organic solvents used for the extraction of 
mycotoxins [Vidal et al., 2013; Goryacheva and De Saeger, 2011]. In literature no aptamers 
against DON are described, even though a patent filed at 25
th
 of November 2011 (patent 
number CN102559686A) mentions the invention of a DON aptamer and describes its 
applications [Shuqing et al., 2012].  
  
1.4.5 Analytical methods for the detection of masked deoxynivalenol forms 
The structural differences of the masked 3-ADON, 15-ADON and DON-3-G compared to 
their parent DON, induce changes in the physicochemical properties, such as solubility and 
polarity leading to differences in suitable experimental conditions for extraction and 
chromatographic analysis. Generally, two different approaches may be followed for the 
determination of masked mycotoxins: (a) the use of an analytical technique able to directly 
detect them (direct methods); or (b) the conversion of the masked mycotoxins into their parent 
forms by enzymatic/acidic/basic hydrolysis before the analysis (indirect methods). 
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For the sample preparation of masked DON forms, several researchers investigated the use of 
extraction solvents containing acetonitrile and water in different ratios, eventually acidified 
with acetic acid and/or formic acid and combined with a clean-up step using SPE or IAC 
[Berthiller et al., 2005; Sasanya, 2008; Berthiller et al., 2007; Zachariasova et al., 2010; 
Vendl et al., 2010]. Most emerging analytical methods are based on simple and rapid 
extraction procedures coupled to very selective and sensitive MS hyphenated 
chromatographic analysis without any clean-up steps [De Boevre et al., 2012b]. In this 
context, a modified QuEChERS (quick easy cheap effective rugged and safe) sample 
preparation procedure, based on the partition between water and acetonitrile by the addition of 
salt mixtures (NaCl and MgSO4), was recently proposed in combination with MS. 
Unfortunately, DON-3G showed poor recovery value, probably because of its high polarity 
which does not effectively allow the transfer into the acetonitrile layer [Zachariasova et al., 
2010; Cirlini et al., 2012]. The majority of the described chromatographic methods use the 
direct approach for the determination of 3-ADON, 15-ADON and DON-3G as all three 
masked forms are commercially available as reference standards.  
The use of immunochemical methods for the detection of the masked DON forms is based on 
the antibody characteristics. Monoclonal antibodies with specificity against 3-ADON were 
reported by Maragos and McCormick (2000) and Maragos et al. (2006) with cross-reactivities 
against DON and 15-ADON less than 15.9% and 2.5%, respectively. Other reported 
monoclonal antibodies showed higher cross-reactivity and therefore no specificity against one 
of the masked DON forms. Therefore, the sum of DON and its masked forms are determined 
instead of its individual occurrence. As an alternative, indirect detection approaches were 
described. Trifluoromethanesulfonic acid (TFMSA) was used by Zhou et al. (2008) and Tran 
and Smith (2011) to acidic hydrolyze the masked DON-3G conjugate and to measure total 
DON concentration in barley, wheat and maize. TFMSA was reported as alternative for 
trichloroacetic acid (TCA) and trifluoroacetic acid (TFA) as the latter demanded very high 
reaction temperatures (> 130 °C). After TFMSA acidic hydrolysis, a DON increase of up to 
75% was observed. Alternative DON-3G hydrolysis was performed under enzymatic 
conditions e.g. by the use of 1,3--glucanase [Nielen et al., 2014]. Deacetylation of 3-ADON 
and 15-ADON to its parent mycotoxin was described as well by the use of enzymes, more 
specific by acetyl esterase [Mills et al., 1990].  
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1.5 DEVELOPMENT OF MONOCLONAL ANTIBODIES 
Monoclonal antibody production by somatic cell fusion or hybridoma technology was 
introduced by Köhler and Milstein in 1975 and is still the most common method for antibody 
development [Kohler et al., 1976]. The technique involves the fusion of a normal antibody-
producing B-cell with a myeloma cell to produce a hybrid cell or hybridoma. The hybridoma 
would possess the immortal growth properties of the myeloma cell while secreting the 
antibody produced by the B-cell. The resulting hybridoma could be cultured to provide 
polyclonal antibodies reacting against different antigens or different epitopes on a particular 
antigen. After screening and selection, a single hybridoma cell line is obtained producing 
large amounts of monoclonal antibodies. An overview of the general hybridoma production 
and monoclonal antibody development process is given in Figure 1.13.  
 
 
Figure 1.13 Stages of hybridoma production and monoclonal antibody development 
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1.5.1 Immunization 
Antigens with a molecular weight below 1 000 Da (e.g. mycotoxins) are not immunogenic. 
They can be made immunogenic by coupling the analyte to a carrier high-molecular weight 
molecule (protein) such as bovine serum albumin (BSA), ovalbumin (OVA) or keyhole limpet 
haemocyanin (KLH). Several research groups already synthesized various DON immunogens 
by the synthesis of a linker between the C3 and/or C15 chemical reactive hydroxyl group of 
DON and a protein. Linkers include hemisuccinates, hemiglutarates or direct linkages using 
the carbodiimide reaction [Casale et al., 1988; Sinha et al., 1995; Usleber et al., 1991; Clare 
Mills et al., 1990] resulting in one end product or a mixture of DON conjugates. As both 
hydroxyl groups are of similar chemical reactivity, the production of a single linker product is 
possible by the use of  a protection scheme [Casale et al., 1988] or the use of an acetyl DON 
derivative followed by deacetylation [Clare Mills et al., 1990]. All of them describe the use of 
rabbits or mice as laboratory animals for the immune response generation. Other chemical 
reactive groups for the formation of a linker are the C8 carbonyl and C12-C13 epoxide groups. 
Previous researchers mentioned the use of carboxymethoxylamine hemihydrochloride for the 
coupling of the carboxymethyl oxime (CMO) linker at the C8 carbonyl function of DON 
[Casale et al., 1988; Usleber et al., 1991]. Until now, the production of specific DON-
antibodies by immunization of C8 coupled DON immunogens in rabbits, mice and guinea pigs 
failed. This could indicate the immunogenic importance of the C8 carbonyl for the generation 
of type B trichothecene antibodies.  As the epoxide group of DON determines its toxicity and 
therefore its immunostimulative effect, no immunogens are described linking DON via its 
epoxide group to a protein [Karlovsky, 2011].  
Injection of an immunogen requires the presence of an adjuvant, which enlarges the humoral 
antibody responses based on up to five of the following mechanisms of action: the “depot” 
effect, the antigen presentation effect, the antigen distribution or targeting effect, the immune 
activation/modulation effect and the cytotoxic lymphocyte (CTL) induction effect. Freund’s 
adjuvant is considered as the gold standard of adjuvants by many immunologists as the 
general immunostimulatory properties have not been surpassed by any adjuvant. 
Unfortunately, the use of Freund’s complete adjuvant (FCA) has been associated with a 
variety of lesions including localized injection site granulomas; subpleural, pleural, hepatic 
and renal granuloma formation; necrotizing dermatitis; and spinal cord compression from an 
injection site granuloma. This has led to numerous regulatory guidelines and 
recommendations concerning the use of FCA in laboratory animals. The Aviation 
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Rulemaking Advisory Committee (ARAC) guidelines for the use of adjuvants in research 
describe the use of alternatives for Freund’s adjuvant such as other water-in-oil or oil-in-water 
emulsions, aluminium compounds or microparticles such as liposomes which serve as depot 
adjuvants. Guidelines are formulated as well for the correct preparation and injection of 
immunogens containing FCA. Examples of recommendations include the use of 
concentrations lower than 0.1 mg/mL of mycobacterial components and the preference of 
subcutaneous or intraperitoneal injection instead of other routes of injection [Stills, 2005; 
Harlow and Lane, 1988].  
During the period of animal immunization, it is important to collect blood from the animal 
and to measure the serum titre with indirect ELISA after each boost injection to monitor the 
production of anti-DON antibodies. The obtained results will influence the decision to 
proceed with the fusion or to boost again. Figure 1.14 shows the kinetics of a typical immune 
response. Primary responses are often very weak. The humoral responses to the second and 
subsequent boosts are totally different. In this stage, the production of IgG antibodies 
increases exponentially, while the IgM fraction decreases [Harlow and Lane, 1988].  
 
 
                                  Primary injection                         Secondary injection 
Figure 1.14 Kinetics of immune response during immunization  
  
1.5.2 Hybridoma production and screening 
Once a good immune response has been obtained, the construction of hybridomas is ready to 
start. Antibody-secreting cells are isolated from the appropriate lymphoid tissue, mixed with 
myeloma cells, centrifuged to generate good cell-to-cell contacts and fused by using 
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and therefore makes the aqueous phase less polar and facilitates the solvation of lipid 
molecules creating a defect in the cell membrane bilayer. With the reduction of the 
electrostatic and hydration repulsion between bilayers due to the decrease in polarity of the 
medium, contact and fusion of the bilayers proceeds. Removal of PEG by dilution, leads to 
the fusion of intra-membrane particles (IMP) formed during the cell fusion process due to the 
replacement of PEG by isotonic buffer [Hui and Boni, 1990; Ahkong et al., 1987].  
The bone marrow and thymus constitute the primary lymphoid tissues and are responsible for 
the production and maturation of B-cells (B-lymphocytes or antibody-secreting cells). After 
maturation, B-cells join the blood system and travel to the secondary lymphoid organs, 
namely the lymph nodes and the spleen where the B-cells become activated by the 
presentation of antigens by macrophages and dendritic cells. As the spleen can be considered 
the largest mass of activated B-cells, this organ is used for cell fusion and hybridoma 
production. 
Spleen cells alone can not survive in vitro and therefore need to be fused with myeloma cells. 
MOPC-21 was the first myeloma cell line used for spleen fusion experiments [Potter et al., 
1965]. As these cells are IgG producers just like spleen cells, mixed antibodies with dual 
specificity were derived after cell fusion. As a solution for this problem, Köhler et al. (1976) 
described a variant of MOPC-21 (P3-NS1-Ag4-1; abbreviated NS1) which lacked heavy 
chain synthesis due to a 50 pair deletion in the VH framework region. Although NS1 myeloma 
cells could still make light chains, they were intracellular degraded and not secreted. The NS1 
light chains could be rescued by binding to the introduced spleen heavy chains giving a not 
correctly folded and non-functional antibody. Subsequently several cell lines have been 
produced which synthesize neither heavy nor light chains, but which allow the production of 
antibody secreting hybridomas after spleen cell fusion [Goding, 1993]. These myeloma cell 
lines include Sp2/0-Ag-14 [Shulman et al., 1978], X63-Ag8.653 [Kearney et al., 1979] and 
NS0/1 [Galfrè and Milstein, 1981].  
After the cell fusion procedure, fused cells (hybridomas) can be selected using hypoxanthine, 
thymidine and aminopterine (HAT). Used myeloma cell lines are deficient in hypoxanthine 
phosphoribosyltransferase (HPRT) or thymidine kinase (TK) required for the salvage pathway 
of nucleotide synthesis and will therefore die in HAT-containing medium because 
aminopterin blocks the normal nucleotide synthesis and the enzyme deficiency blocks 
utilization of hypoxanthine or thymidine in the salvage pathway. If myeloma and B-cells fuse, 
the resulting hybridoma will live indefinitely in culture because the B-cell supplies the 
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missing enzyme for selection in HAT-containing medium and the myeloma cell immortalizes 
the cell line. Unfused B-lymphocytes will only survive in vitro for approximately 1 week 
before they die [Harlow and Lane, 1988; Grimaldi and French, 1995]. An overview of the 
salvage pathway for nucleotide synthesis by using HAT is given in Figure 1.15. 
After the production and culturing of the hybridoma in an appropriate medium, hybridoma 
need to be screened for the successful generation of high-affinity analyte-specific monoclonal 
antibodies. An ideal hybridoma screening method should be fast, reliable and easy to 
accomplish. For generating monoclonal antibodies against low-molecular-weight analytes 
(haptens, e.g., pesticides, antibiotics and mycotoxins), one of the traditional methods for 
hybridoma screening is homologous indirect ELISA, i.e. the linker or spacer arm between the 
analyte and the protein of the coating antigen is the same as the immunogen. However, by 
doing so, a high proportion of false positives are frequently encountered [Cervino et al., 2008]. 
The problem can be associated with the fact that many of the initially selected positive clones 
could have strong affinity to the spacer arms or the whole analyte-linker regions, which leads 
to poor or even no inhibition by the free target compounds [Kim et al., 2003]. Since hapten 
heterology is often employed to modify the performance of competitive immunoassay for 
small molecules [Kim et al., 2003; Wang et al., 2011], it can also be introduced into the steps 
of hybridoma selection. To date, using heterologous ELISA for hybridoma screening is 
limited to very few kinds of monoclonal antibody generation [Liu et al., 2010; Muldoon et al., 
2000; Shim et al., 2010; Wang et al., 2010]. During this research, homologous and 
heterologous ELISA were used and evaluated for the hybridoma screening.  
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Figure 1.15 Salvage pathway for nucleotide synthesis using HAT. The ribonucleotide inosine 
monophosphate (IMP) forms the starting point for the synthesis of purine nucleotides, including adenine 
and guanine nucleobases. Orotidine monophosphate (OMP) forms the last intermediate in the biosynthesis 
of pyrimide nucleotides, including uracyl, cytosine and thymine nucleobases.  
Adenosine monophoshate (AMP), adenosine diphosphate (ADP), deoxyadenosine diphosphate (dADP), deoxyadenosine 
triphosphate (dATP), guanosine monophosphate (GMP), guanosine diphosphate (GDP), deoxyguanosine diphosphate 
(dGDP), deoxyguanosine triphosphate (dGTP), uridine monophosphate (UMP), uridine triphosphate (UTP), cytidine 
triphosphate (CTP), deoxycytidine diphosphate (dCDP), deoxycytidine monophosphate (dCMP), deoxyuridine 
monophosphate (dUMP), deoxythymidine monophosphate (dTMP), deoxythymidine diphosphate (dTDP), deoxythymidine 
triphosphate (dTTP), deoxycytidine triphosphate (dCTP), deoxyribonucleic acid (DNA). 
 
1.5.3 Antibody purification 
Antibody purification involves the enrichment or isolation of monoclonal antibodies from cell 
culture supernatant. Three different purification techniques exist based on physicochemical 
fractionation, class-specific affinity and antigen-specific affinity. Physicochemical 
fractionation includes size-exclusion chromatography (SEC), ammonium sulfate precipitation, 
ion exchange chromatography (IEC) and immobilized metal-ion affinity chromatography 
(IMAC). SEC is based on the separation of components by their molecular weight and 
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therefore antibodies can not be separated from proteins or other macromolecules present in 
the supernatant. Adding 40-50% of ammonium sulfate to the hybridoma supernant will salt 
out the present antibodies while other proteins or non-protein components remain in solution. 
Alternatives for ammonium sulfate include PEG and caprylic acid. Most often, this kind of 
purification is performed prior to column chromatography to improve the performance and 
extend the lifetime of the column. During IEC, buffers with different pH are used to positively 
or negatively charge proteins and withhold them on a conversely loaded column. The 
mechanism of IMAC is based on the interaction of proteins or peptides containing histidine 
residues to the nickel (Ni
2+
) atoms on the column [Ayyar et al., 2012]. The strategy is most 
often used to purify recombinant antibodies as they contain a terminal hexahistidine (HIS) tag. 
In the second purification technique, antibody separation is based on its affinity towards 
protein A, G or L. Protein A and G interact with the heavy constant region, whereas protein L 
has affinity towards the kappa light chain of an antibody. To accomplish antibody purification, 
protein A, G, A/G or L need to be covalently immobilized onto porous resins, such as agarose, 
or magnetic beads. The last purification format is based on antigen-specific affinity and for 
this kind of purification the antigen coupled to a protein is coated onto a surface.  
For purification like IEC, IMAC or affinity purification using protein A, G, A/G or L 
prepared purification columns are commercially available for the manual or automatic 
purification using fast protein liquid chromatography (FPLC). 
The choice of antibody purification method depends on several factors such as the species and 
the intended use. Bergmann-Leitner et al. (2008) evaluated the use of protein G sepharose, 
protein A/G sepharose, PEG and caprylic acid-ammonium sulfate precipitation. The highest 
yield and purity of antibody was obtained using either protein G, protein A/G or caprylic acid-
ammonium sulfate precipitation for rabbit antibody purification, leaving functional antibodies. 
For human antibody purification, PEG precipitation leads to a concentrated antibody solution 
having high recovery rates and yields and an enhanced specific activity. For this origin of 
antibodies, protein G and protein A/G purification methods yielded statistically less functional 
antibody activities compared to the source material. The human or rabbit antibody avidity did 
not decrease during all purification methods.  
For the purification of anti-DON monoclonal antibody, several purification methods are 
described. Maragos and McCormick (2000) describe the use of ammonium sulfate 
precipitation after lipoprotein removal by 5% sodium dextran sulfate and 11.1% calcium 
chloride for the purification of a developed anti-DON antibody. Other researchers describe the 
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single use of ammonium sulfate precipitation for anti-DON antibody purification [Casale et 
al., 1988]. The use of affinity chromatography using protein A or G results also in pure and 
functional anti-DON antibodies [Kohno et al., 2003; Xu et al., 2010].  
 
1.5.4 Antibody characterization 
Most important parameters which need to be determined for the characterization of a purified 
monoclonal antibody include the antibody sensitivity and selectivity. Characterization is 
performed by the use of indirect or direct competitive ELISA or via the use of SPR 
technology. Calibration curves are set up where the absorbance values at 450 nm (for ELISA) 
or response units (for SPR) are set out in function of the competitor (antigen) concentration. 
Using this curve, the linear range for detection and the IC50 value as a measure for the 
antibody sensitivity can be determined. The selectivity of the antibody (or cross-reactivity) is 
measured by comparing IC50 values of chemical structurally related competitors. 
Different researchers described the development and characterization of monoclonal anti-
DON antibodies and an overview of the different antibodies with their IC50 values and cross-
reactivities to structurally similar trichothecenes is presented in Table 1.4. As seen, for all of 
them cross-reactivities towards the masked mycotoxins 3-ADON, 15-ADON and/or DON-3G 
were observed, which is similar to the conclusion taken for the commercially available DON 
ELISA test kits (1.4.3.2). Even though legislation only considers sole DON levels, EFSA 
opinion highlights the importance of the determination of the total DON content of food and 
feed including its masked forms.  
Another possible way to determine the sum of DON and its acetylated derivatives is 
mentioned by Xu et al. (1988) and Kohno et al. (2010). They reported the development of an 
antibody against tri-acetyl-DON, making it possible to determine the sum of DON and its 
acetylated derivatives after acetylation of all hydroxyl functions by the use of acetic anhydride.  
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Table 1.4 Overview of anti-DON antibodies: IC50 and cross-reactivity (CR) values 
 
 
 
 
Trichothecene 
[Maragos and 
McCormick, 2000] 
USDA Clone 4 
[Maragos and 
McCormick, 2000] 
USDA Clone 22 
[Lee et al., 2013] [Li et al., 2012] [Dos Santos et al., 
2011] 
IC50 
(µg/mL) 
CR (%) IC50 
(µg/mL) 
CR (%) IC50 
(µg/mL) 
CR (%) IC50 
(µg/mL) 
CR (%) IC50 
(µg/mL) 
CR (%) 
DON 0.013 100.0 0.018 100.0 0.023 100.0 --- 100.0 --- 100.0 
3-ADON 0.173 7.5 0.003 632.0 n.a. n.a. --- 34.0 --- < 0.5 
15-ADON 0.004 325.0 558.0 0.3 5.5 0.4 --- < 1.0 --- 333.0 
NIV 1.751 0.7 > 20 < 0.1 6.0 0.4 --- < 0.1 --- 5.0 
T2 1.233 1.1 > 20 < 0.1 n.a. n.a. --- < 0.1 --- < 0.5 
HT2 0.195 6.7 > 20 < 0.1 22.5 0.1 --- < 0.1 n.a. n.a. 
Fusarenon-X n.a. n.a. > 20 < 0.1 n.a. n.a. n.a. n.a. n.a. n.a. 
DON-3G n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. 
DOM n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. 
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1.6 DEVELOPMENT OF RECOMBINANT ANTIBODIES 
In the mid-eighties, an innovative technology enabling the cloning of antibody genes and 
thereby bypassing the formation of hybridomas was introduced. In the new developed 
recombinant antibody technology, antibody genes are cloned directly from lymphocytes of 
immunized animals and expressed as an scFv or a fragment antigen binding (Fab) unit in 
bacteria. The expression of recombinant antibodies in bacteria is performed by the use of 
bacteriophages (phages) and therefore the term “phage display” was introduced by  eorge 
Smith. By using this technology, large libraries of antibodies can be designed and built 
followed by the selection of appropriate antibodies (e.g. affinity, selectivity) through 
biopanning [Barbas et al., 2001; Schmitz et al., 2000; Tikunova and Morozova, 2009; 
Hoogenboom et al., 1998]. Recombinant antibody technology has the advantage of low cost 
and high speed production of antibodies which are easy to manipulate and to adapt to different 
applications e.g. fusion with marker molecules for detection purposes. 
 
1.6.1 Recombinant antibody generation through immunoglobulin cleavage 
The cleavage of IgG molecules with papain yields Fab (Figure 1.16B) and Fc fragments as 
presented in Figure 1.16A. The smaller Fv antibody fragment is more difficult to produce by 
enzymatic digestion and is less stable than Fab fragments. Therefore a linker is introduced 
between VH and VL using recombinant technology to produce scFv (Figure 1.16C) improving 
its folding and stability. The size of the linker determines the association state of the scFv 
molecule. Linkers with more than 20 amino acids favour monomeric molecules, whereas 
dimers are favoured with linkers of around 5 amino acids. ScFv containing linkers with a size 
in between 5 and 20 amino acids, appear as a mixture of monomers and dimers [Barbas et al., 
2001]. The use of bispecific antibodies by linking two different scFv (diabody) or two 
different Fab (F(ab’)2) molecules or one scFv with one Fab molecule is described for the 
induction of double epitope binding (from different or the same antigen) [Lu et al., 2002; 
Holliger and Winter, 1997]. Several clinical trials have been conducted using bispecific 
antibodies as mediators to redirect immune effector cells such as natural killer cells and T-
cells towards tumour cells in order to enhance their destruction [Chames and Baty, 2009].  
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Figure 1.16 Fv, Fab and FC fragments of an IgG molecule (A); Fab recombinant antibody (B);  
scFv recombinant antibody (C) 
 
1.6.2 Recombinant antibody generation by polymerase chain reaction 
The process of recombinant antibody production starts with the isolation of antigen-stimulated 
lymphocytes (B-cells) from the spleen of an immunized animal followed by mRNA extraction. 
Hybridomas are also a source of mRNA that predominantly or exclusively encodes a single 
antibody. After reverse transcription of mRNA into complementary deoxyribonucleic acid 
(cDNA), the cDNA is used as a template pool for the amplification of the antibody VH, VL, 
constant heavy 1 (CH1) and constant light (CL) chain genes. Specific complementary 
oligonucleotide primers are chosen to eventually include extra restriction sites and 
amplification by polymerase chain reaction (PCR) of antibody variable and constant chain 
genes is performed [Karu et al., 1995]. For the amplification of light chain genes, two 
different batches of PCR primers need to be selected to distinguish between lambda (λ) and 
kappa () light chain. The ratio between  and λ chains varies significantly among different Ig 
classes or subclasses and animal species. In most murine species, which are the preferable 
laboratory animal species, a /λ ratio of 95/5 is observed. Reasons for this high ratio could be 
a reflection of the large  variable region gene repertoire (> 200 genes) relative to the λ 
variable region repertoire (two genes) or the presence of specific genes regulating B-cell 
differentiation [Woloschak and Krco, 1987]. Isotyping of hybridoma light chains can be 
performed before hand and is recommended to avoid problems in monoclonal antibody 
Fab 
Fc 
 Fv 
A 
B 
C 
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cloning during transcription of less or no functional variable region genes [Schaefer et al., 
2010].  
After PCR amplification and subsequent gel-purification of VH, VL, CH1 and CL chain genes 
to remove any residual primer, the genes are further used for scFv and Fab synthesis. VH and 
VL chain genes are assembled using splicing by overlap extension (SOE)-PCR to form scFv 
recombinant antibody genes. The linker in between VH and VL domains is generated either by 
overlap of the two inner primers or by adding a linker primer whose sequence covers the 
entire linker or more. For Fab formation, CH1 and CL chain genes are first amplified in a 
phage vector to include extra gene sequences to give rise to separate polypeptide production. 
Then, SOE-PCR is performed for VH – CH1 and VL – CL coupling. A second SOE-PCR gives 
rise to the coupling of both SOE-PCR 1 reaction products and therefore the formation of the 
Fab recombinant antibody genes. The gel-purified SOE-PCR products are digested with 
restriction enzymes to create ends compatible with sites at the cloning phage vector [Horton et 
al., 2013; Woloschak and Krco, 1987; Barbas et al., 2001]. The total scFv synthesis by using 
PCR followed by SOE-PCR is illustrated in Figure 1.17. 
 
 
 Figure 1.17 Procedure of scFv synthesis by the use of PCR and SOE-PCR adding a linker primer whose 
sequence covers the entire linker
Sequence tail 
 
VL sense primer 
Sense overlap 
extension primer 
VH sense primer 
Sequence tail 
VH reverse primer VL reverse primer 
Linker 
sequence tail 
Linker 
sequence tail 
Reverse overlap 
extension primer 
PCR 
SOE-PCR 
Linker 
Chapter 1: General introduction and principles 
58 
 
The development of several scFv and Fab anti-DON recombinant antibodies from hybridoma 
cell lines producing monoclonal antibodies is described by previous researchers. Maragos et 
al. (2012) compared their developed scFv and the original anti-DON monoclonal antibody 
using direct ELISA and observed a lower sensitivity of the scFv (IC50 = 36.1 ng/mL) 
compared to the monoclonal antibody (IC50 = 13.8 ng/mL) even though no differences in 
cross-reactivities were determined. The results conclude no or little change in antibody 
selectivity and affinity when removing major framework regions and are conform the 
conclusion taken by Wang et al. (2007). These results are in contradiction with Choi et al. 
(2004) where lower affinity of the scFv antibody fragments (KD = 3.7 x 10
-6
 M) was observed 
compared to the parental monoclonal antibody (KD = 8.8 x 10
-8
 M) [Maragos et al., 2012; 
Wang et al., 2007; Choi et al., 2004]. In Romanozzo et al. (2010), the application of a 
biotinylated anti-DON Fab fragment in an electrochemical immunosensor was evaluated in 
different sample matrices (wheat, breakfast cereal and baby-food). The authors considered the 
immunosensor as robust and insensitive to sample matrix with a quite low DON sensitivity  
(IC50 = 380 ng/mL).  
 
1.6.3 Phage display technology 
Phage display is currently the most widespread method next to the use of yeasts, ribosomes 
and bacterial cells for the display and selection of large collections of antibodies and for the 
engineering of selected antibodies [Sheedy et al., 2007]. Phage display includes the use of 
filamentous phages which are visualised as flexible rods of about 1 µm long and 6 nm wide. 
Inside the rod of wild-type strain phages lies the single-stranded viral DNA with up to 6 407 
nucleotides. At one side of the rod, five copies of the minor coat proteins pIII and pVI (genes 
III and VI, respectively) are present, while on the other side minor coat proteins pVII and pIX 
(genes VII and IX, respectively) are included. PVIII proteins are present over the total length 
of the phage particle [Smith and Petrenko, 1997; Barbas et al., 2001]. The structure of a phage 
with its coat proteins is illustrated in Figure 1.18. 
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Figure 1.18 Structure of phage particle with pIII, pVI, pVII, pVIII and pIX coat proteins 
 
Phages are viruses able to infect strains of Escherichia coli (E. coli) displaying an F pilus. 
Infection is initiated by attachment of the N-terminal domain of pIII to the tip of the pilus, 
which is the part of the phage that enters the cell first. As the process continues, the coat 
proteins of the phage dissolve into the surface of the bacterial cell, whereby the phage DNA 
enters the cytoplasm and turns into a replicative plasmid-like (RF) molecule by the E. coli 
replication enzymes. Double-stranded phage DNA is formed in the bacterial host and forms a 
template for transcription and translation of phage proteins. Continuous replication of the 
double-stranded DNA is followed by extrusion through the cell envelope by the use of coat 
proteins from the cell membrane and emerging as completed virions. These virions are 
secreted continuously without killing the bacterial host [Barbas et al., 2001; Smith and 
Petrenko, 1997; Tikunova and Morozova, 2009]. An overview of the infection process is 
shown in Figure 1.19. 
Smith and Petrenko (1997) showed that foreign DNA fragments could be inserted into 
filamentous phage gene III or gene VIII, which codes for the phage coat protein pIII and 
pVIII, to create a fusion protein with the foreign sequence in the amino-terminal domain. The 
foreign DNA fragments include the genetic material encoding scFv and Fab recombinant 
antibodies. Expression of the fusion product in the E. coli host and its subsequent 
incorporation into the mature phage coat results in the antibody being presented on the phage 
surface, while its genetic material resides within the phage particle.  
 
pVIII pIII pVI pIX pVII 
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Figure 1.19 Infection process of E. coli with phage 
 
Nowadays, small plasmid vectors or phagemids, which contain appropriate cloning sites and a 
phage packaging signal, have become a more popular type of display vectors. Phagemids have 
the advantage of having high transformation efficiencies and are therefore ideally suited for 
the generation of large antibody libraries. Other vector features include an antibiotic 
resistance marker, an origin of replication, a promotor region and an affinity tag to aid in 
purification. Helper phage (e.g. M13K07 or VCSM13) is also required to supply all necessary 
structural proteins for correct packaging of the phage particle. The lacZ promoter is the most 
common promoter used to control expression. Expression may be suppressed by the addition 
of the catabolic repressor glucose or induced by addition of isopropyl--D-1-
thiogalactopyranoside (IPTG) due to its binding to the lac repressor, thereby releasing the 
tetrameric repressor from the lac operator and allowing transcription of genes in the lac 
operon including the antibody genes. 
The pComb3 phagemid vector containing the gene III is designed to express recombinant 
antibodies on the surface of filamentous phage or to express them as soluble proteins. The 
expression of soluble proteins requires the excision of gene III encoding the pIII coat protein. 
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The pComb3H phagemid vector (Figure 1.20A) is modified from pComb3 as the genes have 
been reversed and a single lacZ promoter is incorporated instead of the two separated lacZ 
promoters in the pComb3 phagemid. The transcription of the polypeptide chain is terminated 
by the trp transcription terminator followed by the direction of the chain to the periplasm due 
to the ompA and/or pelB signal peptide. Excision of gene III is necessary as well for the 
expression of soluble proteins. Another pComb3 variant is the pComb3X (Figure 1.20B), 
where the amber codon has been inserted between the 3’ SfiI restriction site and the 5’ end of 
gene III. This allows soluble protein expression without excising the gene III fragment. Two 
different tags, namely the HIS tag and the hemagglutinin (HA) decapeptide tag have been 
inserted for IMAC purification and detection using anti-HA secondary antibody, respectively. 
The pComb3 phagemid and analogues are used by several researchers for the expression of 
Fab, scFv, diabody or other proteins [Urushibata et al., 2010; Andris-Widhopf et al., 2000; 
Barbas et al., 2001]. The pComb8 phagemid vector contains the gene VIII and has been used 
for the display of large fusion proteins such as Fab antibody [Wang et al., 1997; Scholthof et 
al., 1997; Barbas et al., 2001]. The preferable use of the pComb3 or pComb8 vector for the 
expression of Fab is dependent from case to case. For both pComb3 and pComb8 vectors 
different restriction sites are included, such as the SfiI, SacI, SpeI and NheI as illustrated in 
Figure 1.20. 
 
Figure 1.20 pComb3H (A) and pComb3X (B) phagemid vectors with lacZ promoter, SfiI/SacI/SpeI/NheI 
restriction sites, trp transcription terminator, ompA signal peptide, variable light gene chain (VL), variable 
heavy gene chain (VH), linker gene (L), gene III, HIS tag gene, HA tag gene and amber codon. 
 
Another type of phagemid vector is the pET expression system, derived from the pBR322 
plasmid and engineered to take advantage of the features of the T7 bacteriophage gene 10 
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promoting high-level transcription and translation. As the phagemid-encoded RNA 
polymerase is highly specific for the T7 promoter, only the target gene in the E. coli cell will 
be transcribed preventing transcriptional read-through of unwanted plasmid sequences and 
eliminating plasmid instability due to the transcription of toxic proteins. A wide variety of 
pET vectors (transcription and translation vectors) are available differing in leader sequences, 
expression signals, fusion tags and restriction sites.  
After translation, the antibody polypeptide chain needs to be correctly folded by the addition 
of disulfide bonds. Inter-domain disulfide bonds link together heavy and light chain and are 
only present in Fab, whereas intra-domain disulfide bonds responsible for the 
immunoglobulin fold and stability are present in two copies in scFv and four copies in Fab. 
Due to the oxidizing environment and the disulfide bond (dsb) machinery, disulfide bond 
formation takes place in the periplasm of the E. coli cell (Figure 1.21). The first part of the 
dsb machinery includes the oxidative pathway in the periplasm of E. coli cells introducing 
disulfide bonds into newly translocated synthesized proteins catalyzed by DsbA and DsbB 
proteins. The periplasmic thiol-disulfide oxidoreductase DsbA and the cytoplasmic inner-
membrane protein DsbB drive the formation of disulfide bonds by thiol-disulfide exchange. 
During thiol-disulfide exchange, the two cysteines of the DsbA are reduced followed by 
reoxidation of DsbA due to the presence of the DsbB membrane protein making DsbA ready 
to interact with another unfolded protein. To rescue misfolded polypeptides, an isomerization 
system is present in E. coli cells that proofreads and corrects non-native disulfides catalyzed 
by thiol-disulfide oxidoreductase DsbC. DsbC is maintained in a reduced active state by a 
continual flow of electrons from the cytoplasmic thioredoxin to DsbC through the DsbD 
cytoplasmic membrane protein [Heras et al., 2009; Sevier and Kaiser, 2002; Guglielmi and 
Martineaum, 2009].  
Cytoplasm production and folding of recombinant antibodies instead of periplasm folding is 
described by using mutant E. coli strains allowing the formation of stable disulfide bonds by 
the elimination of disulfide bond reduction. A mutant strain was selected containing 
knockouts in the thioredoxin and glutathione pathway (trxB and gor) responsible for the 
maintenance of the reducing environment with an extra point mutation in the ahpC gene 
taking care of normal growth of bacteria. This mutant E. coli strain allowed the expression of 
scFv and Fab fragments at levels comparable to that obtained in the periplasm [Guglielmi and 
Martineaum, 2009; Ritz and Beckwith, 2001].  
 
Chapter 1: General introduction and principles 
63 
 
 
Figure 1.21 The dsb machinery for protein oxidation and isomerization in the periplasm of E. coli cells.  
The periplasmic thiol-disulfide oxidoreductase DsbA and the cytoplasmic inner-membrane protein DsbB 
drive the formation of disulfide bonds by thiol-disulfide exchange. To rescue misfolded polypeptides, an 
isomerization system is present that proofreads and corrects non-native disulfides catalyzed by thiol-
disulfide oxidoreductase DsbC. DsbC is maintained in a reduced active state by a continual flow of 
electrons from the cytoplasmic thioredoxin to DsbC [Sevier and Kaiser, 2002]. 
 
In some situations (e.g. cellular stress), an accumulation of the antibody polypeptide chains 
into insoluble aggregates, known as inclusion bodies, can occur. A number of methods for the 
redirection of proteins from inclusion bodies into the soluble fraction or modification of the 
expression strategy to obtain soluble expression, are described. Techniques to limit the in vivo 
aggregation of recombinant antibody include the cultivation of transformed E. coli cells at 
low temperature, batch cultivation and co-overexpression of molecular chaperones. Specific 
to anti-DON scFv, Choi et al. (2003) described the use of DnaK-DnaJ-GrpE to improve the 
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cytoplasm solubility. Misfolded proteins can be engineered or pushed to gain soluble 
expression by the presence of affinity tags, expression of solubility enhancing maltose binding 
protein and N-utilizing substance A or by site-directed mutagenesis [Sorensen and Mortensen, 
2005].  
 
1.6.4 Biopanning of phage display library 
Phage display libraries can be divided into three types, namely naive, immune and synthetic 
libraries. Naive libraries are generated from genetic material that has never been exposed to 
the antigen(s) prior to library construction, in contrast immune libraries are created using 
lymphocytes from an animal immunized with the antigen of interest. Synthetic libraries are 
made by the in vitro assembly of antibody gene segments and are used together with the naive 
libraries for any antigen without immunization [Sheedy et al., 2007].   
During biopanning using previously described immunochemical methods (1.4.3), the phage 
display library is subjected to affinity selection where recombinant antibodies are selected 
based on their affinity towards a specific antigen. In principle, very large naive or synthetic 
libraries offer the possibility to select high-affinity antibodies with any desired specificity 
without the need for immunization. If an antibody with desired affinity is not isolated from 
such a library, the affinity can be adapted through mutagenesis or immunization may be the 
best option.  
One needs to decide whether to construct a library in the scFv or Fab antibody fragment 
format. The preparation of an scFv format has the following advantages: 1) less PCR steps are 
involved for scFv library construction, 2) the ability to form scFv diabodies enhances the 
avidity for the antigen and enhances the selectivity due to double epitope recognition, 3) 
higher scFv yield during E. coli culturing. The disadvantage of the scFv format is its property 
to multimerize, which is not the case for the Fab format as it is a stable, well-characterized 
protein fragment. The major disadvantage of Fab recombinant antibodies is the generally 
lower expression levels in E. coli [Barbas et al., 2001].  
Doyle et al. (2008) describe the panning of an immune phage library based on single-domain 
variable heavy chain antibody fragments derived from a llama immunized with DON-protein 
conjugates. A 15-ADON recombinant antibody was obtained by panning the library using 
DON-15-OVA conjugates. As most of the other described developed recombinant anti-DON 
antibodies are derived out of hybridomas producing a monoclonal anti-DON antibody, no 
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panning is necessary and therefore not described. Another novel technique is the screening of 
phage library based on mimotope DON peptides which bind to anti-DON monoclonal 
antibodies to form an alternative for mycotoxins in immunoassays and for the further 
development of antibodies [Yuan et al., 1999].  
 
1.6.5 Computational homology modeling and molecular docking 
The ability to model recombinant antibodies based on the determined DNA and amino acid 
sequences and visualize antibody-antigen interactions in three-dimensional space is a 
powerful tool prior to antibody engineering. The structures of many antibodies have been 
determined by X-ray crystallography and are stored at the online Protein Data Bank (PDB). 
Because of the homology among antibody framework domains and the secondary structures 
of CDRs, it is possible to search for a computational model of a new antibody in order to 
predict which CDRs and other residues are important to epitope binding. During this research, 
the SWISS-MODEL web server was used to search for a recombinant antibody model based 
on the amino acid sequence input of the newly derived recombinant antibody [Schwede et al., 
2003]. The derived model can be further used for docking experiments predicting the 
conformation of an antigen-antibody complex from its separated components. Using docking 
servers or programs including SwissDock and UCSF Chimera, the PDB file of the model 
recombinant antibody needs to be loaded together with the PDBQ file of the target antigen. 
The docking server automatically generates possible antigen-antibody clusters based on 
physical non-covalent interaction, which are sorted by a scoring function and the lowest 
energy value (kcal/mol). Although computational docking is still in its infancy, there is no 
doubt that it will become more relevant and widespread in the coming years [Pedotti et al., 
2011; Karu et al., 1995].  
 
1.6.6 Antibody engineering 
The antibodies selected after several rounds of biopanning are functional, even though affinity 
and specificity can be increased. Once the DNA and amino acid sequences of the selected 
recombinant antibodies are known and computational modeling and docking experiments are 
performed, in vitro mutagenesis can be applied to insert, delete, change one or several amino 
acids or exchange entire variable domains. These mutagenesis procedures can have an 
influence on affinity and/or specificity due to a change in orientation of the VH and VL 
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domains, a change in length of the CDRs that enlarge or shrink the binding pocket and an 
increase in flexibility of the CDRs [Karu et al., 1995; Moore, 1989].  
It is generally known that the greatest variation of antibody structure and thus antigen binding 
specificity lies in the three polypeptide loops forming the CDRs of each VH and VL. The third 
CDR of the VH shows the largest diversity in composition and length and is, therefore, 
considered as most important amino acid sequence where mutagenesis can influence the 
specificity of the antibody [Wyat et al., 1999].  
Previous studies have revealed the importance of particular amino acids in the CDR regions 
of antibodies. The dominant role of tyrosine as a molecular contact mediator and serine or 
glycine for providing space and flexibility is mentioned in Koide and Sidhu (2009). The 
amphipathic character of tyrosine is able to tolerate the environmental hydrophilic or 
hydrophobic change that occurs during antigen-antibody complex formation. And this can be 
considered together with its large size enhancing non-covalent interactions and low side chain 
entropy as reasons to consider tyrosine as an important amino acid [Fellouse et al., 2004]. 
Cysteine residues are also important for the formation of disulfide bridges and correctly 
folding of the antibody. Replacing disulfide bridges by valine-alanine pairs leaving a cysteine-
free scFv recombinant antibody was found to increase the stability of the scFv, but seemed to 
be less active than its parent scFv [Worn and Pluckthun, 2001; Schier et al., 1996].  
The changes in amino acid chain can be introduced by several types of in vitro mutagenesis 
procedures grouped in three broad categories, namely random mutagenesis, site-directed 
mutagenesis and shuffling. Using random mutagenesis, mutations are randomly introduced  
throughout the gene by error-prone PCR or bacterial mutator strains. Error-prone PCR uses 
low-fidelity polymerization conditions to introduce a low level of point mutations through out 
the entire gene sequence. The second possibility for random mutagenesis is the selection of 
antibodies from a library amplified in a bacterial mutator strain of E. coli.  
Site-directed mutagenesis can be performed by the existing mutational hot spots. Chowdhury 
and Pastan (1999) have developed a theory introducing the presence of hot spot sequences in 
the DNA encoding the variable domains of antibodies. Mutations of the identified hot spot 
sequences led to a 15- to 50- fold increase in affinity, whereas mutations outside the hot spot 
only increased the affinity four times. Parsimonious mutagenesis is another type of site-
directed mutagenesis developed by Balint and Larrick (1993). The principle of this method is 
to use mutagenesis codons to mutate about 50% of all targeted amino acids while keeping the 
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other 50% intact (wild type). Therefore, crucial amino acids are conserved in about 50% of 
the clones for one mutation and 25% for two mutations [Chames and Baty, 1998].  
Shuffling of antibody genes can be accomplished by chain shuffling, DNA shuffling, 
staggered extension process (StEP) or variations of previously mentioned techniques. Using 
chain shuffling, a particular heavy and light chain from an antibody recognizing a specific 
antigen is shuffled against a complementary library of light and heavy chains. This type of 
mutagenesis is limited to antibodies selected from immune libraries [Kang et al., 1991]. DNA 
shuffling was developed by Stemmer (1994) and involves the digestion of an antibody gene 
with DNase I to create a pool of random DNA fragments followed by annealing cycles in the 
presence of DNA polymerase. DNA shuffling offers several advantages over random and site-
directed mutagenesis as it can be used for longer DNA sequences (> 1 kb) and gives the 
possibility to select clones with mutations outside the binding site of the antibody. StEP is a 
form of DNA shuffling developed in 1998 by Zhao et al. (1998) and consists of priming the 
template sequences followed by several cycles of denaturation and short polymerase catalyzed 
annealing. During each cycle, single DNA fragments can anneal to different templates based 
on sequence complementarity and extend further to create recombinant genes [Sheedy et al., 
2007].  
The effect on antibody affinity and specificity after every possible mutagenesis procedure is 
determined by binding studies. A ranking is made of all antibody-bound phages of the 
secondary phage library and identification is performed of the amino acid change able to 
increase the strength of the antigen-antibody interaction [Xu et al., 2012; Hoogenboom, 
2005].  
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CHAPTER 2: THE DEVELOPMENT OF AN LC-MS/MS METHOD FOR THE      
DETECTION AND QUANTITATION OF DEOXYNIVALENOL IN WHEAT DUST 
 
SUMMARY 
An LC-MS/MS method was developed and validated for the determination of DON in wheat 
dust. Extraction was carried out with acetonitrile/water/acetic acid (79/20/1, v/v/v) followed 
by a hexane defatting step. Analysis was performed using a Waters Acquity ultra performance 
liquid chromatography (UPLC) system coupled to a Quattro Premier XE mass spectrometer. 
The method was validated according to the criteria mentioned in Commission Decision 
2002/657/EC. Due to a high contamination level of wheat dust compared to wheat, LOD and 
LOQ levels were obtained of 358 µg/kg
 
and 717 µg/kg, respectively.  
A study, set up in the growing season 2011-2012, was designed to obtain quantitative data on 
the occurrence of DON in wheat grain and the corresponding wheat dust. The field 
experiment consisted of a complete randomized block design with five wheat varieties sown 
on a field on which maize was grown in the previous season. The impact of the tillage method 
and the influence of the wheat variety resistance on the DON content of wheat and wheat dust 
were investigated. The accumulation of DON in wheat dust was confirmed and a linear and 
sigmoidal relationship between the DON content in wheat dust versus wheat grain was 
determined. DON reduction was obtained by ploughing and by sowing moderately resistant 
wheat varieties. As wheat dust provides equal results and solves the problem of heterogeneity 
during sampling of conventional wheat matrix, the sampling of wheat dust can be considered 
as a promising alternative. 
 
Keywords: LC-MS/MS, deoxynivalenol, wheat dust, validation, correlation 
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2.1 INTRODUCTION 
The sample selection of grain cereals can be made more easy to perform, less labour-
intensive, less costly with a lower error of uncertainty by sampling dust instead of parts of the 
cereal bulk lot [Maestroni and Cannavan, 2011; Whitaker and Slate, 2012; Whitaker and 
Slate, 2005]. Previously, the accumulation of mycotoxins on dust particles was confirmed 
[Krysinska-Traczyk et al., 2001; Tangni and Pussemier, 2006]. Dust is created when grain is 
transported through closed systems such as the (un)loading of a truck. Also, accumulation in 
mills and storage facilities is described [Halstensen et al., 2006; Nordby et al., 2004]. Because 
of the small size of the dust particles and the accumulation of DON in the dust fraction, the 
proposed sampling technique is promising for the determination of DON in wheat.  
The aim of the study described in Chapter 2 was twofold. First of all to develop and validate 
an LC-MS/MS method for the determination of DON in wheat dust. The second aim was to 
obtain quantitative data on the occurrence of DON in wheat grain and dust taken into account 
the different methods controlling FHB infection like crop rotation, tillage (i.e. ploughing) and 
the choice of wheat cultivar.  
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2.2 MATERIALS AND METHODS 
2.2.1 Reagents and chemicals 
LC-MS grade methanol was obtained from BioSolve BV (Valkenswaard, The Netherlands). 
Acetonitrile (Analar Normapur), n-hexane (Hipersolv Chromanorm) and ammonium acetate 
(analytical reagent) were purchased from VWR International (Zaventem, Belgium). Acetic 
acid (glacial, 100%) was obtained from Merck (Darmstadt, Germany). Ethyl acetate and 
dichloromethane were purchased from Acros Organics (Geel, Belgium). Water was obtained 
from a Milli-Q SP Reagent water system from Millipore Corp. (Brussels, Belgium). 
DON (10 mg) and DOM (50 ng/µL) standards were purchased from Fermentek (Jerusalem, 
Israel) and Coring System Diagnostics (Gernsheim, Germany), respectively. The DON 
standard was dissolved in methanol in a concentration of 1 µg/µL and stored at 4
 
°C. Working 
solutions of DON (10 ng/µL) and DOM (2.5 ng/µL) were prepared in methanol and stored at -
18 °C. 
 
2.2.2 Determination of dust particle size and quantity 
Dust fractions were laboratory fractionated by the use of a vibratory sieve shaker (Retsh, 
Aartselaar, Belgium). Freshly harvested wheat samples were cleaned by sieving, separating 
all grain particles smaller than 2.5 mm. A particle size distribution was built up with the 
particles smaller than 2.5 mm using different sieve pore diameters on the sieve shaker. The 
bottom fraction, which can be considered as dust, was further divided into > 100 µm, 50 - 100 
µm and < 50 µm. The quantity of dust of each of these fractions was determined. 
 
2.2.3 Dust collection 
Dust was produced out of wheat samples by the use of a dust collection facility (Figure 2.1). 
Wheat samples were transferred through the dumping pit to the vertical elevator system via 
the Archimedes screw. At the highest point of the system the grains fall into the vertical bin 
on top of which the dust collection device (i.e. vacuum cleaner) was mounted. The dust was 
collected by removing the paper bag of the vacuum cleaner and after weighing the dust was 
transferred into closed containers. 
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Figure 2.1 Schematic view on the laboratory dust collection facility 
 
2.2.4 Sample preparation 
One gram of dust sample was weighed in a Gosselin
 
extraction tube (50 mL). Stock solution 
(20 µL) of the internal standard DOM (2.5 ng/µL) was added. The dust samples were 
vortexed (Labinco BV, Breda, The Netherlands) and soaked for 15 min. The extraction was 
performed with 10 mL acetonitrile/water/acetic acid (79/20/1, v/v/v) for 60 min using the 
Agitator decanter overhead shaker (Agitelec, J. Toulemonde and Cie, Paris, France) followed 
by centrifugation at  3 000 g for 15 min. The extraction residue was filtered using a Whatman 
No 4 filter (VWR International, Zaventem, Belgium). To the filtered residue 10 mL of hexane 
was added for defatting, followed by shaking for 15 min using the Agitator decanter overhead 
shaker. After centrifugation at 3 000 g for 15 min, the hexane layer was removed and the 
filtrate was evaporated until dryness under a stream of nitrogen at 40 °C. Then, the dry 
residue was redissolved in 100 µL injection solvent methanol/water/acetic acid (41.8/57.2/1, 
v/v/v) with 5 mM ammonium acetate. The redissolved sample was centrifuged for 10 min at 
10 000 g prior to LC-MS/MS analysis.  
 
2.2.5 LC-MS/MS analysis 
LC-MS/MS analysis was performed using a Waters Acquity UPLC system coupled to a 
Quattro Premier XE mass spectrometer (Waters, Milford, MA, USA) equipped with an ESI 
Elevator 
Dumping 
pit 
Bin (silo) 
 Bin outlet 
Container 
Vacuum 
cleaner 
(ventilator) 
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interface by injecting a volume of 10 µL. Chromatographic separation was performed using 
an Acquity UPLC BEH C18 column (1.7 µm, 100 mm x 2.1 mm i.d.) equipped with a guard 
column of the same material (5 mm x 2.1 mm i.d.) supplied by Waters (Milford, MA, USA). 
The column was kept at 60 °C, and the temperature of the autosampler was set at 10 °C. A 
mobile phase consisting of water/methanol/acetic acid (94/5/1, v/v/v) containing 5 mM 
ammonium acetate (A) and methanol/water/acetic acid (97/2/1, v/v/v) containing 5 mM 
ammonium acetate (B) was used at a flow rate of 0.3 mL/min. The gradient elution 
programme started at 99% mobile phase A with a linear decrease to 50% mobile phase A in 3 
min. A linear increase to 99% mobile phase B was established in 0.5 min. An isocratic 
gradient of 99% mobile phase B was initiated at 3.5 min for 2 min. Re-equilibration to 99% 
mobile phase A was established after 3 additional min. The duration of each UPLC run was 
8.5 min. The mass spectrometer was operated in the positive electrospray ionization (ESI
+
) 
mode. MS parameters for the analysis were as follows: ESI source block and desolvation 
temperatures: 120 and 400
 
°C, respectively; capillary voltage: 3.2 kV; argon collision gas: 
1.15 x 10
-2
 mbar; cone nitrogen and gas flow: 50 and 800 L/h, respectively. The data 
acquisition was performed using SRM. The optimized MS/MS parameters for the precursor 
ion and product ions of DON and DOM were determined. DON was set at m/z 297.10 ([M + 
H]
+
) with product ions of m/z 231.20 (quantifier ion) and m/z 249.20, while DOM was 
determined at m/z 281.00 ([M + H]
+
) with product ions of m/z 109.10 (quantifier ion) and m/z 
137.00. The mycotoxins eluted at 2.54 min and 3.10 min, respectively. Masslynx version 4.1 
and Quanlynx version 4.1. software (Micromass, Manchester, UK) were used for data 
acquisition and processing. 
 
2.2.6 Method validation 
The method was validated in terms of linearity, apparent recovery, LOD, LOQ, precision and 
accuracy based on the Commission Decision 2002/657/EC of 12 August 2002 concerning the 
performance of analytical methods and the interpretation of results. Although this EU 
legislation is not particularly established for dust analysis, it was chosen as a reference 
because of its clear criteria for LC-MS/MS contaminant analysis. 
Blank wheat dust was spiked during 3 consecutive days at 6 different concentration levels of 
250, 500, 1 000, 3 000, 9 000, 18 000 µg/kg with DON. DOM was added as internal standard 
and the quantitation was performed by the use of the relative standard peak area. A linear 
regression was applied. 
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The apparent recovery was calculated by the use of a matrix-matched calibration curve. In 
detail, blank dust samples were spiked with DON at different concentration levels and were 
analysed using the optimized LC-MS/MS method. The observed signal was plotted against 
the actual concentration. The measured concentration was determined using the calibration 
curve, and the apparent recovery was calculated by Equation 2.1. 
 
Equation 2.1    
% apparent recovery = measured concentration (µg/kg) / actual spiked concentration (µg/kg) x 100 
 
LOD and LOQ were determined as 3, respectively 6 times the standard error of the intercept, 
divided by the slope of the standard curve. Also, the LOD and LOQ values were verified 
according to the IUPAC guidelines, stating that the signal-to-noise ratio (s/n) should be more 
than 3 and 10 times, respectively. 
The intra-day precision or repeatability (RSDr) of the method was determined by repeated 
analysis on the same day of dust samples spiked at different concentration levels (1 000, 3 000,   
7 500, 9 000, 17 000 µg/kg). The same experiments were performed on 3 consecutive days for 
the determination of the inter-day precision or within-laboratory reproducibility (RSDR) and 
accuracy. Out of the accuracy data, biases were evaluated and a conclusion was taken 
according to the acceptability of the method. All calculations were performed and processed 
using Microsoft Office Excel 2010 and IBM SPSS 21. 
 
2.2.7 Field trial and sample pretreatment 
The experimental field trial was set up to investigate the influence of maize-wheat rotation, 
tillage method and wheat variety on the DON content of wheat grain and the corresponding 
wheat dust. Therefore, a randomized complete block design with two soil tillage (i.e. 
ploughing) systems, five wheat varieties and four replications was set up. During the growing 
season 2011, maize was grown on the experimental field. After harvesting the maize, one half 
of the field was ploughed before sowing, while on the other part wheat was sown after 
minimal tillage. In November 2011, five winter wheat varieties, namely Azzerti and Homeros 
(susceptible) and Sahara, Mulan and Tabasco (moderately resistant) were sown. One 
fungicide treatment was applied with a fungicide containing a strobilurin and a triazole. The 
field trial is explained in detail in Landschoot et al. (2013). 
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To estimate the DON content in the fresh harvested wheat derived from the different wheat 
varieties under the different tillage conditions, wheat grains were firstly analysed for DON 
presence using the Veratox
®
 DON 5/5 ELISA test kit following the manufacturer’s protocol 
(Biognost, Neogen, Leest, Belgium). 
The mixing of the collected field samples (± 30-35 kg) was based on the fact that there was no 
significant influence of the pre-crop; only tillage or no tillage seemed to be important. So 
wheat derived from the same variety and with the same soil treatment were mixed to derive 
ten different wheat samples (± 150 kg). The ten samples were mixed in a vertical screw mixer 
and were divided into four subsamples (± 30-35 kg). From each subsample, 500 g was ground 
using the M20 grinder (Ika Werke, Staufen, Germany). The equipment was decontaminated 
after each milling step by the use of water and Disolol
®
. All subsamples were transferred to a 
laboratory bin equipped with a vacuum pump, sucking the dust from the wheat kernels. 
 
2.2.8 Dust correlation study 
The identity of DON within the wheat and wheat dust samples of all wheat varieties was 
controlled according to the identification criteria set in Commission Decision 2002/657/EC. 
Every analytical run consisted of a standard control mix, seven samples of the calibration 
curve and a maximum of 20 samples. All calculations were performed and processed using 
Microsoft Office Excel 2010 and IBM SPSS 21.  
The DON content of the wheat samples from the field trial was determined using the LC-
MS/MS method described by De Boevre et al. (2012b). An extra batch of wheat samples (n = 
12) was randomly collected in Belgium to enlarge the DON contamination range of the curve. 
From each wheat specimen, dust was produced and collected with the vacuum cleaner. The 
dust samples were analysed using the developed and validated LC-MS/MS method. Verifying 
a possible correlation, the Pearson correlation coefficient was determined for the batch of 
samples. Matrix effects of dust were evaluated in terms of peak response of wheat dust 
compared to wheat at DON levels between 300 µg/kg and 9 600 µg/kg. 
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2.3 RESULTS AND DISCUSSION 
2.3.1 Determination of dust particle size and quantity 
The particle size distribution of wheat particles smaller than 2.5 mm collected after cleaning 
of different wheat samples obtained by a vibratory sieve shaker, is presented in Table 2.1. 
Only 1.5% of the wheat sample (± 13 kg) showed to be smaller than 2.5 mm. When sieved on 
the vibratory system, 1.5% of this fraction was found to be smaller than 1 mm. The bottom 
fraction (dust), which was divided into > 100 µm, 50 - 100 µm and < 50 µm, was weighed 
and it was found that the < 50 µm fraction was most abundant (Figure 2.2). Therefore, it was 
decided to use this fraction for LC-MS/MS analysis.  
 
Table 2.1 Size distribution for wheat particles smaller than 2.5 mm 
Sieve pore 
diameter 
Residual 
amount 1 
(g) 
Residual 
amount 2 
(g) 
Residual 
amount 3 
(g) 
Mean 
weight 
(g) 
SD (g) Percentage 
(%) 
Cumulative 
sieve residue 
(%) 
3.15 mm 17.02 11.25 9.82 12.70 3.81 6.35 6.35 
2.0 mm 164.00 170.25 172.04 168.76 4.22 84.38 90.73 
1.4 mm 14.09 12.89 13.28 13.42 0.61 6.71 97.44 
1.0 mm 2.04 2.15 1.88 2.02 0.14 1.01 98.45 
800 µm 0.78 1.03 0.75 0.85 0.15 0.43 98.88 
710 µm 0.33 0.42 0.42 0.39 0.05 0.20 99.07 
500 µm 0.51 0.64 0.76 0.64 0.13 0.32 99.39 
400 µm 0.20 0.30 0.32 0.27 0.06 0.14 99.53 
355 µm 0.08 0.12 0.13 0.11 0.03 0.06 99.58 
bottom 0.43 0.58 0.53 0.51 0.08 0.26 99.84 
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Figure 2.2 Cumulative distribution of the dust fractions in which three fractions can be distinguished:  
< 50 µm, 50 - 100 µm and > 100 µm 
 
2.3.2 Optimization of sample preparation and clean-up 
De Boevre et al. (2012b) described the use of LLE with acetonitrile/water/acetic acid (79/20/1, 
v/v/v) as extraction solvent and a hexane defatting step, as sample preparation for wheat 
matrix. A supplemental clean-up step with C18 columns 500 mg/6 mL (Achrom, Zulte, 
Belgium) was investigated. SPE was performed under acidic conditions by the use of 
acetonitrile/water/acetic acid (79/20/1, v/v/v) as extraction solvent. After the hexane defatting 
step, one part of the extract was filtered through a Whatman glass filter. Another part of the 
defatted extract was further purified by the use of a MultiSep 226 AflaZon+ column and 
acetonitrile/acetic acid (99/1, v/v) as washing solvent. Both purified extracts were combined and 
evaporated until dryness under a stream of nitrogen at 40 °C [Monbaliu et al., 2010a; Monbaliu 
et al., 2010b]. Additional sample preparation experiments were performed under neutral 
conditions. For these experiments, the extraction efficiency was tested by the use of 
methanol/water (90/10, v/v) and 100% ethyl acetate followed by 100% dichloromethane 
[Delmulle et al., 2006]. All cleaned samples were firstly visually evaluated, as the colour was 
a measure of the dirtiness of the sample. Dust samples extracted under neutral conditions were 
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eliminated due to the obtained dirty extract and it was decided not to proceed with these 
extracts to protect the LC-MS/MS equipment.  
 
2.3.3 Optimization of the LC-MS/MS method 
For the chromatographic separation two different columns were compared: the ZORBAX 
Eclipse XDB C18 column and Symmetry C18 with a Symmetry C18 guard column. For the 
Zorbax Eclipse XDB C18 column, a mobile phase consisting of water/methanol (95/5, v/v) and 
methanol/water (95/5, v/v) buffered with 10 mM ammonium acetate and adjusted to pH 3 
with glacial acetic acid was used [De Boevre et al., 2012b]. The Symmetry C18 column was 
used in combination with a mobile phase consisting of water/methanol/acetic acid (94/5/1, 
v/v/v) containing 5 mM ammonium acetate and methanol/water/acetic acid (97/2/1, v/v/v) 
containing 5 mM ammonium acetate [Monbaliu et al., 2010b]. Both columns were kept at 
room temperature and the flow rate was 0.2 mL/min and 0.3 mL/min, respectively. For the 
detection, MS/MS conditions were optimized for DON and DOM via direct injection into the 
mass spectrometer with a syringe pump at a flow rate of 10 µL/min. Cone voltages of 26 V 
and 37 V were applied and compared. In total two different sample preparation methods were 
combined with two different LC methods and two different MS/MS conditions. For the choice 
of the most optimal combination of sample preparation, LC and MS/MS conditions, the 
following factors were taken into account: the resulting relative peak area, the costs and time 
for sample preparation. According to the observed signal (expressed as relative peak area) for 
both extraction methods and LC-methods, a 4.4-fold higher signal was observed using no 
clean-up, cone voltage 26 V and the Symmetry C18 column. Adding a clean-up step increased 
the signal with a factor of 4.7, although it was decided not to add the SPE clean-up in the final 
sample preparation method for wheat dust. In conclusion, the most optimal results were 
obtained using the combination of the Symmetry C18 column for chromatographic separation 
and the MS/MS conditions with 26 V as cone voltage. 
Another parameter for optimization was the total run-time for each LC. By using the 
Symmetry C18 column, it was only possible to have a chromatographic separation of DON 
and DOM in 18 min. Therefore, UPLC conditions were preferred. The Acquity UPLC BEH 
C18 column was suitable due to similar characteristics as the LC column. The same LC-
MS/MS conditions were used, only the temperature of the column was set at 60 °C. Using 
these UPLC conditions, it was possible to reduce the time of each run to 8.5 min. The DON 
and internal standard DOM showed a retention time of 2.54 min and 3.10 min, respectively. 
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As a consequence, a sufficient separation of DON and DOM with 60 s difference (Figure 2.3), 
was obtained.  
 
 
 
 
    
 
Figure 2.3 UPLC-MS/MS chromatogram of a spiked wheat dust sample: DON 1 000 µg/kg (A) and DOM 
50 µg/kg (B) 
 
2.3.4 Method validation 
The LC-MS/MS method was successfully validated for DON in wheat dust based on the 
Commission Decision 2002/657/EC. A DON spiking range from 250 - 18 000 µg/kg was 
taken for the calibration curve, because of the high DON concentration in dust observed by 
ELISA and LC-MS/MS. The linearity was evaluated by the correlation coefficient and a lack 
of fit test. A correlation coefficient (r) of 0.998 and a p-value of 0.551 conclude that the 
calibration curve revealed good linearity. The apparent recovery ((RSD, %), n = 3) 
determined at medium level (1 000 and 3 000 µg/kg) was 97% (SD = 13) and 109% (SD = 4), 
respectively. The LOD and LOQ were 358 µg/kg
 
and 717 µg/kg, respectively. During the 
precision study, RSDs were measured at five different concentration levels; however, only the 
data obtained at the medium and high level (7 500 and 17 000 µg/kg) were recorded. For the 
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intra-day precision an RSDr of 6.87% and 2.09%, respectively, for the medium level and high 
level was observed. For the inter-day precision an RSDR of 9.02% and 2.25%, respectively, 
was determined. The RSDr and RSDR data obtained are in agreement with the acceptable RSD 
values for repeatability according to Commission Decision 2002/657/EC. A maximum 
deviation of the DON concentration (accuracy) of 26% was observed for all spiking levels. 
Therefore the method can be accepted.  
 
2.3.5 Analysis of field trial wheat and dust samples 
To estimate the DON content in wheat dust, the dust fraction < 50 µm and non-sieved wheat 
grains were firstly analysed using the Veratox
®
 DON 5/5 ELISA test kit [Zachariasova et al., 
2008]. According to the screening method, the DON content in the dust was a tenfold of the 
DON content in the wheat grain.  
Four samples of each wheat variety and soil treatment were subjected to ELISA screening for 
DON determination and the results are presented in Table 2.2. The DON legal limit was 
exceeded in 87.5% of the samples and the highest DON concentration was found in the wheat 
variety Azzerti, sown after minimal tillage, with a mean DON concentration of 5 380 µg/kg. 
An independent-samples t-test revealed a lower DON content of wheat samples with soil 
treatment tillage for Homeros, Mulan, Sahara and Tabasco compared to the wheat samples 
without tillage (p-values respectively 0.007, 0.012, 0.008 and 0.019). For Azzerti, however, 
no significant difference (p-value = 0.228) was seen between tillage and no tillage.  
The wheat samples showed DON concentrations between 1 450 µg/kg and 10 670 µg/kg, 
which means that each sample exceeded the limit for human consumption set at 1 250 µg/kg. 
As all LC-MS/MS results (Table 2.3) showed to be higher than the ELISA measurements 
(Table 2.2), an underestimation of the DON in wheat measured by ELISA can be concluded. 
However, the conclusions are analogous. The wheat variety Azzerti showed again the highest 
DON contamination level with a mean concentration of 7 596 µg/kg with tillage. A lower 
DON content of wheat samples with soil treatment tillage was discovered for Mulan, Sahara 
and Tabasco compared to the wheat samples without tillage by the use of an independent-
samples t-test (p-values, respectively, of 0.002, 0.004 and 0.005). For Azzerti and Homeros 
no significant difference in DON level (p-values, respectively, of 0.972 and 0.122) was seen 
between tillage and no tillage. The resulting DON concentration of the corresponding wheat 
dust samples showed values above 8 000 µg/kg. This shows the accumulation of DON in 
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wheat dust. By the use of an independent-samples t-test, the wheat dust analysis results with 
regard to the tillage method (tillage and no tillage) were compared for each winter wheat 
variety. P-values of 0.388 and 0.471 for, respectively, Azzerti and Homeros, revealed no 
significant difference in DON content between tillage and no tillage for wheat dust. For 
Mulan, Sahara and Tabasco, p-values were determined of 0.043, 0.003 and 0.006 respectively. 
This means that for these wheat varieties a significantly lower DON content in wheat dust was 
observed in wheat sown after tillage.   
 
Table 2.2 DON concentration (µg/kg) of the harvested wheat samples (n = 4) determined by ELISA 
 Mean 
(µg/kg) 
SD 
Azzerti No tillage 5 380 2 094 
Tillage 4 602 1 417 
Homeros No tillage 4 779 1 771 
Tillage 3 186 1 237 
Mulan No tillage 2 287 1 321 
Tillage 1 456 1 352 
Sahara No tillage 2 936 820 
Tillage 2 126 784 
Tabasco No tillage 3 689 1 268 
Tillage 2 479 1 477 
 
2.3.6 Dust correlation study 
The LC-MS/MS results for each wheat sample and the corresponding dust sample are 
presented in a scatterplot (Figure 2.4). For the extra batch of wheat samples (n = 12) a 
correlation between the DON concentration in dust versus the DON concentration in wheat 
was proved according to the correlation coefficient, r (0.970). For these samples, wheat dust 
showed a 13-fold accumulation of DON compared to wheat. In the field trial study the 
correlation between the DON content in wheat and dust was 0.829 (r) and a five-fold 
accumulation of DON in wheat dust was observed. This difference can be explained by the 
fact that the wheat samples from the different varieties and soil treatments showed higher 
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DON concentrations starting from 1 450 µg/kg. These extra results completed the calibration 
curve in the range above the limit for human consumption (1 250 µg/kg). When analysing the 
scatterplot, a logarithmic relationship between the DON content in wheat dust versus wheat 
grain was observed. Therefore, it can be concluded that the 13-fold accumulation of DON in 
wheat dust is present until 1 250 µg/kg for wheat (limit for human consumption) and 17 761 
µg/kg for wheat dust. When a higher contamination level is observed, the sigmoidal curve 
with the following equation y = 5 935 ln(x) – 28 423, needs to be considered and a five-fold 
accumulation of DON in wheat dust is observed.  
 
Table 2.3 DON concentration (µg/kg) of the harvested wheat and wheat dust samples (n = 4) determined 
by LC-MS/MS 
 Wheat Wheat dust 
Mean 
(µg/kg) 
SD Mean 
(µg/kg) 
SD 
Azzerti No tillage 7 573 623 22 723 3 524 
Tillage 7 596 1 069 21 973 5 253 
Homeros No tillage 5 502 615 25 799 3 737 
Tillage 4 157 1 293 25 833 4 967 
Mulan No tillage 4 274 767 14 789 902 
Tillage 1 483 997 8 182 2 205 
Sahara No tillage 4 701 618 26 622 2 795 
Tillage 2 534 728 17 123 933 
Tabasco No tillage 4 711 532 27 559 1 144 
Tillage 3 147 324 14 821 5 005 
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Figure 2.4 A scatterplot of the DON concentration in dust (y-axis) versus wheat (x-axis). For wheat 
samples with a DON contamination lower than 1 250 µg/kg (limit for human consumption), wheat dust 
showed a 13-fold accumulation of DON compared to wheat. With higher DON contaminated wheat, a 
sigmoidal relation of the DON content between wheat and wheat dust was observed.  
 
 
As mentioned in Landschoot et al. (2013), maize-wheat rotation can be considered as an 
influencing factor on the DON content of the wheat crop during the next growing season. 
During the growing season 2012 wheat sown after maize reached a six times higher DON 
content compared to wheat sown after a crop different from maize. The susceptibility of the 
wheat variety had most influence on the DON content of wheat and wheat dust (Kruskal-
Wallis test, p-value < 0.05). An independent samples t-test revealed that the moderately 
resistant varieties Mulan, Sahara and Tabasco had a significant lower DON content than the 
susceptible varieties Azzerti and Homeros. For wheat and wheat dust no significant difference 
in DON content was observed between tillage and no tillage for the susceptible wheat 
varieties Azzerti and Homeros. The determined matrix effects of wheat dust at different DON 
contamination levels had values between 0.814 and 1.038, which corresponds to a minor ion 
suppression in dust matrix compared to wheat matrix.  
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2.4 CONCLUSION 
Based on the results of Chapter 2, it can be stated that an LC-MS/MS method was 
successfully developed and validated for the determination of DON in wheat dust. The 
developed LC-MS/MS method was used in an experimental field trial, where the influence of 
maize-wheat rotation, tillage method (i.e. ploughing) and wheat variety on the DON content 
of wheat grain and the corresponding wheat dust, was found. 
Moreover, a significant correlation between DON in wheat dust and DON in wheat was found. 
However, this relationship is concentration-dependent, for concentrations up to 1 250 µg/kg a 
linear relationship can be used to predict the DON content in wheat dust. When a higher 
contamination level is observed, a sigmoidal curve is able to predict the DON content in a 
reliable way. 
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CHAPTER 3  
 
 
THE DEVELOPMENT OF MONOCLONAL 
ANTIBODIES AGAINST DEOXYNIVALENOL 
 
 
 
 
 
 
 
 
 
 
 
 
    Adapted from 
 
Heterologous screening of hybridomas for the development of broad-specific monoclonal 
antibodies against deoxynivalenol and its analogues 
Guo, Y.; Sanders, M.; Galvita, A.; Heyerick, A.; Deforce, D.; Bracke, M.; Eremin, S.; De Saeger, S. 
World Mycotoxin Journal 7 (3), 257-265 (2014) 
 
The immunogen synthesis strategy for the development of specific anti-deoxynivalenol 
monoclonal antibodies 
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CHAPTER 3: THE DEVELOPMENT OF MONOCLONAL ANTIBODIES AGAINST 
DEOXYNIVALENOL 
 
SUMMARY 
An immunogen synthesis strategy was designed to develop monoclonal anti-DON antibodies 
with limited cross-reactivity against structurally similar trichothecenes. A total of eight 
different DON immunogens were synthesized, differing in the kind of linker and the position 
of the linker on the DON molecule. After immunization, antisera from mice immunized with 
different DON immunogens were checked for the presence of interesting antibodies. Then, 
both homologous and heterologous ELISA were performed for hybridoma screening. Under 
this strategy, three monoclonal antibodies against DON and its analogues were generated. A 
new monoclonal antibody 13H1 could recognize DON and its analogues in the order of HT-2 
toxin > 15-ADON > DON, with IC50 ranging from 1.14 to 2.13 µg/mL. Another monoclonal 
antibody 10H10 manifested relatively close sensitivities to DON, 3-ADON and 15-ADON, 
with IC50 values of 22, 15 and 34 ng/mL, respectively. Using an indirect ELISA format, 
decreased the 10H10 sensitivity to 15-ADON with 92%. A third monoclonal antibody 2A9 
showed to be very specific and sensitive to 3-ADON, with IC50 of 0.38 ng/mL. Using both 
2A9 and 10H10 monoclonal antibodies allows determining sole DON contamination.  
 
Keywords: deoxynivalenol; monoclonal antibodies; immunogens; ELISA; cross-reactivity 
 
 
 
 
 
 
 
 
Chapter 3: The development of monoclonal antibodies against deoxynivalenol 
90 
 
3.1 INTRODUCTION 
The objective of the study described in Chapter 3, was to improve the specificity of the 
ELISA assay by developing highly specific monoclonal anti-DON antibodies. Several 
antibodies to DON have been reported and all of them show high cross-reactivity against the 
acetylated derivatives 3-ADON and 15-ADON which reduces their specific character. 
Sensitivity of the produced antibodies, measured by the IC50 value ranged from approximately 
20 ng/mL to 3 ng/mL [Casale et al., 1988; Mills et al., 1990; Sinha et al., 1995; Maragos and 
McCormick, 2000; Usleber et al., 1991; Xu et al., 2010; Dos Santos et al., 2011]. 
The high affinity of the monoclonal antibody to 3-ADON or 15-ADON is likely to derive 
from the chemistry used to prepare the immunogen. The ester linkage of 3-ADON or 15-
ADON, as illustrated in Figure 1.7, may resemble the linkage of the DON-carrier protein 
immunogen. Therefore, it was decided to use different procedures, to make linkers with 
varying length and chemical structure between DON and the carrier protein.  
Homologous and heterologous screening was performed to select the hybridoma producing 
anti-DON antibodies. Results indicated that monoclonal antibodies selected by heterologous 
ELISA were broad-selective to DON and its analogues, which were different from other 
previous anti-DON antibodies. To the best of our knowledge, it is the first report to employ 
hapten heterology for hybridoma screening to produce broad-specific monoclonal antibodies 
against DON and its analogues.  
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3.2 MATERIALS AND METHODS 
3.2.1 Reagents and chemicals 
DON, 3-ADON and  5-ADON standards were obtained from Fermentek (Jerusalem, Israel). 
Other mycotoxin reference standards namely nivalenol (NIV), HT-2 toxin, T-2 toxin, 
fusarenon-X (FUS-X) and DOM were purchased from Sigma-Aldrich (Bornem, Belgium), 
except that DON-3G was from Biopure Referenzsubstanzen GmbH (Tulln, Austria). 
Colorburst™ blue 3,3',5,5'-tetramethylbenzidine (TMB) substrate solution containing 
hydrogen peroxide was supplied by Alerchek (Springvale, Maine, USA). Rabbit anti-mouse 
immunoglobulins (anti-mouse IgG secondary antibody; protein concentration of 2.5 g/L) were 
purchased from DakoCytomation (Glostrup, Denmark). N,N’-carbonyldiimidazole, cyanuric 
chloride (CC), N,N’-diisopropylethylamine, glutaric anhydride, 1-ethyl-3-[3-
dimethylaminopropyl] carbodiimide hydrochloride (EDC), N,N’-dicyclohexylcarbodiimide 
(DCC), 1-butane boronic acid, sodium tetraborate, carboxymethoxylamine 
hemihydrochloride, -aminobutyric acid, N-hydroxysuccinimide (NHS), sulfo-NHS, 
tetrahydrofuran (THF), dimethylformamide (DMF), dimethyl sulfoxide (DMSO), acetic acid, 
potassium carbonate, copper (II) sulfate, sodium ascorbate, 4.7-diphenyl-1.10-
bathophenanthroline disulfonic acid disodium salt, arginine, glycine, aspartic acid, D-
phenylalanine, lysine, TFA, triisopropylsilane (TIS), methyl tertiary-butyl ether (MTBE), 
PEG, bovine serum albumin (BSA), ovalbumin (OVA), horseradish peroxidase (HRP), rabbit 
anti-mouse IgG secondary antibody labelled with horseradish peroxidase (Sec Ab-HRP), 
phosphate buffered saline (PBS, 0.01 M, pH 7.4) powder, carbonate-buffered saline (CBS, 
0.05 M, pH 9.6) capsule, complete and incomplete Freund’s adjuvants, Tween 20 and skim 
milk powder were obtained from Sigma-Aldrich (Bornem, Belgium). Hydroxylamine, o-2 
propynylhydrochloride was purchased from Focus Synthesis (San Diego, USA). O-propargyl-
hydroxylamine hydrochloride was kindly provided by the Laboratory of Medicinal Chemistry 
(Ghent, Belgium). The Oasis HLB cartridges were obtained from Waters (Zellik, Belgium). 
Chlorotrityl chloride resin was purchased from Merck (Darmstadt, Germany). Dulbecco’s 
modified Eagle’s medium (DMEM), fetal bovine serum, penicillin, streptomycin and 
carbenicillin were purchased from Invitrogen (Merelbeke, Belgium). The CM5 sensor chips 
and ethanolamine-HCl were originating from GE Life Sciences (Diegem, Belgium). HBS-N
+
 
buffer containing 0.01 M 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid (HEPES) 
pH 7.4 and 0.15 M NaCl was also bought at GE life Sciences. n-Hexane (Hipersolv 
Chromanorm) was purchased from VWR International (Zaventem, Belgium). Water was 
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obtained from a Milli-Q SP Reagent water system from Millipore Corp. (Brussels, Belgium). 
Other chemicals and solvents were of analytical grade. 
Nunc-Immuno™ F96-well microplates and Nunclon™ cell culture plates were from Nalge Nunc 
International (Roskilde, Denmark). Protein concentrators (9  molecular weight cut-off 
(MWCO), 20 mL) were purchased from Thermo Scientific (Rockford, USA).  
 
3.2.2 Preparation of deoxynivalenol immunogens 
3.2.2.1 Synthesis procedure 
DON is a hapten due to its small size and therefore cannot elicit an immune response. 
Consequently, for the synthesis of immunogens, DON was coupled to a protein through a 
linker to increase the molecular weight. In search for specific anti-DON antibodies, different 
synthetic strategies were followed. Firstly, DON was coupled to a carrier protein via the C3 
and/or C15 position using a linker with a carboxyl function (Series I). To decrease the 
probability of cross-reacting monoclonal antibodies, a second DON series of immunogens 
was generated by coupling the carrier protein via a linker on C3 and/or C15 without a carboxyl 
function (Series II). To reduce even further the possibility of cross-reacting monoclonal 
antibodies the linkage to the carrier protein was introduced through reaction with the C8 
carbonyl function of DON, delivering a last series of immunogens (Series III). The used 
carrier proteins were BSA for the immunogen and OVA or HRP for the coating/competitive 
antigen in indirect or direct ELISA, respectively. The synthetic pathways underneath are 
described for BSA. The basic chemical structure of the three different series of immunogens 
is illustrated in Figure 3.1.  
 
 
Figure 3.1 The three different series of immunogens 
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The first immunogen of the series I is DON-3,15-hemiglutaryl (HG)-BSA (Figure 3.6A) and 
was formed by the reaction of DON with glutaric anhydride in dry pyridine. Concisely, to a 
solution of 5 mg of DON (16.87 µmol) in 500 µL of dry pyridine, 100 mg of glutaric 
anhydride (0.88 mmol) was added and the solution was heated at 100 °C for 8 h. After 
evaporation, the residue was dissolved in 7.5 mL of chloroform and washed three times with 5 
mL of 0.1M HCl. A purification step was performed using Oasis HLB
®
 cartridges by a 
method derived from De Smet et al. (2010). Briefly, 5 µg of the crude DON-HG conjugate 
was dissolved in 1 mL of methanol/water (10/90, v/v) pH 2.3 and loaded on a preconditioned 
column. After loading, the sorbent was dried for 15 s by applying vacuum. DON-HG was 
eluted by washing the column with 1 mL of methanol/water (55/45, v/v) followed by 1 mL of 
methanol. The sorbent was dried for 15 s by applying vacuum. After purity determination by 
Time-of-Flight (TOF) MS, an aliquot of 1 mg of the synthesized DON-HG (1.92 µmol) was 
dissolved in 0.5 mL PBS using ultrasonication and transferred to 30 mg BSA (0.45 µmol) in 1 
mL of PBS. Then 20 mg of EDC (0.10 mmol) was added to the above mixture and incubated 
for 5 h at room temperature with stirring [Mills et al., 1990; Usleber et al., 1991; Kohno et al., 
2003].  
To obtain DON with one HG linker, namely DON-3-HG-BSA (Figure 3.6B), prior protection 
of the 7-OH and 15-OH groups as a cyclic boronate ester allowed to use similar reaction 
conditions as for DON-3,15-HG-BSA [Casale et al., 1988]. The synthesis reaction is 
illustrated in Figure 3.2. Briefly, to a solution of 1 mg of DON (3.37 µmol) in 500 µL of dry 
pyridine, 3 mg of 1-butane boronic acid (0.029 mmol) was added and the solution was left 
stirring overnight at room temperature to yield 7,15-o-butylboronyl-DON. To the reaction 
product, 155 mg of glutaric anhydride (1.36 mmol) was added together with extra pyridine 
(500 µL) and the mixture was incubated for 3 h at 100 °C with stirring. After evaporation, the 
synthesized DON-HG (2.44 µmol) was dissolved in 500 µL of DMF together with 10 mg 
NHS (0.087 mmol) and 20 mg DCC (0.097 mmol) for activation of the carboxylic acid 
residues and the mixture was left agitating for 4 h at room temperature and during the night at 
4 °C. The activated DON-HG hapten was added dropwise to 3 mg of BSA (0.044 µmol) in 2 
mL of CBS buffer and left stirring for 2 h at room temperature and afterwards overnight at 
4 °C. 
Additionally in the first series of immunogens, common DON-BSA carbamate conjugates 
(Figure 3.6C and 3.6D) were synthesized by the N, N’-carbonyldiimidazole (CDI) coupling 
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reaction, adopted from published literature [Xiao et al., 1995; Maragos and McCormick, 
2000]. 
 
Figure 3.2 Pathway for DON-3-HG production using a chemical protection group 
 
Within series II, DON-CC-BSA conjugates (Figure 3.6E and 3.6F) were synthesized by first 
dissolving 1 mg of DON (3.37 µmol) in 480 µL of cold acetonitrile (Figure 3.3). A solution of 
620 µg of cyanuric chloride (3.36 µmol) in 1.24 mL of acetonitrile was prepared and cooled 
to -20 °C. The DON solution was added over 1 h to the vigorously stirred solution of cyanuric 
chloride. A solution of 870 µg N,N’-diisopropylethylamine (6.73 µmol) in 260 µL of cold 
acetone was added to the solution of DON and cyanuric chloride and stirred for 5 h at 55-60 
°C followed by stirring for 16 h at room temperature. For coupling to BSA, a solution of 1.83 
mg of BSA (0.027 µmol) in 1090 µL of 0.1 M sodium tetraborate (pH 9.2) was prepared. The 
solution was cooled to 4 °C and 3.5 mg of DON, a 10-fold molar excess with respect to the 
available amino groups was added and the resulting mixture was stirred for 1 h at 4 °C 
[Abuchowski et al., 1977; Abuknesha and Griffith, 2005]. 
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Figure 3.3 Synthesis of DON-CC 
 
In an effort to further lower the chance for cross-reactivity against 3-ADON and  5-ADON, 
the C8 carbonyl function of DON was used as a reactive site to attach an appropriate linker 
via an oxime moiety (Series III). Hereto a CMO strategy was applied (Figure 3.6 ) [Burkin et 
al.,  999]. To investigate the effect of the length of the linker between DON and the protein 
and with the aim of lowering the immune response against the linker itself, we also introduced 
a carboxypropyl imine (CPI) linker at the C8 position of DON (Figure 3.6H). For this 
purpose, 0.5 mg of DON ( .69 µmol) was reacted with 750 µg of carboxymethoxylamine 
hemihydrochloride (5.88 µmol) in presence of 500 µL of dry pyridine for the DON-CMO 
synthesis and with  .6 mg of -aminobutyric acid ( 5.50 µmol) in   mL DMF for the DON-
CPI synthesis. After overnight reaction at room temperature, the reaction mixture was 
concentrated and the residue redissolved in 200 µl of water/DMSO ( / .5, v/v). Next, 2 mg of 
sulfo-NHS (9.2  µmol) and 4 mg of EDC (0.02  mmol) were added together with  .78 mg of 
BSA (0.026 µmol) and the volume was adjusted to   mL by further dilution with water. The 
reactions were performed for 2 h at room temperature followed by washing and purification 
as described for previous immunogen synthesis.  
Finally click chemistry was adopted for linking C8 of DON without carboxyl function (Figure 
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condensed to propargyl-hydroxylamine hydrochloride. Briefly, 2 mg of DON (6.76 µmol) 
was reacted with 1.81 mg of O-propargyl-hydroxylamine hydrochloride (25.52 µmol) in 
presence of THF/acetic acid (1/1, v/v) at 40 °C. After 2 h an additional 170 µg of O-
propargyl-hydroxylamine hydrochloride was added and the mixture was stirred for an other 
4.5 h to obtain DON-oxime. For the synthesis of azido-BSA, 10.686 mg of BSA (0.16 µmol) 
was dissolved in water together with 4 mg of potassium carbonate and 0.5 mg of copper (II) 
sulfate. Then, 1 mg of imidazole-1-sulfonylazide hydrochloride (4.79 µmol) was added and 
the reaction was left agitating overnight. For the click reaction, 0.5 mg of DON-oxime (1.43 
µmol) was transferred to an aqueous solution of azido-BSA (1.42 mg) containing 25 µg 
copper (II) sulfate (10 mM), 20 µg sodium ascorbate (10 mM) each and 54 µg 4,7-diphenyl-
1,10-bathophenanthroline disulfonic acid disodium salt (10 mM). The reaction went on for 14 
h at room temperature [Ikuina et al., 2003; Van Dongen et al., 2009; Horak et al., 2010; 
Goddard-Borger and Stick, 2007]. 
The click chemistry immunogen product was further expanded by the introduction of a N-
azido cyclic peptide (630.3 g/mol) (Figure 3.6J). The cyclic peptide increases the distance 
between DON and BSA and renders the DON molecule more available for the immune 
system. Through solid phase peptide synthesis using 2-chlorotrityl chloride resin and a 
Fmoc/tBu protection scheme, the amino acids glycine, aspartic acid, D-phenylalanine, lysine 
and arginine were succesively coupled to each other. After mild acid cleavage of the peptide 
from the resin, cyclization of the peptide was performed followed by treatment with 
TFA/TIS/H2O (95/2.5/2.5, v/v/v) to cleave off the protecting groups in solution. The peptide 
was then precipitated in MTBE/hexane (1/1, v/v) and redissolved in methanol for a diazo 
transfer. For the click chemistry (Figure 3.5), 1 mg of DON-oxime (2.84 µmol) was reacted 
with 1.78 mg of cyclic peptide (2.84 µmol) under previously mentioned conditions. Under 
CDI reaction conditions the obtained DON-cyclic peptide (2.84 µmol) was coupled to 3.9 mg 
of BSA (0.058 µmol) in water/DMSO (1/5, v/v) for 3 h at room temperature [Dijkgraaf et al., 
2007; Dai et al., 2000]. 
All DON immunogens were dialysed against 4 L PBS to remove low molecular weight 
substances and concentrated using Pierce Concentrator columns 20 mL/9K MWCO. An 
overview of the DON immunogens is given in Figure 3.6. The DON-BSA and DON-CC-BSA 
synthesis resulted in a reaction mixture containing BSA coupled via its linker to the 3-OH and 
15-OH groups of DON. Due to their similarity in mass and chemical properties it was not 
possible to separate the reaction mixture prior to immunization. The DON-3,15-HG-BSA 
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synthesis did not resulted in a mixture of one and two hemiglutaryl linkers as an excess of 
glutaric anhydride was used. 
 
 
 
Figure 3.4 Synthesis of DON-azido-BSA by the use of click chemistry 
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Figure 3.5 Synthesis of DON-cyclic peptide-BSA by the use of click chemistry
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Figure 3.6 Overview of the DON immunogens only illustrating the amino group of the protein. A: DON-
3,15-HG-BSA; B: DON-3-HG-BSA; C: DON-3-BSA; D: DON-15-BSA; E: DON-3-CC-BSA; F: DON-15-
CC-BSA; G: DON-CMO-BSA; H: DON-CPI-BSA; I: DON-azido-BSA; J: DON-cyclic peptide-BSA. 
 
3.2.2.2 Determination of synthesis success 
The successful synthesis of the DON-3,15-HG-linker was confirmed by mass spectrometry 
LCT Premier XETM TOF (Waters, Milford, MA, USA), equipped with a standard ESI and 
modular LockSpray TM interface in the positive and negative electrospray ionization (ESI
+/-
) 
mode. The purified DON-3,15-HG mixture was infused in acetonitrile/water (1/1, v/v) at 10 
µL per min. The purity of the final product was assessed by HPLC and photo diode array 
(PDA) detection (190-400 nm) using a Phenomenex Luna 2.5 mm C18 (2)-HST column. A 
mobile phase consisting of eluents A (water, 0.1% formic acid) and B (acetonitrile, 0.1% 
formic acid) was used at a flow rate of 0.4 mL/min. A linear gradient of 10-100% solvent B 
was applied over 9 min. Other mass measurements of DON-linker syntheses were performed 
by direct injection of the reaction product into the Quattro Premier XE mass spectrometer 
(Waters, Milford, MA, USA). The mass spectrometer was operated in ESI
+/-
 mode. Masslynx 
version 4.1 was used for data acquisition. 
After coupling to the protein, the immunogen was characterized by the use of indirect 
competitive ELISA. All incubations, except for the first coating step, were carried out at 
37 °C. After each incubation, the plates were washed three times (300 µL/well) with PBST 
(PBS containing 0.05% (v/v) Tween 20)  using an automatic microplate washer “96PW” 
(TECAN, Salzburg, Austria).  
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3.2.3 Immunizations 
To obtain antibody-producing B-lymphocytes against DON, 6 to 8-week-old Balb/C female 
mice (ethical approval according to ECD 10/08) were subjected to an injection with the 
different DON immunogens emulsified with complete or incomplete Freund’s adjuvant. For 
each group of mice, 40- 00 µg of the DON immunogen was administered and injections were 
repeated every 3-4 weeks. Antisera titres were checked one week after each boost injection. 
When mice reached sufficient antisera titres, three days before cell fusion a last injection was 
given with the immunogen diluted in PBS. 
 
3.2.4 Cell fusion 
Mice were sacrificed by cervical dislocation and cell fusion of mouse spleen cells and 
myeloma cells (NSO cells) was performed. PEG 1500 was added as fusing reagent and HAT 
for the selection of the fused cells. The cells were distributed into 96-well culture plates and 
cultured in a humidified, 37 °C, 5% CO2 incubator. Culture supernatant was screened by 
indirect ELISA to determine the positive hybridomas producing antibody against DON. These 
hybridomas were further screened for the production of the target antibody and cloned by 
limiting dilution. 
 
3.2.5 Hybridoma selection and cloning 
Ten to twelve days after cell fusion, plates of hybridoma culture supernatants were initially 
screened by non-competitive indirect ELISA, based on homologous or heterologous DON 
antigens. The positive wells were picked out and screened again by competitive ELISA. Only 
those wells that gave substantial inhibition (more than 20%) by DON and had no cross-
reactivity with OVA were selected. The interesting hybridomas were expanded, rechecked 
and subcloned by limiting dilution for 2-3 cycles to ensure the monoclonality. The resulting 
stable clones were expanded and stored in liquid nitrogen. For large-scale production of 
monoclonal antibodies, each cell line was cultured in a two-compartment bioreactor CELLine 
350 (INTEGRA Biosciences AG, Zizers, Switzerland) for more than three months. The 
collected supernatant was further used for monoclonal antibody characterization. 
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3.2.6 Indirect ELISA  
High-binding polystyrene 96-well microplates were coated with the prepared DON conjugates 
coupled to OVA diluted in CBS ( 00 μL/well). After incubation at 4 °C overnight, the plates 
were blocked with 2% (w/v) skim milk in PBS (300 μL/well) for 30 min. For competitive 
indirect ELISA analysis, standard solutions of DON and PBS control were added (50 
μL/well), followed by adding 50 μL/well of diluted antibodies (antisera or culture 
supernatants) in PBS. For the characterization of the synthesized immunogens, in PBS diluted 
reference DON monoclonal antibodies clone 4 or 22 were used, kindly provided by C. 
Maragos (USDA). After shaking and incubation for 1 h,  00 μL/well of SecAb-HRP was 
added and incubated for another   h. Then,  00 μL/well of TMB substrate solution was added. 
The reaction was stopped after  5 min with 2 M sulphuric acid (50 μL/well), and the 
absorbance at 450 nm was measured by a Bio-Rad model 550 microplate reader (Richmond, 
CA, USA). 
 
3.2.7 Direct ELISA  
The microplates were coated with  00 μL/well of anti-mouse IgG secondary antibody diluted 
in CBS (5 μg/mL) by an overnight incubation at 4 °C. Then, the plates were blocked in the 
same way, mentioned above. For testing, antibodies diluted in PBS were added ( 00 μL/well). 
After 1 h of incubation and the washing step, standard solutions of DON and PBS control 
were added (50 μL/well), followed by adding another 50 μL/well of DON-CC-HRP or DON-
HRP diluted in PBS. The plates were shaken and incubated for another 1 h, and colour 
development was carried out and measured as described in the procedure of indirect ELISA.  
 
3.2.6 Characterization of monoclonal antibodies 
3.2.6.1 By using ELISA 
Checkerboard assays, in which antibodies were titrated against various amounts of coating 
antigens were conducted to select appropriate working concentrations for evaluation of assay 
sensitivities to DON. Standard competitive curves were obtained by plotting relative 
absorbance (ratio of absorbance measured at the standard concentration and zero 
concentration: B/B0×100%) against the logarithm of analyte concentration. IC50 values (i.e., 
analyte concentrations at which the maximum absorbances were inhibited by 50%) were 
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determined to assess the assay sensitivity. To evaluate the specificity or assay selectivity of 
the antibody, a set of DON analogues were utilized to perform cross-reactivity studies. IC50 of 
each tested compound was based on its corresponding competitive curve. Cross-reactivity 
(CR) values were calculated according to the following equation: CR(%) = [IC50 (DON) / IC50 
(analogue)]×100%，where CR values were calculated using IC50 values with units of µg/mL. 
Similarly, CRmolar values were calculated using IC50 molar values with units of nmol/mL. 
 
3.2.6.2 By using SPR 
The characterization of the obtained monoclonal antibody was performed on a Biacore 3000 
(GE Healthcare, Uppsala, Sweden) SPR instrument. DON-OVA was immobilized on a CM5 
sensor chip by the use of amine coupling. During the immobilization, HBS-N
+
 buffer was 
used as a running buffer at a flow rate of 10 µL/min. The sensor chip was activated using a 
mixture of 400 mM EDC and 100 mM NHS in water. Then, DON-OVA diluted to 100 µg/mL 
with a 10 mM acetate buffer (pH 4.2), was loaded on the activated sensor chip. Finally, a 1 M 
ethanolamine-HCl solution (pH 8.5) was used as a blocking solution. The activation, 
immobilization and blocking was carried out for 2 547 s. 
During all kinetic runs, the flow rate of HBS-N
+
 buffer used for the association and 
dissociation was set at 30 µL/min. The regeneration of the sensor chip surface was performed 
using 10mM NaOH at 10 µL/min for 60 s. For the determination of the affinity of the 
monoclonal antibody towards the DON coated on the sensor chip, different concentrations of 
the antibody (31.25 ng/mL, 62 ng/mL, 125 ng/mL, 250 ng/mL and 500 ng/mL) were injected 
over the sensor surface. In order to check sensitivity and cross-reactivity, DON and 3-ADON 
were analysed by SPR. Each toxin was dissolved in HBS-N
+
 buffer and mixed with 500 
ng/mL of monoclonal antibody. Calibration curves for each toxin were obtained and IC50 
values were calculated from the RU value at the midpoint of the calibration curve. Cross-
reactivity values were calculated in the same way as for the ELISA results. 
The BIAevaluation software was used for the calculations, using a 1:1 Langmuir model and 
local fitting of the data. 
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3.3 RESULTS AND DISCUSSION 
3.3.1 Determination of synthesis success  
When the desired synthesis products were obtained based on the exact mass measurements 
performed by direct injection into the Quattro Premier XE mass spectrometer or the LCT 
Premier XETM TOF mass spectrometer, further coupling to BSA and OVA or HRP was 
performed. The synthesized immunogens and coating antigens were characterized by 
competitive ELISA using reference monoclonal antibodies (clone 4 or 22, USDA). If the B0 
value was equal to or higher than 1 and decreasing B values were obtained when using 
increasing standard DON concentrations, the testing conjugates were confirmed and used for 
immunization or further ELISA experiments. 
 
3.3.2 Determination of antisera titres by using indirect ELISA 
Antisera titres were determined by an indirect homologous ELISA using the immunizing 
haptens coupled to OVA instead of BSA as coating antigen. By using the same format, the 
cross-reactivity against OVA was determined as well. An overview of all immunized mice 
and the corresponding antisera titre measurement is given in Table 3.1. The best antisera titres 
were obtained for the mice injected with DON-BSA and DON-CC-BSA. For DON-3,15-HG-
BSA, high antisera titres were found, but the cross-reactivity against OVA was high. It was 
concluded that antibodies were probably formed against the protein instead of the target DON. 
This could be explained by the presence of two linkers on the DON molecule, which makes it 
less free for activation of the immune system of the mouse.  
Table 3.2 lists the polyclonal antibody characteristics from the best DON-CC-BSA mouse. 
Judged from the working concentration of antigen and antiserum, it is clear that the polyclonal 
antibody had much higher affinity to the homologous hapten DON-CC, suggesting the strong 
recognition of both DON and the CC bridge region. But concerning the inhibition results, the 
DON-OVA coated ELISA was more sensitive to DON, which proved that the heterologous 
format did improve the assay sensitivity for DON.  
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Table 3.1 Overview of immunized mice with corresponding antisera titre 
 Immunogen Amount Primary 
injection 
Intraperitoneal 
boost 
injections 
Final 
injection 
Cell 
fusion 
Antisera 
titre 
Cross-
reactivity 
to OVA 
1 DON-3,15-HG-BSA 75 µg SC + IP 3 /* /* + + 
2 DON-3,15-HG-BSA 75 µg SC + IP 4 ok ok + + 
3 DON-3,15-HG-BSA 100 µg SC + IP 4 ok ok + + 
4 DON-3,15-HG-BSA 100 µg SC + IP 4 ok ok + + 
5 DON-CC-BSA 40 µg SC + IP 4 ok ok ++ - 
6 DON-CC-BSA 40 µg SC + IP 4 ok ok ++ - 
7 DON-CC-BSA 60 µg SC + IP 4 ok ok ++ - 
8 DON-CC-BSA 60 µg SC + IP 4 ok ok ++ - 
9 DON-3-HG-BSA 100 µg SC + IP 7 /* /* - - 
10 DON-3-HG-BSA 100 µg SC + IP 7 ok ok +/- - 
11 DON-azido-BSA 75 µg SC + IP 4 /* /* +/- - 
12 DON-BSA 100 µg SC + IP 4 ok ok ++ - 
13 DON-BSA 100 µg SC + IP 4 ok ok ++ - 
14 DON-azido-BSA 75 µg SC + IP 4 ok ok +/- - 
15 DON-azido-BSA 75 µg SC + IP 4 /* /* +/- - 
16 DON-CMO-BSA 75 µg SC + IP 6 ok ok +/- - 
17 DON-CMO-BSA 75 µg SC + IP 7 ok ok +/- - 
18 DON-CMO-BSA 75 µg SC + IP 7 ok ok +/- - 
19 DON-CPI-BSA 75 µg SC + IP 5 ok ok + - 
20 DON-CPI-BSA 75 µg SC + IP 5 /* /* + - 
21 DON-CPI-BSA 75 µg SC + IP 7 ok ok + - 
22 DON-azido-BSA 75 µg SC + IP 4 ok ok +/- - 
23 DON-azido-BSA 75 µg SC + IP 4 ok ok +/- - 
24 DON-cyclic peptide-
BSA 
75 µg SC + IP 4 ok ok +/- - 
25 DON-cyclic peptide-
BSA 
75 µg SC + IP 4 ok ok +/- - 
* mouse died during procedure; subcutaneous (SC), intraperitoneal (IP) 
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The antisera from the DON-BSA injected mice could recognize both DON-OVA and DON-
CC-OVA very well, despite that the dose of DON-CC-OVA was higher than that of DON-
OVA (Table 3.2). However, using the heterologous coating antigen did not promote the assay 
sensitivity for DON. By contrast, the polyclonal antibody derived from DON-BSA displayed 
stronger affinity to the free DON than that from DON-CC-BSA. The phenomena must be 
associated with the fact that DON-BSA contained a smaller linkage compared to DON-CC-
BSA, leading to the reduced influence from the spacer arm. Given that the molecular weight 
of DON is less than 300 Da, the influence of the linkage arm is indeed crucial [Chappey et al., 
1994].  
 
Table 3.2 Characteristics of antisera from the best DON-CC-BSA and DON-BSA mice 
Immunogen ELISA format Serum dilution Coating antigen 
(µg/mL) 
Maxium 
absorbance  
Inhibition by  
2 µg/mL DON (%) 
DON-CC-BSA Homologous 1/16 000 DON-CC-OVA (1) 0.96 11.2 
DON-CC-BSA Heterologous 1/4 000 DON-OVA (4) 0.92 34.8 
DON-BSA Homologous 1/16 000 DON-OVA (0.5) 0.88 57.9 
DON-BSA Heterologous 1/16 000 DON-CC-OVA (4) 0.81 54.5 
 
For DON-CMO-BSA, DON-CPI-BSA, DON-azido-BSA and DON-cyclic peptide-BSA a 
relative low titre, but no cross-reactivity against OVA, was determined. When the ELISA 
response of the serum of the immunized mice reached a plateau phase using a high serum 
dilution, the mice were sacrificed by cervical dislocation. 
 
3.3.3 Hybridoma selection and subcloning 
3.3.3.1 Hybridoma screening by indirect ELISA 
The best DON-CC-BSA mouse was first sacrificed for hybridoma production. Due to a great 
amount of spleen cells, seventeen 96-well plates were used to distribute the fused cell 
suspension. Non-competitive indirect ELISA based on both DON-CC-OVA and DON-OVA 
were used for primary hybridoma screening. When using DON-CC-OVA (4 µg/mL) for 
homologous screening, almost all the wells were visually positive. This could be envisaged 
from the very high titre of antiserum and the satisfying fusion rate (every well contained at 
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least one cluster of hybridomas). In contrast, using DON-OVA (8 µg/mL) for heterologous 
screening, only a few wells in each plate manifested strong signals. These wells showed even 
deeper colour in the corresponding DON-CC-OVA-coated plate. In other words, these 
double-checked positive wells exhibited higher affinity to the DON part than other wells did. 
By contrast, it seemed that many hybridomas could secrete antibodies that recognize the 
whole DON-CC structure or the CC linker, which led to the high background of DON-CC-
OVA coated ELISA, as the CC ring structure is also an important epitope for eliciting the 
immune response.  
In total, 47 positive wells were quickly selected based on the results of DON-OVA coated 
heterologous ELISA. After adding the fresh medium overnight, they were rechecked by 
competitive indirect ELISA. Top 6 wells with both strong signal and substantial inhibition by 
DON were expanded and re-selected. Eventually, the best clone 13H1 was subjected to 
subcloning for three cycles to get a stable single-cell line.  
 
3.3.3.2 Hybridoma screening by direct ELISA 
Since the antiserum titre of the DON-BSA mice was very high, it could be foreseen that a 
great number of positive clones would be obtained when using indirect ELISA with DON-
OVA for hybridoma screening. Moreover, the standard indirect ELISA screening can result in 
a large number of false positives, which gives rise to a lot of unnecessary workload and 
exorbitant waste of the precious experimental materials in the following procedures. With the 
aim of efficiently selecting the target clones that can secrete high-affinity monoclonal 
antibodies, direct ELISA was applied to screen hybridomas from the DON-BSA mice, 
although the sensitivity of direct ELISA was not as high as that of indirect ELISA [Cervino et 
al., 2008]. However, from another point of view, only clones with high affinity to the target 
antigen should be detected as the positives by direct ELISA, reducing the number of clones 
with fairly low affinity. 
For initial screening of DON-BSA hybridomas, non-competitive direct ELISA based on both 
DON-HRP and DON-CC-HRP were carried out. Likewise, much more positive wells were 
found when using the homologous tracer DON-HRP, compared to the heterologous tracer 
DON-CC-HRP. The wells, which were positive from the DON-CC-HRP-based ELISA, gave 
even stronger signals in the corresponding DON-HRP-based ELISA. Thus, the top 8 positive 
wells were easily chosen for further inhibition tests by competitive direct ELISA. Among 
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them, two clones 10H10 and 14D4 could recognize free DON very well and exhibited cross-
reactivity to both 3-ADON and 15-ADON; two other clones 2A9 and 4B10 had much higher 
affinity to 3-ADON but very poor reactivity to DON. Subsequently, hybridomas 10H10, 
14D4, 2A9 and 4B10 were subcloned to obtain the final stable single-cell lines. Given that 
10H10/14D4 and 2A9/4B10 monoclonal antibodies possessed very similar characteristics, 
only clone 10H10 and 2A9 were used for large-scale culturing. 
To be emphasized: the advantage of heterologous screening is that it can notably reduce the 
proportion of false positives, and hence one may efficiently get the interesting hybridomas 
with high affinity to the free target analyte. Consequently, it generates time and is labour-
saving as well as being cost-effective.  
As no hybridoma were found producing anti-DON antibodies out of the mice injected with 
DON immunogens belonging to the third series, the previous statement about the 
immunogenic importance of the C8 carbonyl function in the DON molecule was confirmed 
[Usleber et al., 1991]. 
 
3.3.4 Characterization of monoclonal antibodies  
3.3.4.1 By using ELISA 
The clones 13H1, 10H10 and 2A9 were individually cultured in CELLine 350 bioreactors for 
large-scale production of monoclonal antibodies. In view of practical applications, the 
competitive direct ELISA format, a popular format in commercial ELISA kits, was used for 
monoclonal  antibody characterization. After checkerboard titration, the standard curves were 
set up with the optimal working dilutions of monoclonal antibodies and tracers. As shown in 
Figure 3.7, for clone 13H1, the heterologous format based on DON-HRP did improve the 
assay sensitivity to DON, with IC50 value decreasing from 4.34 µg/mL (DON-CC-HRP-traced 
ELISA) to 2.13 µg/mL (DON-HRP-traced ELISA). In contrast, for clone 10H10, the 
heterologous format based on DON-CC-HRP was less sensitive (IC50 = 0.064 µg/mL) than the 
homologous format based on DON-HRP (IC50 = 0.022 µg/mL). For clone 2A9, only a 
homologous ELISA format was performed using DON-HRP and an IC50 value of 0.202 
ng/mL was determined. These results confirmed that the degree of hapten heterology could 
influence the assay sensitivity of direct competitive ELISA, but whether improving or not, it 
depends on the specific case. The assay sensitivity may not be in parallel with the degree of 
hapten heterology, and this finding is similar to that of Wang et al. (2011).  
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For cross-reactivity measurement DON-HRP-traced competitive direct ELISA was used, 
including eight common DON analogues. Table 3.3 lists the cross-reaction results of 
monoclonal antibodies 13H1, 10H10 and 2A9. 
It seemed that the 13H1 antibody could be considered as a unique broad-selective antibody, 
with even higher sensitivity to HT-2 toxin and 15-ADON than to DON, minor affinity toward 
NIV, DOM and DON-3G, and very low cross-reactivity against 3-ADON, while no obvious 
cross-reaction with T-2 toxin and FUS-X was found. Interestingly, this monoclonal antibody 
could recognize HT-2 toxin but not T-2 toxin, although both of them belong to type A 
trichothecenes (absence of a carbonyl at the C8) and just differ at the C4. The observations 
were mainly ascribed to the immunogen DON-CC-BSA, in which the CC linker must be 
located more at the C15 than at the C3 and it significantly affected the electronic configuration 
of the DON molecule. Probably, the molecular property of the immunizing hapten DON-CC 
was more close to HT-2 toxin than to other tested compounds, which led to the fact that the 
generated antibody had the greatest affinity to HT-2 toxin. These results were in agreement 
with Muldoon et al.’s perspective that both steric and electronic features governed antibody 
recognition [Muldoon et al., 2000]. 
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Figure 3.7 Standard curves of direct competitive ELISA with DON or 3-ADON based on different 
monoclonal antibodies (A: 13H1, B: 10H10 and C: 2A9) and tracers (n = 3). B/B0: ratio of absorbance 
measured at the standard concentration and zero concentration. As the experiment was repeated on 3 
consecutive days, the inter-day precision and accuracy was determined by the standard deviation and 
represented by the error bars on the calibration curve.  
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Table 3.3 Cross-reactivity of monoclonal antibodies 13H1, 10H10 and 2A9 
  Clone 13H1 Clone 10H10 Clone 2A9 
Compound MW IC50 
(µg/mL) 
CR (%) IC50 
molar 
(nmol/ 
mL) 
CR 
molar 
(%) 
IC50 
(µg/mL) 
CR (%) IC50 
molar 
(nmol/ 
mL) 
CR 
molar 
(%) 
IC50 
(µg/mL) 
CR (%) IC50 
molar 
(nmol/ 
mL) 
CR 
molar 
(%) 
DON 296 2.13 100 7.20 100 0.022 100 0.074 100 0.202   0.188 0.682 0.182 
3-ADON 338 34.12 6 100.95 7 0.015 147 0.044 167 0.00038 100 0.00124 100 
15-ADON 338 1.62 131 4.79 150 0.034 65 0.101 74 0.432 0.088 1.278 0.097 
NIV 312 7.69 28 24.65 29 > 10 < 0.2 > 32 < 0.2 n.a. n.a. n.a. n.a. 
T-2 toxin 466 > 100 < 2 > 214.6 < 3 > 10 < 0.2 > 21 < 0.3 n.a. n.a. n.a. n.a. 
HT-2 toxin 424 1.14 187 2.69 268 > 10 < 0.2 > 24 < 0.3 n.a. n.a. n.a. n.a. 
FUS-X 354 > 100 < 2 > 282.5 < 3 > 10 < 0.2 > 28 < 0.3 n.a. n.a. n.a. n.a. 
DON-3G 458 15.67 14 34.21 21 0.072 31 0.157 47 0.025 1.498 0.055 2.271 
DOM 280 5.47 39 19.54 37 0.079 28 0.282 26 n.a. n.a. n.a. n.a. 
 
1
11
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Monoclonal antibody 10H10 showed better sensitivity to 3-ADON than to DON, moderate 
affinity to 15-ADON, and minor cross-reactions with DON-3G and DOM, but no cross-
reactivity towards the other trichothecenes. It was interesting to observe that this anti-DON 
monoclonal antibody could recognize both 3-ADON (IC50 = 0.015 µg/mL) and 15-ADON 
(IC50 = 0.034 µg/mL) very well, and the differences among the three CR values were much 
smaller than those from other reported anti-DON monoclonal-based ELISAs [Li et al., 2012; 
Maragos et al., 2006; Maragos and McCormick, 2000; Tangni et al., 2010; Xu et al., 2010]. 
In other words, the discrepancies of the assay sensitivities to DON, 3-ADON and 15-ADON 
are so narrow that it is suitable to utilize this novel monoclonal antibody for simultaneous 
detection of the three mycotoxins. As a result, the “total” DON content can be rapidly 
estimated in one assay and an overall health risk of DON exposure for the consumers can be 
assessed. The broad-selectivity of this monoclonal was probably due to the involved strategy 
of heterologous screening for hybridomas instead of the homologous one. Previous 
researchers [Liu et al., 2010; Muldoon et al., 2000; Wang et al., 2010] also indicated that 
application of this screening strategy increased the likelihood of isolating hybridomas 
secreting very broad-specific monoclonal antibodies.  
A very sensitive anti-3-ADON antibody was developed out of clone 2A9 with an IC50 value 
of 0.38 ng/mL. Setting the monoclonal antibody activity for 3-ADON as 100%, the cross-
reactivity values for DON, 15-ADON and DON-3G (Table 3.4) were determined as 0.188%, 
0.088% and 1.498% and can be considered as negligible. In comparison with other previously 
reported monoclonal antibodies for 3-ADON such as the ones described at Maragos et al. 
(2006) and Maragos and McCormick (2000) (Table 3.4), the newly developed clone 2A9 is 
probably the most sensitive and specific antibody to 3-ADON [Baumgartner et al., 2010; 
Casale et al., 1988].  
Note that when comparing target analytes to analogues with different molecular weight (MW), 
cross-reactivity values calculated from units of mole per volume should be more accurate than 
those from units of weight per volume (though the latter are often used) [Xu et al., 2009], 
since cross-reactivity is a structure-related phenomenon in antibody-antigen binding. 
Generally, the gaps between CR and CRmolar values would not be too big, except that the 
antibody is broad-specific and shows high affinity to the analogue whose MW has a very 
significant deviation from that of the target analyte. Herein, as for the cross-reactivity of 
monoclonal antibody 13H1 to HT-2 toxin, the usual CR was 187%, while the CRmolar 
increased up to 268%. Also, as described in a few references [Ruprich and Ostrý, 2008; 
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Tangni et al., 2010], some DON-ELISA tests displayed very high cross-reactivity to the 
masked form DON-3G and the corresponding CRmolar values must be much larger than the 
normal CR values. Hence, we suggest that evaluation of the cross-reactivity of a broad-
specific antibody should be based on the CRmolar values as far as possible. Certainly, CR data 
obtained in the current work can be somewhat different from the values declared later in the 
future application studies (because of various assay formats, sample matrices and so on), but 
the general tendency should be similar. 
 
Table 3.4 Comparison of cross-reactivity results between clone 2A9 and other anti-DON monoclonal 
antibodies 
Compound  Clone 2A9 
Direct ELISA 
Mab 1-6.2.6 
Indirect ELISA 
[Maragos et al., 2006] 
USDA Clone 22 
Direct ELISA 
[Maragos and McCormick, 
2000] 
IC50 
(ng/mL) 
CR (%) IC50 
(ng/mL) 
CR (%) IC50 
(ng/mL) 
CR (%) 
3-ADON  0.38 100 1.70 100 2.88 100 
DON  202.14          0.188 15.80 10.7 18.20 15.8 
15-ADON  431.79 0.088 68.90 2.4 558.00 0.52 
DON-3G  25.36 1.498 n.a. n.a. n.a. n.a. 
 
The previously mentioned characterization results were obtained by the use of direct 
competitive ELISA, which is a general method for the characterization of monoclonal 
antibody. Characterization of the 10H10 monoclonal antibody was also repeated by indirect 
competitive ELISA using DON-OVA (4 µg/mL) and DON-CC-OVA (4 µg/mL) coating and 
DON, 3-ADON and 15-ADON for competition. This comparison between direct and indirect 
ELISA is illustrated in Table 3.5. The sensitivity of the antibody towards DON and 3-ADON 
measured by indirect ELISA is approximately two times (DON-OVA coating) and five times 
(DON-CC-OVA coating) the value measured by direct ELISA. For 15-ADON, the sensitivity 
decreased at least ten times when using indirect ELISA. When looking to the CRmolar values 
for direct ELISA and indirect ELISA with DON-OVA coating, the same cross-reactivity is 
seen for 3-ADON, but the cross-reactivity towards 15-ADON lowered 6.7 times when using 
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indirect ELISA. It can even be concluded that the 10H10 antibody shows only cross-reactivity 
to 3-ADON when using indirect ELISA with DON-OVA coating. When using an indirect 
ELISA format with DON-CC-OVA coating, the cross-reactivity against 3-ADON increased 
three times and the cross-reactivity against 15-ADON decreased four times compared to the 
direct ELISA format. So, the characterization of the monoclonal antibody depends on the type 
of ELISA and the coating antigen used.  
 
Table 3.5 Comparison between direct and indirect ELISA for antibody characterization (clone 10H10) 
   IC50 (µg/mL) CR (%) IC50 molar 
(nmol/ mL) 
CR molar 
(%) 
Direct ELISA  DON 0.022 100 0.074 100 
  3-ADON 0.015 147 0.044 167 
  15-ADON 0.034 65 0.101 74 
Indirect ELISA DON-OVA DON 0.040 100 0.135 100 
  3-ADON 0.028 142 0.083 162 
  15-ADON 0.421 9 1.250 11 
 DON-CC-OVA DON 0.113 100 0.383 100 
  3-ADON 0.024 480 0.070 547 
  15-ADON 0.637 18 1.885 20 
 
3.3.4.2 By using SPR 
The characterization of the 10H10 monoclonal antibody was performed by the use of SPR as 
well. After DON-OVA coating and blocking of the CM5 sensor surface of the Biacore 3000, a 
total amount of 12 000 RU of DON-OVA remained. The interaction between antibody and 
immobilized DON-OVA on the sensor chip was determined by monitoring real-time RU 
changes for a range of antibody concentrations (31.25 ng/mL, 62.5 ng/mL, 125 ng/mL, 250 
ng/mL and 500 ng/mL) in HBS-N
+
 buffer. The antibody was injected over the surface, 
followed by a dissociation phase which consisted of a flow of HBS-N
+
 buffer. After the 
dissociation, the surface was regenerated by the injection of 10 µl 10 mM NaOH. In Figure 
3.8, the SPR sensorgram is shown of the kinetic study using a flow of antibody only. The 
injection of the highest antibody concentration (500 ng/mL) gave an increase in signal of 100 
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RU. Decreasing the antibody concentration by half, decreased the RU in the same way. As 
seen in Figure 3.8, the association phase was followed by a constant dissociation phase which 
indicates a strong interaction between the antibody and the DON-coated surface. A 
dissociation constant KD of 4.73 x 10
-11
 was obtained during these experiments. This KD gives 
an idea about the minimum amount of antibody necessary for a particular experiment and 
therefore the affinity of the antibody to the antigen. This value is related to the sensitivity. As 
a KD of 10
-11
 was determined, the antigen DON can be detected in a picomolar (pM) range. 
The sensorgram of the 10H10 monoclonal antibody was compared to the Langmuir model and 
it can be concluded that there is no significant difference between the resulted curve and the 
model curve (χ2 = 0.489).  
Calibration curves were set up for DON and 3-ADON as this is the only cross-reacting 
mycotoxin using DON-OVA coating (Figure 3.9). The antibody (500 ng/mL) was first mixed 
with increasing toxin concentrations and the mixture was injected over the surface of the 
sensor chip. The portion of antibody, which did not bind to the mycotoxin but to the DON-
OVA-immobilized sensor chip was detected by SPR. RU values obtained by SPR were 
correlated with the mycotoxin concentration. Out of the calibration curves, IC50 values of 3.17 
ng/mL and 2.49 ng/mL and molar IC50 values of 10.71 ng/mL and 7.37 ng/mL were found for 
DON and 3-ADON, respectively. Relative to DON a cross-reactivity and molar cross-
reactivity of respectively 127% and 145% was found for 3-ADON. So, there can be 
concluded that SPR gives more than 10 times better sensitivity values compared to indirect 
ELISA using the same coating antigen. Similar cross-reactivity values were found for SPR 
and direct or indirect ELISA. 
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Figure 3.8 SPR sensorgram by monitoring the SPR angle (plotted as response units (RU)) in function of 
time injecting different concentrations of the 10H10 monoclonal antibody on a DON-OVA coated CM5 
sensor surface.  1 RU corresponds to 0.0001° shift in SPR angle or to 1 pg/mm
2
 of surface coverage. The 
association phase was followed by a constant dissociation phase which indicates a strong interaction 
between the antibody and the DON-OVA-coated surface. 
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Figure 3.9 Calibration curve by monitoring the SPR angle (plotted as response units (RU)) in function of 
the concentration of competitor (antigen) DON (A) or 3-ADON (B) injected together with 500 ng/mL of 
10H10 monoclonal antibody on a DON-OVA-coated CM5 sensor surface. 1 RU corresponds to 0.0001° 
shift in SPR angle or to 1 pg/mm
2
 of surface coverage. As the experiment was repeated on 3 consecutive 
days, the inter-day precision and accuracy was determined by the standard deviation and represented by 
the error bars on the calibration curve.  
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3.4 CONCLUSION 
In Chapter 3, the development and characterization of three anti-DON monoclonal antibodies 
is described. The superior monoclonal antibody 10H10 has relatively similar affinity to DON, 
3-ADON and 15-ADON, with IC50 values of 22, 15 and 34 ng/mL, respectively. This is, so 
far, the first broad-specific monoclonal antibody against DON and its two acetylated forms, 
which can be used for simultaneous monitoring of the three mycotoxins. Thus, it could be 
further applied to different kinds of DON-related immunoassays, or immunoaffinity columns 
for sample clean-up before chromatographic analysis. The monoclonal  antibody 2A9 can be 
called an anti-3-ADON monoclonal antibody, because of its very sensitive and specific 
characteristics towards 3-ADON. Furthermore, when applying monoclonal antibody 10H10 in 
an indirect ELISA using DON-OVA coating, almost no affinity for 15-ADON is observed. So, 
when monoclonal antibodies 10H10 and 2A9 are used together in an indirect ELISA format, 
the DON content without its acetylated derivatives can be determined. 
By using a three-series synthesis strategy for the development of specific monoclonal 
antibodies against DON, previous statements were confirmed and new conclusions could be 
made. The place of the linker on the DON molecule is of importance for the immunogenic 
response. When a linker is positioned on the C3 or C15 of DON for the synthesis of an 
immunogen, the produced antibody shows higher cross-reactivity against 3-ADON or 15-
ADON, respectively. When coupling a linker to the carbonyl C8 of DON, no high anti-DON 
immune response was observed. This emphasizes the immunogenic importance of the C8 
carbonyl function. The size of the linker does not seem to influence the immunogenicity of 
the injected conjugate. The kind of linker has an influence on the electrostatic configuration of 
the DON molecule and therefore on the antigenic determinant of DON which is available for 
the immune system of the mouse.  
Finally, we conclude that it is possible to produce specific antibodies against trichothecene 
mycotoxins such as 3-ADON by synthesizing the proper immunogen with the suitable linker 
and screening the hybridomas carefully. By changing the ELISA format and/or coating 
antigen, it is possible to influence the selectivity and cross-reactivity of the monoclonal 
antibody. 
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CHAPTER 4: THE DEVELOPMENT AND VALIDATION OF AN ELISA METHOD 
FOR RAPID SCREENING OF DEOXYNIVALENOL IN WHEAT DUST 
 
SUMMARY 
A sample preparation and ELISA method was developed and validated for the screening of 
DON in wheat and wheat dust. Extraction was carried out with water and was successful due 
to the polar character of DON. ELISA experiments were performed using the developed 
10H10 anti-DON monoclonal antibody (chapter 3). The method was validated according to 
the criteria mentioned in Commission Regulation 519/2014/EC and Commission Decision 
2002/657/EC. A small survey was executed on 16 wheat lots and their corresponding dust 
samples. The samples were analysed according to the developed sample preparation and 
ELISA procedure. A linear and logarithmic correlation (r = 0.887 and 0.928, respectively) 
were found for the DON concentration in dust versus the DON concentration in wheat. 
Therefore, it is possible to estimate the cereal contamination through dust analysis.  
 
Keywords: deoxynivalenol, monoclonal antibodies, ELISA, wheat, wheat dust 
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4.1 INTRODUCTION 
As mentioned in Chapter 2, DON accumulates in wheat dust. Former research highlighted the 
risk of developing respiratory diseases with people working in the agricultural sector, 
especially during the process of grain harvesting and threshing [Zukiewicz-Sobczak et al., 
2012]. Dust contaminated with mould spores and/or mycotoxins may cause asthma, allergic 
alveolitis, chronic bronchitis, allergic rhinitis, mucous membrane irritation, certain infectious 
diseases and cancer due to long-term inhalation [Pettigrew et al., 2010; Krysinska-Traczyk et 
al., 2001; Halstensen et al., 2004].  
The American Conference of Governmental Industrial Hygienists (ACGIH, 1997) has defined 
three grain dust mass fractions in relation to potential health effects: (1) the inhalable fraction 
(dust particle diameter of 100 µm that enters the airways region), (2) the thoracic fraction 
(dust particle diameter of 10 µm which deposits in the tracheobronchial regions) and (3) the 
respirable fraction (dust particle diameter of 4 µm which enters the gas-exchange regions). 
Thus, the smaller the dust particle size and the bigger the surface area, the more dangerous in 
terms of health risks. As indicated in Figure 2.2 the most abundant dust fraction in wheat has 
a particle size smaller than 50 µm. The health risk should surely be taken seriously.  
At the moment, no fast screening technique exists for the determination of mycotoxins in 
grain dust as no regulatory limits for mycotoxins in grain dust and no mycotoxin absorption 
data after inhalation are yet available.  
As mentioned in Chapter 2, there is a more homogenous distribution of mycotoxins in grain 
dust compared to grain cereals. Due to the possibility of continuously sampling through the 
entire grain movement process (recovery of only 20 g dust out of a wheat bulk lot of 100 kg), 
a more representative sample can be taken. For dust, a grinding step is not necessary prior to 
sample extraction making it less time-consuming than the conventional cereal sampling. 
Chapter 4 describes the development and validation of a simple sample preparation and 
ELISA method for the determination of DON in wheat and wheat dust using the developed 
10H10 monoclonal antibody. 
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4.2 MATERIALS AND METHODS 
4.2.1 Reagents and chemicals 
DON standard was obtained from Fermentek (Jerusalem, Israel). DON-HRP was prepared as 
previously described in Chapter 3. 
Colorburst™ blue TMB substrate solution containing hydrogen peroxide was supplied by 
Alerchek (Springvale, Maine, USA). Rabbit anti-mouse immunoglobulins (anti-mouse IgG 
secondary antibody; protein concentration of 2.5 g/L) were purchased from DakoCytomation 
(Glostrup, Denmark). PBS (0.01 M, pH 7.4) powder, CBS (0.05 M, pH 9.6) capsule,  Tween 
20 and skim milk powder were obtained from Sigma-Aldrich (Bornem, Belgium). Water was 
obtained from a Milli-Q SP Reagent water system from Millipore Corp. (Brussels, Belgium). 
Other chemicals and solvents were of analytical grade.  
Nunc-Immuno™ F96-well microplates were from Nalge Nunc International (Roskilde, 
Denmark).  
 
4.2.2 Dust collection 
Dust was produced out of wheat samples by the use of a dust collection facility as mentioned 
in Chapter 2 and illustrated in Figure 2.1.  
 
4.2.3 Chemical composition of wheat dust 
The chemical composition of two different batches of wheat dust was determined to better 
understand possible interfering components for the monoclonal antibody in ELISA. First, 
between 3 and 5 g of wheat dust was weighed in a cup and placed in an oven. Starting from room 
temperature, every 5 h the temperature of the oven increased with 5 °C until a temperature of 
550 °C was reached. Afterwards, the cup was cooled down in an desiccator and the water 
together with the organic fraction was determined by calculating the difference in weight before 
and after incineration. Based on Dashek et al. ( 986), the moisture content of spring wheat dust 
has a value between 4.97% and 8.08% depending on the duration of drying at 60 °C. Previous 
researchers have measured a percentage of ash between 7.9% and 28.5% [Parnell et al.,  986; 
Martin,  98 ]. Then,  00 mg of the ash was redissolved in 5 mL 6 M HCl followed by 5 mL 3 M 
HCl while heating. After cooling down, 50 mL of water was added and the solution was filtered 
by the use of a Whatman No 5 filter (VWR International, Zaventem, Belgium). The filtered 
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solution was analysed by inductively coupled plasma with atomic emission spectroscopy (ICP-
AES) to determine and  uantify the mineral composition of the inorganic fraction of the wheat 
dust.  
 
4.2.4 Sample preparation 
One gram of wheat and half a gram of the corresponding wheat dust was weighed in a 
Gosselin
 
extraction tube (50 mL). The extraction was performed by adding 30 mL of water for 
30 min and 50 mL of water for 20 min respectively, using the Agitator decanter overhead 
shaker (Agitelec, J. Toulemonde and Cie, Paris, France), followed by a short centrifugation at   
3 000 g for 5 min prior to ELISA to remove small particles from the supernatant. 
 
4.2.5 Direct ELISA 
All incubations, except for the first coating step, were carried out at 37 °C, and after each 
incubation, the plates were washed three times (300 µL/well) with PBST using an automatic 
microplate washer “96PW” (TECAN, Salzburg, Austria). High-binding polystyrene 96-well 
microplates were coated with  00 μL/well of anti-mouse IgG secondary antibody diluted in 
CBS (5 μg/mL). After incubation at 4 °C overnight, the plates were blocked with 2% (w/v) 
skim milk in PBS (300 μL/well) for 30 min. For competitive direct ELISA analysis, an 
appropriate dilution of 10H10 monoclonal antibody (100 µL/well) was added to the 96-well 
plate, followed by an incubation step of 1 h. After this, standard solutions of DON and PBS 
control were added (50 μL/well) for the standard curve and wheat or wheat dust extract (non-
diluted, 1/2, 1/5 and 1/10 dilution) (50 µL/well) for the unknown grain sample. DON-HRP 
(50 µL/well) was added for competition of binding to the antibody and this was incubated for 
another hour. Then,  00 μL/well of TMB substrate solution was added. The reaction was 
stopped after  5 min with 2 M sulphuric acid (50 μL/well), and the absorbance at 450 nm was 
measured by a Bio-Rad model 550 microplate reader (Richmond, CA, USA). 
Standard competitive curves were obtained by plotting relative absorbance (ratio of 
absorbance measured at the standard concentration and zero concentration: B/B0×100%) 
against the logarithm of analyte concentration. IC50 values were determined to assess the 
assay sensitivity. Matrix-matched standard competitive curves were made by spiking blank 
wheat and wheat dust samples at different DON concentration levels until 3 000 µg/kg and  
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15 000 µg/kg, respectively. Blank samples were considered as blank if no DON 
contamination was found after LC-MS/MS analysis. 
 
4.2.6 Method validation 
The ELISA methods for the determination of DON in wheat and wheat dust were validated 
according to the criteria for the validation of semi-quantitative screening methods mentioned 
in Commission Regulation 519/2014/EC and Commission Decision 2002/657/EC. Twenty 
blank wheat and wheat dust samples and twenty wheat and wheat dust samples contaminated 
around the screening target concentration (STC) were analysed over 5 different days. The 
DON concentration was determined using matrix-matched standard competitive curves. The 
determined validation parameters include the apparent recovery, analytical range, limit of 
detection, sensitivity and intra-assay accuracy and precision. The fitness for purpose of the 
screening methods was determined by the evaluation of the cut-off value and false suspect 
rate.  
 
4.2.7 Collection of wheat and corresponding dust samples 
Wheat samples (n = 16) were randomly collected in Belgium and Hungary in the framework 
of the European FP7 MycoHunt project (“Rapid biosensor for the detection of mycotoxin in 
wheat”). As only 20 g of dust can be recovered out of a wheat bulk lot of 100 kg, extensive 
efforts were made to receive a sufficient amount of DON contaminated wheat samples from 
grain millers, but only 16 samples could be obtained. Out of one part of every wheat sample, 
dust was aspirated by the use of the dust collection facility, while the other part of the wheat 
sample was ground. 
 
4.2.8 Dust correlation study 
Using the developed and validated sample preparation and ELISA method, the DON content 
of the 16 wheat and corresponding wheat dust samples was determined. All calculations were 
performed and processed using Microsoft Office Excel 2010 and IBM SPSS 22. Verifying a 
possible correlation, the Pearson correlation coefficient was determined for the batch of 
samples.  
Chapter 4: The development and validation of an ELISA method for rapid screening of deoxynivalenol in wheat dust 
126 
 
4.3 RESULTS AND DISCUSSION 
4.3.1 Chemical composition of wheat dust 
The water plus organic fraction as determined by the difference in weight before and after 
incineration resulted in 27.94% and   .65% for the two different wheat dust batches, which lies 
in the range mentioned by Martin ( 98 ). The mineral composition of the inorganic fraction, is 
shown in Table 4. . In batch  , the most predominant minerals were Fe,   and P and for batch 2, 
most mineral components were present in a higher  uantity with extremely high values for Fe, , 
Mg, Na and P. Therefore it can be concluded that the water and organic fraction and the mineral 
composition of wheat dust can be different from batch to batch.  
It is generally known that changing the composition of PBS buffer or PBST buffer by adding 
extra sodium or phosphate, can have an influence on the outcome of an ELISA. Therefore, it can 
be concluded that a different mineral composition of wheat dust can change the ELISA results in 
the same way. 
 
Table 4.1 Mineral composition of wheat dust 
Mineral Concentration batch   
(µg/g) (n   2) 
Concentration batch 2 
(µg/g) (n   2) 
Cu 5  339 
Fe 27 400 13 450 
  3  700 79 300 
Mg 8 700 44 650 
Mn 768 2 320 
Na   900 11 100 
P  0 400 46 150 
S 3 630 9 870 
Zn 700 3 380 
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4.3.2 Optimization of sample preparation 
The wheat and wheat dust matrix effect on the sensitivity of the developed 10H10 monoclonal 
antibody was evaluated. The results are presented in Figure 4.1. As seen, the sensitivity of the 
antibody decreased from a value of 22 ng/mL to 56 ng/mL and 61 ng/mL in wheat and wheat 
dust extract, respectively. As the sensitivity was reduced by half when working in a cereal 
matrix, it can be concluded that a matrix effect needs to be considered for wheat and wheat 
dust. Therefore it was decided to use matrix-matched calibration curves during the 
optimization experiments and for the ELISA screening of contaminated wheat and wheat dust 
samples.  
 
 
Figure 4.1 Calibration curve of DON in PBS, wheat and wheat dust extract with the 10H10 monoclonal 
antibody using a direct ELISA format. As the experiment was repeated on 3 consecutive days, the inter-
day precision and accuracy was determined by the standard deviation and represented by the error bars 
on the calibration curve.  
 
During the optimization experiments, blank wheat and wheat dust extracts were spiked with 
DON standard dissolved in acetonitrile (100 ng/µL) at a level of 3 000 µg/kg for wheat and 
between 4 000 µg/kg and 30 000 µg/kg for wheat dust. The best sample preparation 
conditions were determined based on the measured apparent recovery values. As DON is 
good water soluble (solubility of 11 g/L), there should be no problem of using water as 
extraction solvent.  
DON concentration (ng/mL) 
 1                              10                            100                          1 000          
B
/B
0
 (
%
) 
PBS 
Wheat extract 
Wheat dust extract 
90 
80 
70 
60 
50 
40 
30 
20 
10 
0 
Chapter 4: The development and validation of an ELISA method for rapid screening of deoxynivalenol in wheat dust 
128 
 
First of all, half a gram of wheat dust was spiked with DON at a level of 4 000 µg/kg, 12 000 
µg/kg and 20 000 µg/kg and extracted by overhead shaking for 1 h using 5 mL of water. After 
centrifugation, half of the supernatant was filtered using a Whatman No 4 filter (VWR 
International, Zaventem, Belgium) and diluted 1/10, 1/100 and 1/1 000 with water prior to 
direct ELISA. The ELISA results using the dust extracts without filtration are presented in 
Table 4.2. As seen for the 4 000 µg/kg spike, the best recoveries were found with the 1/100 
diluted samples. This is normal as the linear range of the 10H10 antibody in wheat dust matrix 
lays in between 110 µg/kg and 4 060 µg/kg taken into account the 0.5 g of wheat dust and 5 
mL of extraction solvent. Based on this linear range, only the 1/10 and 1/100 dilution would 
be quantifiable. As not much difference was seen between the use of filter or no filter, it was 
clear that small particles did not influence the antibody or the ELISA format. Therefore, no 
filter was used in further experiments. A very low recovery (below 32%) was observed for the 
spiked wheat dust samples at a level of 12 000 µg/kg and 20 000 µg/kg. Therefore it was 
concluded that a higher extraction volume or a certain percentage of methanol was necessary 
to extract large DON concentrations. 
 
Table 4.2 Direct ELISA recovery results for wheat dust spiked at 4 000 µg/kg, 12 000 µg/kg and 20 000 
µg/kg 
Spiking level Extraction 
ratio (g/mL) 
Dilution DON concentration 
(µg/kg) 
Recovery (%) 
4 000 µg/kg 1/10 1/10 2 060 51.60 
  1/100 5 010 125.25 
  1/1 000 52 110 1302.75 
12 000 µg/kg 1/10 1/10 3 780 31.52 
  1/100 1 980 16.53 
  1/1 000 100 950 841.27 
20 000 µg/kg 1/10 1/10 7 340 36.70 
  1/100 4 510 22.54 
  1/1 000 23 220 116.11 
 
The same experiment was performed using only wheat dust samples spiked at 20 000 µg/kg 
extracting with water or water with 10% methanol (5 mL) to evaluate the influence of organic 
solvent on the extraction efficiency. No difference in recovery was observed between the use 
of water and water with 10% methanol as extraction solvent (p-value = 0.442) with a 
maximum recovery of 52%. When increasing the extraction volume of water up to 10 mL, 25 
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mL and 50 mL, the recovery increased with a maximum and optimal recovery value at 50 mL 
extraction volume and no subsequent dilution of supernatant prior to ELISA. All recovery 
values at spiking levels of 4 000 µg/kg, 8 000 µg/kg, 12 000 µg/kg, 16 000 µg/kg and 30 000 
µg/kg lay in the range 75% - 153%. The extraction duration was the last parameter which was 
optimized. Spiked dust samples were extracted for 10, 20, 30 min and 1 h and the recovery 
was calculated and compared. A maximum recovery was reached after 20 min of water 
extraction.  
For the optimization of wheat extraction, one gram of wheat was spiked with DON at a level 
of  3 000 µg/kg and extracted by overhead shaking for 1 h using 5 mL, 10 mL or 30 mL of 
water. The influence of centrifugation (3 000 g, 5 min) of wheat extracts prior to ELISA was 
determined and no difference was seen in the ELISA results when using a centrifuged extract 
or not (p-value = 0.098). As no difference in recovery was noticed between an extraction time 
of 30 min and 1 h (p-value = 0.488), it was decided to use the shorter extraction time of 30 
min. We choose to use 30 mL of extraction volume in later experiments as an increase in 
recovery of 20% was observed compared to 5 and 10 mL of extraction solvent. In the optimal 
wheat sample preparation conditions the determined mean recovery was 100.17%. 
 
4.3.3 Method validation 
The ELISA methods were successfully validated for DON in wheat and wheat dust based on 
Commission Regulation 519/2014/EC and Commission Decision 2002/657/EC. A DON 
spiking range from 100 - 3 000 µg/kg and 500 - 15 000 µg/kg was taken for the wheat and 
wheat dust calibration curve, respectively. The linearity was evaluated by the correlation 
coefficient (r) and a lack of fit test.  
The calibration curve showed good linearity for wheat, with a r of 0.998 and a p-value of 
1.000. The apparent recovery ((RSD, %), n = 5) determined at 2 000 and 10 000 µg/kg was  
96% (SD = 10) and 102% (SD = 7). A LOD determined as the IC10 (i.e. 10% inhibitory 
concentration) of 233 µg/kg
 
or 4.67 ng/mL was calculated. The analytical range of the assay 
was set as 386 - 7 894 µg/kg based on the IC20 and IC80 value, though the maximum spiking 
level for the calibration curve was 3 000 µg/kg. During the precision study, relative standard 
deviations (RSDs) were measured at the different concentration levels; however, only the data 
obtained at the medium and high level (1 500 and 3 000 µg/kg) were recorded. For the intra-
day precision an RSDr of respectively, 3.87% and 7.93% for the medium level and high level 
was observed. For the inter-day precision an RSDR of 7.50% and 8.73%, respectively was 
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determined. The RSDr and RSDR data obtained are in agreement with the acceptable RSD 
values for repeatability of quantitative methods according to Commission Decision 
2002/657/EC. A maximum uncertainty (U) of the determined DON concentration was 22% 
for all spiking levels. For the determination of the fitness for purpose of the screening method, 
the STC was set at the maximum DON regulatory level in unprocessed cereals other than 
durum wheat, oats and maize (1 250 µg/kg) and the contamination level of the 20 positive 
control samples was taken around this STC, namely at 1 500 µg/kg. The calculations of the 
cut-off level and the rate of false suspected results were based on the relative responses of the 
blank samples and positive control samples. As a cut-off value a relative response of 0.58 or 1 
167 µg/kg was measured, which approximately corresponds to the STC. For the determination 
of the false suspect results, a t-value of 5.68 was calculated which corresponds to the event 
that a result of a negative control sample is above the cut-off value. Based on this t-value and 
the degrees of freedom (19), a probability of false suspect samples for a one tailed distribution 
of less than 0.01% was determined.  
The calibration curve for wheat dust revealed good linearity as well, giving a r of 0.998 and a 
p-value of 1.000. The apparent recovery ((RSD, %), n = 5) determined at 2 000 and 10 000 
µg/kg was 96% (SD = 6) and 108% (SD = 5). The analytical range of the assay was set as 744 
- 13 775 µg/kg and a LOD of 458 µg/kg
 
or 9.15 ng/mL was calculated. RSDs were recorded 
at a medium concentration level of 2 000 µg/kg and a high concentration level of 8 000 µg/kg. 
For the intra-day precision an RSDr of respectively, 7.33% and 9.28% for the medium level 
and high level was observed. For the inter-day precision an RSDR of 8.16% and 9.47%, 
respectively was determined. A maximum uncertainty of the determined DON concentration 
was 29% for all spiking levels. As no maximum levels are yet established for DON in wheat 
dust, the STC was chosen at a higher concentration than for wheat based on the research 
results described in Chapter 2 and was set at 8 000 µg/kg. The calculations of the cut-off level 
and the rate of false suspected results were based on the relative responses of the blank 
samples and positive control samples. As a cut-off value a relative response of 0.36 or 6 326 
µg/kg was measured. For the determination of the false suspect results, a t-value of 7.32 was 
calculated which corresponds to the event that a result of a negative control sample is above 
the cut-off value. By the use of the t-value and the degrees of freedom (19), a probability of 
false suspect samples for a one tailed distribution of less than 0.01% was determined. 
Based on the above described validation results, both ELISA methods show to be acceptable 
for their purpose. An overview of the validation results is given in Table 4.3. 
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Table 4.3 Overview of validation results of the wheat and wheat dust ELISA screening methods 
 Wheat Wheat dust 
Parameters Spiking level 
(µg/kg) 
Results Spiking level 
(µg/kg) 
Results 
r  0.998  0.998 
Apparent recovery 2 000 96 % 2 000 96 % 
10 000 102 % 10 000 108 % 
LOD  233 µg/kg  458 µg/kg 
Analytical range  386 – 7 894 µg/kg  744 – 13 775 µg/kg 
RSDr 1 500 3.87 % 2 000 7.33 % 
3 000 7.93 % 8 000 9.28 % 
RSDR 1 500 7.50 % 2 000 8.16 % 
3 000 8.73 % 8 000 9.47 % 
U  < 22 %  < 29 % 
False suspect result  < 0.01 %  < 0.01 % 
 
 
4.3.4 Analysis of wheat and wheat dust samples 
The DON content of wheat and dust samples (n = 16) was determined according to the 
described direct ELISA method. Each wheat and corresponding wheat dust sample was 
analysed once. All wheat samples were contaminated with DON in a range of 14 µg/kg to      
1 113 µg/kg with a mean contamination level of 244 µg/kg (median = 75 µg/kg). Dust 
samples clearly showed higher levels in a range from 607 µg/kg to 14 043 µg/kg with a mean 
contamination of 5 012 µg/kg (median = 1 518 µg/kg). According to the Commission 
Regulation (EC) No 1881/2006 of 19 December 2006 setting maximum levels for certain 
contaminants in foodstuffs, for DON in unprocessed cereals other than durum wheat, oats and 
maize the maximum limit was set at 1 250 µg/kg. No wheat samples exceeded this maximum 
limit.  
 
4.3.5 Dust correlation study 
The ELISA results for each wheat sample and the corresponding dust sample are presented in 
a scatterplot (Figure 4.2). A sigmoidal correlation between the DON concentration in wheat 
dust versus the DON concentration in wheat was proved according to the correlation 
coefficient, r (0.928) and a trend analysis of the residuals. When not considering the data 
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points with a DON concentration in wheat lower than 200 µg/kg (< LOD), a linear correlation 
(r = 0.889) was found. The slope of the trend line described a value of 5.023 which 
corresponds to a 5-fold accumulation of DON on small particles and is different to the slope 
(13.192) found after LC-MS/MS analysis of wheat and their corresponding wheat dust 
samples (Chapter 2). As limited wheat and corresponding wheat dust samples were obtained 
and only at a concentration level in wheat lower than 1 200 µg/kg, the uncertainty of the slope 
corresponding to the linear curve is high. Also, no conclusion can be taken about whether to 
use the linear or logarithmic curve.  
 
 
Figure 4.2 A scatterplot of the DON concentration in dust (y-axis) versus wheat (x-axis). A sigmoidal 
correlation between the DON concentration in wheat dust versus the DON concentration in wheat was 
observed (r = 0.928). When not considering the data points with a DON concentration in wheat lower than 
200 µg/kg (< LOD), a linear correlation (r = 0.889) was found. 
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4.4 CONCLUSION 
Based on the results of Chapter 4, it can be stated that the ELISA methods were successfully 
developed and validated for rapid screening of DON in wheat and wheat dust. The developed 
ELISA methods were used in an experimental field trial, where a linear and logarithmic (r = 
0.889 and 0.928, respectively) correlation was found between the DON content in wheat dust 
versus the DON content in wheat. At the moment, no decision can be made about whether to 
use the linear or logarithmic calibration curve as more contaminated wheat and corresponding 
dust samples are necessary.  
The chemical composition results of wheat dust reveal that certain wheat dust samples can have 
a very high mineral content. These minerals, like Fe,   and P can influence the ELISA results. 
As a high extraction volume (50 mL) was used, the concentration of these minerals and their 
influence on the developed ELISA format can be considered as negligible.  
In general, the sampling of dust and subsequent ELISA analysis can be considered as a fast 
and easy-to-use technique which can be performed on-site. The determined ELISA results 
show together with the LC-MS/MS data described in Chapter 2, the possibility of estimating 
the DON content in cereals through the determination of DON in dust. 
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CHAPTER 5: THE DEVELOPMENT OF SPECIFIC RECOMBINANT ANTIBODIES 
AGAINST DEOXYNIVALENOL 
 
SUMMARY 
There is a need for a sensitive screening technique for the determination of DON in cereal 
samples. Currently, only for DON maximum levels were set by the European Commission. 
Therefore, specific monoclonal antibodies against DON with minimal cross-reactivity against 
other mycotoxins like 3-ADON or 15-ADON need to be developed. By using the hybridoma 
technology, three different monoclonal anti-DON antibodies were developed but each of them 
showed cross-reactivity against structurally related trichothecene analogues. Therefore it was 
decided to use recombinant immunotechnology to synthesize more specific anti-DON 
antibodies. A recombinant scFv antibody was developed from the RNA of the hybridoma 
producing anti-DON monoclonal antibodies and checked for its binding properties towards 
DON. No specificity tests were carried out as too low E. coli expression levels were obtained 
to set up ELISA calibration curves. Using the Swiss Model program, molecular modeling of 
the constructed scFv was performed. The binding of the ligand DON to the model scFv was 
predicted by SwissDock. 
 
Keywords: deoxynivalenol, recombinant antibodies, molecular modeling, docking 
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5.1 INTRODUCTION 
The objective of Chapter 5 was to improve the specificity of the 10H10 monoclonal anti-
DON antibody and to relocate the specific character of the 2A9 monoclonal anti-DON 
antibody towards DON. Recombinant antibody technology involves the handling of key 
antibody fragments and expression in E. coli, allowing low-cost and high-speed production 
and purification, which are important advantages for medical, diagnostic and therapeutic 
applications [Choi et al., 2004].  
One of the most popular types of recombinant antibodies is the scFv, which is easily produced 
by several expression systems. In this chapter, the development of a DON scFv is described in 
detail. Repertoires of PCR amplified VH and VL chain antibody gene fragments were cloned 
into a phagemid vector to produce scFv-displaying phage particles. During this study, the 
phage display vector pComb3XSS was employed to express DON scFv on the surface of 
filamentous phage particles [Maragos et al., 2012; Fitzgerald et al., 2011; Fallecker et al., 
2013]. Based on the sequencing results of the developed DON scFv, modeling and docking 
experiments were carried out to evaluate the possible interaction sites and strength towards 
the DON antigen.  
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5.2 MATERIALS AND METHODS 
5.2.1 Reagents and chemicals 
Colorburst™ blue TMB substrate solution containing hydrogen peroxide was supplied by 
Alerchek (Springvale, Maine, USA). Expedeon InstantBlue
TM
 stain and TMB membrane 
substrate were purchased from Thermo Scientific (Rockford, USA). PBS (0.01 M, pH 7.4) 
powder, CBS (0.05 M, pH 9.6) capsule, Tween 20, skim milk powder, RNase-free water, 
agarose, NaH2PO4, sodium dodecyl sulfate (SDS), 2-mercaptoethanol, bromophenol blue, 
Tris(hydroxymethyl)aminomethane (TRIS), glycine, BSA, Triton X-100, lysozyme, 
imidazole, tryptone, yeast extract, NaCl, KCl, MgCl2.6H2O, MgSO4.7H2O, glucose, agarose, 
3-(N-morpholino)propanesulfonic acid (MOPS), glycerol, KH2PO4, K2HPO4 and anti-HA-
HRP were obtained from Sigma-Aldrich (Bornem, Belgium). DMEM, fetal bovine serum, 
penicillin, streptomycin, carbenicillin and Platinum Taq DNA polymerase High Fidelity were 
purchased from Invitrogen (Merelbeke, Belgium). TRIzol and SuperScript II reverse 
transcriptase kit, IPTG and One shot chemically competent TOP 10F’ E. coli cells were 
bought at Life Technologies (Ghent, Belgium). The iScript Advanced cDNA synthesis kit for 
reverse transcription polymerase chain reaction (RT-PCR) was obtained from BioRad 
(Nazareth, Belgium). RNeasy mini kit, Qiashredder kit and nickel-nitrilotriacetic acid (Ni-
NTA) resin were purchased from Qiagen (Manchester, UK). GoTaq G2 Flexi DNA 
polymerase and 1 kB DNA ladder were obtained from Mybio (Kilkenny, Ireland). T4 DNA 
ligase, deoxyribonucleotide triphosphate (dNTP) solution mix, Phusion High Fidelity DNA 
polymerase, SfiI restriction enzyme and Antarctic phosphatase with corresponding buffer 
were bought at New England Biolabs (Dublin, Ireland). XL1-Blue electroporation-competent 
E. coli cells were purchased from Agilent technologies (Cork, Ireland). Vivaspin 5-kDa cut-
off columns were bought at GE Life Sciences (Diegem, Belgium). Nucleospin Extract II kit 
was obtained from Labquip Ireland (Dublin, Ireland). Other chemicals and solvents were of 
analytical grade. Water was obtained from a Milli-Q SP Reagent water system from Millipore 
Corp. (Brussels, Belgium). 
The E. coli growth media were prepared as follow. For the super optimal broth with catabolic 
repressor (SOC) medium, 20 g of tryptone, 5 g of yeast extract, 10 mL of 1 M NaCl and 2.5 
mL of 1 M KCl were combined and water was added to 970 mL. The broth was autoclaved 
and cooled down to room temperature prior to the addition of 5 mL of 1 M MgCl2.6H2O, 5 
mL of 1 M MgSO4.7H2O and 10 mL of 2 M glucose (filtered solutions). To prepare Luria-
Bertani (LB) broth, 10 g of tryptone, 5 g of yeast extract and 10 g of NaCl were dissolved in 1 
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L of water. An amount of agar (15 g/L) was added to the LB broth for the preparation of agar 
plates. The super broth (SB) consisted of 10 g of MOPS, 30 g of tryptone and 20 g of yeast 
extract dissolved in 1 L of water. The terrific broth (TB) was prepared by mixing 12 g of 
tryptone, 24 g of yeast extract, 4 mL of glycerol and adding water up to 900 mL. The LB 
broth or agar and SB and TB broth were autoclaved as well prior to use. For the TB broth 
extra nutrients were added including 2.31 g KH2PO4 and 12.54 g K2HPO4 dissolved in 100 
mL of water, 5 mL of glycerol, 5 mL of 10% (w/v) glucose and 1 mL of 1 M MgSO4.7H2O. 
Nunc-Immuno™ F96-well microplates were from Nalge Nunc International (Roskilde, 
Denmark).  
 
5.2.2 First strand cDNA synthesis 
The mouse hybridoma cell line 10H10 against DON and 2A9 against 3-ADON was 
established and maintained in DMEM supplemented with 10% (v/v) fetal bovine serum, 100 
U/mL penicillin and 100 µg/mL streptomycin. For total mRNA isolation from the hybridoma 
cell line, TRIzol was used according to the manufacturer’s instructions. Out of the derived 
mRNA, cDNA was synthesized using the iScript Advanced cDNA synthesis kit for RT-PCR 
containing reverse transcriptase and the corresponding reaction mix. Because of failure of 
correctly folded cDNA synthesis using this procedure, for the 2A9 hybridoma cell line, 
mRNA was extracted using the RNeasy mini kit combined with the Qiashredder kit. After 
confirmation of successful mRNA extraction using gel electrophoresis, cDNA was generated 
by reverse transcription using the SuperScript II reverse transcriptase kit. 
 
5.2.3 Construction of scFv expression vector 
The cDNA was used as a template for the amplification of VH and VL genes. Primers sourced 
from Eurofins MWG (Ebersberg, Germany) were compatible with the primers described by 
Barbas et al. (2001). For the amplification of 2A9 cDNA, a mix of V5’ MSCVK1-17 sense 
and V3’ MSCJK12-BL, MSCJK4-BL and MSCJK5-BL reverse primers and a mix of VH 5’ 
MSCVH1-19 sense and VH3’ MSCG1ab-B, MSCG3-B and MSCM-B reverse primers were 
used. For the 10H10 cDNA, the V 5’ MSCV  7 sense primer and the mix of V3’ 
MSCJK12-BL, MSCJK4-BL and MSCJK5-BL reverse primers and VH 5’ MSCVH5 sense 
primer and the mix of VH3’ MSCG1ab-B, MSCG3-B and MSCM-B reverse primers were 
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combined. The optimal MgCl2 concentration for DNA amplification of the 2A9 and 10H10 
cDNA using goTaq DNA polymerase was set at 4 mM and 3 mM. The PCR products were 
purified using the Nucleospin Extract II kit. The VH and VL purified fragments were joined 
via a glycine-serine linker by SOE-PCR using high fidelity Phusion Taq and 2 mM MgCl2 for 
the 2A9 DNA and high fidelity Platinum Taq and 1.5 mM MgSO4 for the 10H10 DNA to 
produce a 700-800 bp fragment that was cloned into the pComb3XSS vector via the SfiI 
restriction sites. The cyclic DNA of the pComb3XSS is presented in Figure 5.1. 
 
Figure 5.1 Cyclic DNA of pComb3XSS vector 
 
First of all, the SOE-PCR products and the cyclic DNA of the pComb3XSS were digested 
using SfiI restriction enzymes. Subsequently, to 1 µg of the PCR products, 4 µL of NEB 
buffer and 16 units of SfiI enzyme was added and the volume was adjusted to 50 µL with 
water. For the pComb vector, 20 µg of the DNA was combined together with 20 µL of NEB 
buffer and 120 units of SfiI enzyme and the volume was adjusted to 100 µL with water. The 
digests were incubated for 5 h in a warm water bath at 50 °C. To the digested pComb vector, 
Chapter 5: The development of specific recombinant antibodies against deoxynivalenol 
142 
 
5 µL of Antarctic phosphatase enzyme together with 10 µL of reaction buffer was added and 
this was incubated for 30 min at  37 °C and inactivated for 20 min at 65 °C. The digested 
SOE-PCR and pComb products were run on a 1% and 0.6% agarose gel, respectively. The 
digested SOE-PCR, pComb and stuffer were cut out and purified using the Nucleospin 
Extract II kit. The concentrations were determined using a Nanodrop ND-1000 
spectrophotometer (Thermo Scientific, Rockford, USA). 
Ligation of the digested SOE-PCR into the digested pComb vector was performed overnight 
at room temperature using T4 DNA ligase enzyme and the corresponding buffer. In detail, 
140 ng of the digested pComb vector was added to 70 ng of digested SOE-PCR insert 
together with 1 µL of T4 DNA ligase (400 units) in the appropriate buffer. The ligation 
efficiency of the pComb vector was tested by ligating it with the gel-purified stuffer fragment 
that was generated during SfiI digestion of the vector DNA (control 1). The amount of uncut 
or partly cut vector DNA was estimated by setting up a ligation reaction that contains only 
vector DNA (control 2). These two control ligations were performed using the same amount 
of pComb vector DNA. 
Transformation of the ligated product into a commercially available strain of XL-1 Blue or 
One shot chemically competent TOP 10F’ was performed. For the transformation into XL-1 
Blue E. coli cells, a Gene Pulser Xcell electroporation system was used. The electroporation 
was performed at 2.5 kv, 25 µF, 200 Ω during 4.0 msec. The transformation into One shot 
chemically competent TOP 10F’ E. coli cells was performed by incubation on ice and 42 °C 
for 30 min and 30 sec, respectively, followed by transfer of the cells on ice. The time lapse 
between applying the pulse and transferring the cells to the pre-warmed SOC growth medium 
was kept to an absolute minimum to ensure optimal recovery of the transformed E. coli cells. 
The transformed culture was serially diluted and plated on selective LB agar containing 
carbenicillin (100 µg/mL) plates.  
 
5.2.4 Expression of scFv antibody 
One colony of the E. coli cells was picked and the DNA was amplified using PCR to confirm 
the transfer of the DNA encoding the DON scFv. Another E. coli colony was transferred to 5 
mL of TB growth medium containing carbenicillin (100 µg/mL) and cultured overnight at 
37 °C while shaking at 240 rpm. Of the overnight culture, 1 mL was transferred into 400 mL 
of fresh SB medium containing carbenicillin (100 µg/mL) and grown at 37 °C with shaking 
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(240 rpm) until an OD600 of 0.6 was reached. Then, 1 mM IPTG was added to the culture and 
incubated overnight at 30 °C with shaking (240 rpm). The culture was spun at 1 466 g for 10 
min to pellet the bacterial cells and the pellet was thoroughly resuspended in 15 mL of lysis 
buffer (50 mM NaH2PO4, 300 mM NaCl and 10 mM imidazole, pH 7.5) and transferred to 
ice. This was sonicated on ice for 3 min (6 sec intervals) at an amplitude of 40 using a 
microtip Vibra Cell
TM
 sonicator (Sonics, Newtown, USA). The cell debris was then removed 
by centrifuging at 13 201 g and 4 °C for 20 min and the lysate supernatant was filtered 
through a 0.2 µm filter prior to purification using IMAC. 
 
5.2.5 Purification of scFv antibody 
Purification of the filtered lysate was performed by IMAC using Ni-NTA resin. The Ni-NTA 
slurry was added to a 10 mL column and equilibrated with lysis buffer (50 mM NaH2PO4, 300 
mM NaCl and 10 mM imidazole, pH 7.5). Then, the filtered lysate was transferred to the 
equilibrated column and the flow through was collected. The column was washed with 8 mL 
of 50 mM NaH2PO4, 1 M NaCl, 10% (v/v) glycerol, 1% (v/v) Triton X-100 and 20 mM 
imidazole (pH 7.5) followed by 16 mL of 50 mM NaH2PO4, 300 mM NaCl and 20 mM 
imidazole (pH 7.5) and the flow-through was again collected. Elution of bound scFv was 
performed using a high concentration of imidazole by adding 5 mL elution buffer (50 mM 
NaH2PO4, 300 mM NaCl and 250 mM imidazole, pH 8.0). The eluate containing the scFv was 
buffer-exchanged against PBS using a 5 kDa cut-off Vivaspin column (GE Life Sciences, 
Diegem, Belgium). The scFv concentration was determined by the use of a Nanodrop ND-
1000 spectrophotometer. 
During the optimization of the expression and consequent purification procedures, the 
different flow-through and elution fractions were subjected to indirect competitive ELISA, 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and Western 
blotting assay. 
 
5.2.6 Indirect ELISA 
All incubations, except for the first coating step, were carried out at 37 °C, and after each 
incubation, the plates were washed three times (300 µL/well) with PBST followed by three 
times washing with PBS. High-binding polystyrene 96-well microplates were coated with the 
prepared DON conjugates coupled to OVA diluted in CBS ( 00 μL/well). After incubation at 
Chapter 5: The development of specific recombinant antibodies against deoxynivalenol 
144 
 
4 °C overnight, the plates were blocked with 2% (w/v) skim milk in PBS (300 μL/well) for 30 
min. In the first step, 100 μL/well of diluted scFv antibodies in PBS was added. After 
incubation for 1h, 100 μL/well of anti-HA-HRP was added and incubated for another 1 h. 
Then,  00 μL/well TMB substrate solution was added. The reaction was stopped after 15 min 
with 2 M sulphuric acid (50 μL/well), and the absorbance at 450 nm was measured by a Bio-
Rad model 550 microplate reader (Richmond, CA, USA). 
 
5.2.7 SDS-PAGE and Western blotting assay 
Flow-through and elution fractions were mixed with loading buffer (5% (w/v) SDS, 5% (v/v) 
2-mercaptoethanol, 20% (v/v) glycerol and 20 µg/mL bromphenol blue in 125 mM Tris pH 
6.8) in a ratio 3/1 (v/v), heated at 98 °C for 5 min and separated by SDS-PAGE using 
electrophoresis buffer containing 5 mM Tris pH 8.3, 19.6 mM glycine and 0.01% (w/v) SDS. 
For SDS-PAGE analysis, the separated proteins were visualized by the use of Instant Blue 
stain. Prior to Western blotting the SDS-PAGE gels containing the separated proteins were 
electrophoretically transferred onto a nitrocellulose membrane at 20 V for 15 min. The 
nitrocellulose membrane was blocked with 5% (w/v) BSA in PBS for 45 min, followed by the 
addition of anti-HA-HRP and subsequent incubation for 1 h. Then TMB substrate solution 
was added and the colour development was observed. 
 
5.2.8 ScFv antibody sequence analysis 
The DNA sequencing of the scFv antibodies was performed at Source Bioscience (Tramore, 
Ireland). The CDR and FR regions of the VH and VL chain were determined at the Abnum 
server (http://www.bioinf.org.uk) by the use of the Kabat numbering system. A proteomic 
study was performed for the total scFv protein structure using the online ExPASy and 
PSIPRED program (http://bioinf.cs.ucl.ac.uk).  
 
5.2.9 Modeling and docking experiments 
Computational homology modeling was performed using the SWISS-MODEL web server. 
ScFv model templates were identified based on the sequence of the 10H10 scFv and the 
template with the greatest identity was selected. Using the CASTp server, surface accessible 
pockets for different molecules such as receptors and ligands were determined. The solvent 
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accessibility, which determines the arrangement of amino acid residues, was measured by the 
ASAView automated server [Ahmad et al., 2004]. Molecular docking of the 10H10 model 
scFv and the DON ligand was performed using the online SwissDock and UCSF Chimera 
programs. Different clusters were generated sorted by FullFitness energy value (kcal/mol). 
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5.3 RESULTS 
5.3.1 First strand cDNA synthesis 
First of all, the RNA from the 2A9 and 10H10 hybridomas was extracted by using TRIzol and 
the cDNA was synthesized by the iScript Advanced cDNA kit. Further amplification of the 
2A9 cDNA using the primers described by Barbas et al. (2001) did not succeed even though 
the cDNA pattern observed by gel electrophoresis indicated it to be correct. As the problem 
could be a non-correctly folded cDNA, RNA extraction and cDNA synthesis were repeated 
using the RNeasy mini and the Qiashredder kit, followed by SuperScript II reverse 
transcriptase. After this, a correctly folded cDNA was obtained which was further used for 
scFv construction. The electrophoretic separation of the RNA and cDNA on a 1% agarose gel 
together with a 1 kB DNA ladder, is illustrated in Figure 5.2. Compared to the description by 
Barbas et al. (2001), a normal pattern with two bands at a size of 850 bp and 1500 bp for 
RNA and a smear for cDNA, was observed. 
 
                                                        
Figure 5.2 Agarose gel electrophoresis of 2A9 RNA (a) and cDNA (b)  
 
5.3.2 Construction of scFv expression vector 
For the construction of the 2A9 and 10H10 scFv, different parameters were optimized. 
Different MgCl2 (1 mM, 1.5 mM, 2 mM, 3 mM and 4 mM) concentrations were used during 
the goTaq polymerase reaction. Using a combination of VH 5’ sense primers MSCVH -19 or 
single MSCVH primers together with a combination of VH3’ reverse primers MSC  ab-B, 
MSCG3-B and MSCM-B, it was possible to select the optimal primer composition for VH 
amplification. The determination of a Vκ or Vλ light chain was performed using specific Vκ5’ 
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sense/ Vκ3’ reverse primers and Vλ5’ sense/ Vλ3’ reverse primers respectively. As no 
amplification was observed using the combination of Vλ primers, the presence of Vκ light 
chains was concluded for both 2A9 and 10H10 antibody. The optimal primer composition for 
Vκ amplification was selected by using a combination of Vκ5’ sense primers MSCV  -17 or 
single MSCVK primers together with a combination of Vκ3’ reverse primers MSCJ  2-BL, 
MSCJK4-BL and MSCJK5-BL. Figure 5.3 shows the PCR amplification of 10H10 VH and Vκ 
using the optimized conditions. The VH and Vκ DNA products were derived using optimized 
PCR conditions and ran on an agarose gel, the bands were cut out and purified for further 
SOE-PCR reaction.  
 
                                            
Figure 5. 3 Agarose gel electrophoresis after PCR amplification of 10H10 VH and Vκ .  
Control (a, b), Vκ (c, d) and VH (e, f). 
  
During SOE-PCR, two different high fidelity polymerases were used. First of all, Platinum 
Taq was used for the linking of the VH and Vκ of both 2A9 and 10H10 DNA products. A 
SOE-PCR product at a size of 750 bp was seen for 10H10 after agarose gel electrophoresis on 
a 1% gel (Figure 5.4). As for 2A9, no SOE-PCR product at this size was observed, it was 
decided to use another high fidelity polymerase enzyme, namely Phusion Taq. After SOE-
PCR, 2 bands were observed for the 2A9 SOE-PCR at a size of 500 bp and 700 bp (Figure 
5.4). The 2A9 and 10H10 SOE-PCR reactions were optimized using different concentrations 
of MgCl2 (1.5 mM, 2 mM, 2.5 mM and 3 mM) and MgSO4 (1.5 mM, 2 mM and 2.5 mM) for 
the Phusion Taq and Platinum Taq polymerase, respectively. The 2A9 (2 bands) and 10H10 
(1 band) SOE-PCR products derived using optimized PCR conditions and ran on a 1% 
agarose gel were cut out and purified. 
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Figure 5.4 Agarose gel electrophoresis after SOE-PCR amplification. A: 10H10 SOE-PCR using (a) 
optimized PCR conditions, (b) no polymerase (control), (c) no VH and Vκ. B: 2A9 SOE-PCR using (a) 1.5 
mM MgSO4, (b) 2 mM MgSO4, (c) 2.5 mM MgSO4, (d) no VH and Vκ.  
 
The purified pComb3XSS vector DNA and SOE-PCR were digested using the SfiI restriction 
enzyme and the digests were run on a 0.6% and 1% agarose gels, respectively. In Figure 5.5, 
the separation of two different amounts of the digested pComb vector on a 0.6% agarose gel is 
shown. Four different DNA bands are noticed. The first DNA band corresponds to the non-
digested pComb and has a size of around 5 500 bp. Underneath, there is a second DNA band 
with a size of around 3 500 bp, which is the digested pComb. The two other bands with a size 
of around 1 700 bp and 2 300 bp are corresponding to the single and double cut stuffer. 
Ligation of the digested SOE-PCR into the digested pComb vector was performed together 
with two control ligations to determine ligation efficiency (control 1) and the amount of uncut 
or partly cut pComb vector DNA (control 2). After transfer of the ligated products into the E. 
coli cells, the plated colonies were checked on the LB agar plus carbenicillin plates. More 
colonies were found on the first control plates concluding that a pComb vector of good quality 
and ligation efficiency was observed. The number of colonies found on the second control 
plates was less than 10% of the amount of colonies on the SOE-PCR-pComb ligated plate, 
which means that a low background was observed. 
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Figure 5.5 Agarose gel electrophoresis of a high (a) and low (b) amount of digested pComb3XSS vector 
with (1) the non-digested pComb vector (5 500 bp), (2) the digested pComb vector (3 500 bp), (3) single cut 
stuffer (2 300 bp), (4) double cut stuffer (1 700 bp).  
 
5.3.3 Expression and purification of scFv 
The transformed 10H10 XL-1 Blue E. coli cells were grown up in 2 mL of SB growth 
medium containing carbenicillin (100 µg/mL). Expression was performed overnight at 30 °C 
using 1 mM IPTG. The unpurified lysate from the expressed transformed XL-1 Blue E. coli 
cells was checked for the presence of 10H10 scFv using indirect ELISA. Therefore, the 
induced cultures were centrifuged at 825 g for 10 min. For cell lysis, the cell pellets were 
resuspended in 300 µL of PBS containing 1 mg/mL lysozyme followed by a freeze-thaw 
process. During this freeze-thaw process cells were frozen at -80 °C for 5 min followed by 
thawing in a 37 °C water bath for 3 min; this process was repeated twice. The cell debris was 
pelleted by centrifugation at 13 201 g for 5 min and the supernatant was used for indirect 
ELISA as this contains the scFv antibodies. For the indirect ELISA, 96-well microtitreplates 
were used coated with DON-OVA 4 µg/mL and 100 µL of the non-diluted supernatant was 
added to the plates. When measuring the optical density at 450 nm, no absorbance was 
observed. Another type of E. coli cells, namely One shot chemically competent TOP 10F’ 
cells, were used for the expression of the 10H10 scFv antibody to see any difference in 
expression behaviour. The same process of cell lysis and ELISA screening was used and 
again no absorbance was observed at 450 nm. 
The transformed 10H10 XL-1 Blue E. coli cell culture was scaled up using a volume of 400 
mL of SB growth medium with carbenicillin (100 µg/mL). The SB medium was compared to 
other media, namely TB medium and overnight expressing medium in terms of scFv antibody 
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expression. Cell lysis was performed by dissolving the cell pellet in PBS containing 1 mg/mL 
lysozyme followed by the freeze-thaw process or by dissolving the cell pellet in lysis buffer 
containing 50 mM NaH2PO4, 300 mM NaCl and 10 mM imidazole (pH 7.5) followed by 
sonication. Purification of the filtered lysate was performed by IMAC using Ni-NTA resin 
under the conditions described in 5.2.5. The best scFv production conditions were observed 
using TB medium containing 100 µg/mL as E. coli growth medium. As not much difference 
was seen in the use of a freeze-thaw process and sonication for cell lysis, it was decided to 
further use the sonicator as this was more easy to handle with larger cell culture volumes. The 
concentration of the purified 10H10 scFv using optimal expression and purification conditions 
was set as 0.24 mg/mL as measured by the Nanodrop ND-1000 spectrophotometer. The 
different flow-through and elution fractions were subjected to SDS-PAGE and Western 
blotting (Figure 5.6). The different fractions that were analysed are the supernatant of the E. 
coli cells to see if the scFv antibody leaves the periplasmic region prior to cell lysis, the lysate, 
the flow-through, the flow-through after washing the Ni-NTA column and the eluate. Protein 
bands were observed at a size of around 27 kDa for the supernatant, the lysate, the flow-
through and eluate (purified scFv). It can be concluded that the 10H10 scFv is present in the 
eluate even though some of the scFv antibody is lost due to the transfer of the scFv out of the 
periplasmic region of the E. coli cells before cell lysis and some is lost during purification. 
The purified 10H10 scFv diluted 1/10 was used in an indirect ELISA assay using different 
coating antigens, each of them belonging to the three different series of the immunogen 
synthesis strategy, namely DON-OVA, DON-CC-OVA and DON-CMO-OVA at a 
concentration of 4 µg/mL, 8 µg/mL, 16 µg/mL and 32 µg/mL. The results are presented in 
Table 5.1. As seen, the maximal absorbance occurred using DON-CC-OVA as coating 
antigen. As little difference in absorbance was seen between 8 µg/mL and 16 µg/mL in 
absorbance, it was decided to use the DON-CC-OVA 8 µg/mL as coating antigen in further 
experiments. 
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Figure 5.6 SDS-PAGE (A) and Western blot (B) of different flow-through and elution fractions during Ni-
NTA purification of 10H10 scFv: (a) supernatant E. coli cells, (b) lysate, (c) flow-through, (d) flow-through 
after washing the column, (e) eluate (purified scFv). 
 
Table 5.1 Indirect ELISA of purified 10H10 scFv using different coating antigens in different 
concentrations 
Coating antigen Coating 
concentration 
(µg/mL) 
Absorbance (n = 2) 
DON-OVA 4 0.174 
 8 0.173 
 16 0.194 
 32 0.260 
DON-CC-OVA 4 0.442 
 8 0.568 
 16 0.589 
 32 0.565 
DON-CMO-OVA 4 0.144 
 8 0.112 
 16 0.102 
 32 0.099 
 
The transformed 2A9 XL-1 Blue E. coli cells were grown in 2 mL of TB growth medium 
containing carbenicillin (100 µg/mL). Expression was performed overnight at 30 °C using 1 
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coli colonies was checked for the presence of 2A9 scFv using indirect ELISA with 96-well 
plates coated with DON-OVA 8 µg/mL or DON-CC-OVA 8 µg/mL. Therefore, the induced 
cultures were centrifuged at 825 g for 10 min. For cell lysis, the cell pellets were resuspended 
in 300 µL of PBS containing 1 mg/mL lysozyme followed by a freeze-thaw process. The cell 
debris was pelleted by centrifugation at 13 201 g for 5 min and the supernatant was subjected 
to indirect ELISA. The results are presented in Table 5.2. As seen, the absorbance values were 
generally higher for the DON-CC-OVA coating than for the DON-OVA coating. When a 
higher absorbance value was reached for one E. coli clone using DON-OVA coating, the 
signal was higher as well for the DON-CC-OVA coating. The highest absorbance value was 
seen for the cell clones C1, E1, G1 and H1. Therefore, these were further considered for large 
scale 2A9 scFv production. 
To select optimal expression conditions for 2A9 scFv production, the first 8 clones (A1-H1) 
were selected and were grown up in 2 mL of TB growth medium containing carbenicillin (100 
µg/mL). Expression was performed overnight at 25 °C or 30 °C using 0.1 mM, 0.2 mM, 0.5 
mM, 1 mM, 2 mM or 4 mM IPTG. The unpurified lysate from the different expressed 
transformed XL-1 Blue E. coli colonies was checked for the optimal 2A9 scFv expression 
using indirect ELISA with DON-CC-OVA 8 µg/mL as coating antigen. The same experiment 
was performed for the 10H10 transformed XL-1 Blue E. coli cells to see if the use of a 
different induction temperature or IPTG concentration would increase small scale scFv 
production. The results are presented in Table 5.3. For the 2A9 transformed XL-1 Blue E. coli 
cells, maximum absorbance and therefore maximum scFv production was noticed for clone 
C1, E1 and F1 using an induction temperature of 30 °C and an IPTG concentration of 1 mM. 
For the 10H10 transformed XL-1 Blue E. coli cells, low absorbance values were seen for all 
scFv expression conditions. Some increasing trend in scFv production was observed using a 
lower induction temperature and an IPTG concentration of 0.1 mM, but the signal was too 
low to make any conclusion. So in general, it can be concluded that the 10H10 scFv 
production in small-scale is too low to be able to detect in an ELISA and the 2A9 scFv 
production can be increased by using an induction temperature of 30 °C and an IPTG 
concentration of 1 mM. 
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Table 5.2 Indirect ELISA of lysate 2A9 scFv of 64 different clones (A1-H8) using DON-OVA or DON-CC-
OVA coating antigen 8 µg/mL 
Coating antigen  1 2 3 4 5 6 7 8 
DON-OVA A    0.042 0.041 0.046 0.040 0.041 0.039 0.079 0.050 
 B 0.043 0.042 0.066 0.052 0.041 0.040 0.050 0.041 
 C 0.079 0.045 0.048 0.054 0.041 0.041 0.040 0.042 
 D 0.044 0.043 0.043 0.042 0.049 0.062 0.053 0.067 
 E 0.114 0.044 0.048 0.042 0.044 0.045 0.046 0.049 
 F 0.088 0.041 0.056 0.052 0.047 0.042 0.040 0.061 
 G 0.091 0.048 0.047 0.042 0.042 0.047 0.042 0.042 
 H 0.139 0.048 0.050 0.112 0.045 0.042 0.041 0.044 
DON-CC-OVA A 0.042 0.041 0.044 0.040 0.040 0.039 0.098 0.052 
 B 0.045 0.047 0.090 0.060 0.040 0.041 0.039 0.041 
 C 0.165 0.045 0.046 0.063 0.044 0.042 0.040 0.042 
 D 0.043 0.041 0.041 0.041 0.057 0.096 0.066 0.064 
 E 0.295 0.050 0.061 0.081 0.045 0.055 0.070 0.057 
 F 0.110 0.041 0.066 0.041 0.044 0.045 0.043 0.079 
 G 0.159 0.055 0.048 0.042 0.048 0.041 0.042 0.043 
 H 0.210 0.047 0.055 0.134 0.047 0.051 0.052 0.048 
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Table 5.3 Indirect ELISA of lysate 2A9 and 10H10 scFv obtained using different IPTG concentrations and induction temperatures during the expression of 8 
different clones using DON-CC-OVA coating antigen 8 µg/mL 
 
  Induction temperature 25 °C Induction temperature 30 °C 
 IPTG conc 0.1 mM 0.2 mM 0.5 mM 1 mM 2 mM 4 mM 0.1 mM 0.2 mM 0.5 mM 1 mM 2 mM 4 mM 
2A9 clone A1 0.044 0.043 0.042 0.041 0.039 0.040 0.040 0.041 0.039 0.039 0.039 0.040 
 clone B1 0.050 0.045 0.043 0.042 0.042 0.040 0.040 0.046 0.042 0.046 0.042 0.041 
 clone C1 0.105 0.072 0.091 0.084 0.076 0.056 0.085 0.093 0.077 0.157 0.148 0.103 
 clone D1 0.085 0.045 0.044 0.041 0.041 0.040 0.041 0.041 0.039 0.040 0.041 0.039 
 clone E1 0.076 0.079 0.072 0.111 0.067 0.067 0.070 0.074 0.115 0.214 0.195 0.161 
 clone F1 0.091 0.097 0.092 0.075 0.071 0.086 0.069 0.093 0.069 0.171 0.100 0.191 
 clone G1 0.086 0.081 0.086 0.076 0.089 0.071 0.084 0.085 0.093 0.116 0.173 0.102 
 clone H1 0.093 0.103 0.080 0.070 0.066 0.076 0.083 0.083 0.063 0.103 0.069 0.072 
10H10 clone A1 0.088 0.068 0.066 0.059 0.055 0.049 0.046 0.047 0.045 0.047 0.044 0.048 
 clone B1 0.060 0.060 0.061 0.051 0.053 0.047 0.044 0.046 0.045 0.044 0.045 0.047 
 clone C1 0.062 0.054 0.057 0.053 0.050 0.049 0.044 0.047 0.047 0.046 0.047 0.050 
 clone D1 0.058 0.051 0.057 0.050 0.058 0.050 0.052 0.048 0.050 0.047 0.046 0.051 
 clone E1 0.059 0.049 0.055 0.054 0.050 0.054 0.048 0.048 0.050 0.048 0.046 0.057 
 clone F1 0.068 0.058 0.052 0.053 0.051 0.050 0.052 0.052 0.046 0.049 0.049 0.049 
 clone G1 0.074 0.057 0.056 0.051 0.052 0.049 0.100 0.067 0.047 0.048 0.052 0.055 
 clone H1 0.082 0.065 0.061 0.055 0.053 0.052 0.066 0.070 0.056 0.055 0.057 0.057 
 
 
 
 
1
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The transformed 2A9 XL-1 Blue E. coli cell culture was scaled up using a volume of 400 mL 
of TB growth medium with carbenicillin (100 µg/mL). Cell lysis was performed by dissolving 
the cell pellet in lysis buffer containing 50 mM NaH2PO4, 300 mM NaCl and 10 mM 
imidazole (pH 7.5) followed by sonication. Purification of the filtered lysate was performed as 
for the transformed 10H10 E. coli cells. The different flow-through and elution fractions were 
subjected to SDS-PAGE and Western blot analysis (Figure 5.7). The different fractions that 
were analysed are the lysate, the flow-through, the flow-through after washing the Ni-NTA 
column and the eluate. Protein bands were observed at a size of around 25 kDa for the lysate, 
the flow-through and eluate (purified scFv). For the Western blot, protein bands were 
observed at a much lower size (around 17 kDa) and the eluate did not seem to be pure as 
several protein bands of different sizes were observed. When analysing the lysate and purified 
2A9 scFv in an indirect ELISA assay using DON-CC-OVA 8 µg/mL as coating antigen, only 
a signal was observed for the 2A9 lysate. It can be concluded that the majority of the 2A9 
scFv is not binding to the Ni-NTA column and therefore gets lost during purification. As an 
alternative purification method MgSO4 precipitation was tested, but this seemed to destroy the 
conformation and solubility of the antibody.  
 
 
             
Figure 5.7 SDS-PAGE (A) and Western blot (B) of different flow-through and elution fractions during Ni-
NTA purification of 2A9 scFv: (a) lysate, (b) flow-through, (c) flow-through after washing the column, (d) 
eluate (purified scFv).  
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5.3.4 ScFv antibody sequence analysis 
Different purified and non-purified 2A9 XL-1 Blue E. coli samples were send off for 
sequencing, but from none of them a good sequence result could be obtained. The amino acid 
sequence of the 10H10 scFv antibody could be determined and is shown in Figure 5.8. The 
sequence has a total length of 243 amino acids including a flexible linker of glycine and 
serine residues, a HA decapeptide and HIS tag. The amino acid numbering and CDRs of the 
VH (green) and VL (blue) domains were determined according to Kabat et al. (2001). A total 
molecular weight of 26 251.9 Da and an isoelectric point of 8.28 was determined out of the 
ExPASy proteonomic study. The same molecular weight/size of protein was seen in the SDS-
PAGE and Western blot analysis of the purified 10H10 scFv antibody, which confirms the 
previous results. Using the PSIPRED program, the secondary structure of the antibody was 
determined. The program detected 19 -sheet folds, 20 random coils and no α-helices in the 
secondary structure of the scFv antibody. This is in agreement with the actual secondary 
structure of scFv antibodies.  
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VL-CDR1 
VL-CDR2 
VL-CDR3 
1          10           20      30 
 
S L E V Q L Q Q S G A E L A R P G A S V K M S C K A S G Y T  
                                       40                                        50                                     60  
 
F T R Y T M Y W V K Q R P G Q G L E W I G Y I N P R N A Y S  
                                       70                                     80                                       90 
 
N Y N Q K F K D K A T L T A D R S S N T A Y M Q L N S L T F  
                                      100                                      110 
 
E D S A V Y Y C A M G T S E N G Y W G Q G T L V T V S G G  
120                                  130                                140                                     150 
 
G S G G G G G G S S R S E L D I L L T Q S P A F L S V S P G E  
                                  160                                    170                                    180 
 
R I S F S C R A S Q S I G T S M H W F Q Q R T N G S P R L L I  
                                190                                 200                                 210 
 
K F A S E S V S G I P S R F S G S G S G T D F T L S I N S V E S  
                       220          230 240  
             
E D I A D Y Y C Q Q S Y N W P W T S G G G T K L E I K S S G  
 
       VH-CDR              β-sheet 
       VL-CDR              Random coil 
 
Figure 5.8 10H10 scFv amino acid sequence, mentioning the amino acid numbering, CDRs of the VH and 
VL domains and secondary protein structure according to the Kabat nomenclature 
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5.3.5 Modeling and docking experiments 
Using the SWISS-MODEL web server, a computational homologue model of the 10H10 scFv 
was found with 61.92% identity. The homologue mouse scFv model is recognized in the 
protein databank (PDB) as 4H0G and is an scFv antibody which recognizes the antigen 2-
amino-2-hydroxymethyl-propane-1,3-diol (TRS). The three-dimensional secondary structure 
of the model scFv and its antigen TRS is illustrated in Figure 5.9A. Also, a comparison is 
made between the three-dimensional structure of the TRS and DON antigen (Figure 5.9B/C). 
The secondary protein structure of the model scFv consists of 21 -sheet folds, 22 random 
coils and 3 α-helices.  
   
                     
         
Figure 5.9 Three-dimensional structure of the model scFv-TRS interaction with the illustration of the -
sheet folds (yellow), random coils (white) and α-helices (purple) of the model scFv (A), two-dimensional 
structure of the TRS antigen (B) and three-dimensional structure of TRS and our target DON (C). 
    A     B 
    C 
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The CASTp automated server identifies surface accessible pockets for different molecules, 
including scFv receptors and ligands. When submitting the PDB code of the model scFv, a 
total of 42 different binding pockets at the model scFv were identified sorted by volume and 
area. The largest and most accessible binding pocket had a volume of 553.4 Å
3
 and an area of 
2070.2 Å
2
. Based on this knowledge, the binding pockets of the model scFv suitable for 
binding with the target, namely the original TRS antigen or the DON antigen were determined 
using the online SwissDock and UCSF Chimera programs. A total of 33 and 62 different 
clusters binding in the different scFv pockets, were generated for the DON and TRS antigen 
respectively. The top 3 of most energetically enhanced interactions between the target and the 
model scFv is shown in Table 5.4. The FullFitness energy for all determined model scFv-
DON clusters is negative and therefore favorable. The FullFitness values are higher than the 
ones for the model scFv-TRS interaction, but still very good. The Gibbs free energy is even 
lower than for the original scFv-target interact, which means that more energy will be released 
when DON binds to the model scFv. The three-dimensional structure of the energetic most 
favourable model scFv-DON cluster is presented in Figure 5.10. The first part of this figure 
illustrates the ribbons representation of the model scFv-DON cluster. As shown, a hydrogen 
bond is formed between the C3 of DON and the glutamine amino acid of the model scFv. The 
second part of the figure represents the hydrophobic surface of the model scFv. The blue parts 
are the most hydrophilic parts and the colour goes from white to orange for more hydrophobic 
regions. Hydrogen bonds and hydrophobic interactions, together with electrostatic forces and 
Van der Waals bonds are responsible for the antibody-antigen interactions and give therefore 
an indication of the strength of the scFv-target cluster. 
 
Table 5.4 Energetically favourable scFv clusters for the target DON and TRS 
Antigen Number of 
SwissDock 
clusters 
Cluster rank FullFitness 
(kcal/mol) 
Estimated Δ  
(kcal/mol) 
DON 33 1 -849.85 -7.14 
  2 -849.83 -6.65 
  3 -849.66 -6.77 
TRS 62 1 -1100.13 -5.56 
  2 -1099.95 -5.00 
  3 -1099.02 -5.35 
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Figure 5.10 Three-dimensional structure of the model scFv-DON interaction: ribbons representation with 
VL chain (red) and VH chain (blue) (A) and hydrophobic surface from blue (hydrophilic) to orange colour 
(hydrophobic) (B). 
    A 
    B 
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The determination of solvent accessibility is an important step to three-dimensional structure 
prediction as it determines the packaging arrangement of amino acid residues. The solvent 
accessibility or accessible surface area was determined by the use of the ASAView automated 
server by uploading the PDB format of the model scFv. The results were given by the 
generation of a spiral plot sorting all amino acid residues (size of the circle) by their relative 
solvent accessibility (Figure 5.11). The blue and red colours represent the positive charged 
residues (R: arginine, K: lysine, H: histidine) and negative charged residues (D: aspartic acid, 
E: glutamic acid), respectively. The green circles stand for the polar uncharged residues (G: 
glycine, N: asparagine, Y: tyrosine, Q: glutamine, S: serine, T: threonine, W: tryptophan) and 
the yellow circles are the cysteine amino acids. All other hydrophobic residues (P: proline, A: 
alanine, V: valine, I: isoleucine, L: leucine, M: methionine, F: phenylalanine) are represented 
by a grey colour. When having a look at the model scFv in the Swiss-PDB viewer and UCSF 
Chimera programs, glutamine 5 (Q5) is responsible for the hydrogen bond (Figure 5.10) 
between the C3 of DON and the model scFv. This Q5 residue is presented in the outer shelf of 
the spiral plot in a green circle at the left side (Figure 5.11), which confirms its accessibility.  
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Figure 5.11 Spiral plot of amino acid residues of model scFv based on their solvent accessibility. Blue 
circles: positive charged residues, red circles: negative charged residues, green circles: polar uncharged 
residues, yellow circles: cysteine residues, grey circles: hydrophobic residues. The size of the circle is a 
measure of the solvent accessibility; maximum circle size represents maximum solvent accessibility.  
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5.4 CONCLUSION 
Based on the results of Chapter 5, it can be stated that two recombinant scFv anti-DON 
antibodies were developed out of the hybridoma producing the 2A9 and 10H10 monoclonal 
antibodies. Optimized conditions for culturing and expression of E. coli cells containing the 
pComb3XSS expression vector were set up, e.g. the growth medium, IPTG concentration and 
expression temperature. An indirect ELISA format was developed based on the different 
synthesized DON coating antigens described in Chapter 3. The best results were obtained 
using the DON-CC-OVA coating (heterologous) at a concentration of 8 µg/mL. As an 
absorbance of 0.568 was obtained using the 10H10 scFv, it can be concluded that the antibody 
did not loose its affinity for the DON antigen. Moreover, removing the constant domains of 
the antibody, leaving only one variable heavy and light chain did not decrease the ruggedness 
of the antibody structure. To characterize the scFv antibody in terms of specificity, a higher 
amount of soluble scFv antibody was needed.  
Different purified and non-purified 2A9 XL-1 Blue E. coli samples were send off for 
sequencing, but from none of them a good sequence result could be obtained. The amino acid 
sequence of the 10H10 scFv could be determined and CDR regions of VH and VL were 
indicated based on Kabat et al. (2001). Based on this information, modeling and docking 
experiments were performed. A model scFv was found with 61.92% identity compared to the 
10H10 scFv. Using this model, an assessment of DON-scFv possible interactions/clusters was 
performed.  
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GENERAL CONCLUSIONS 
The doctoral research focused on the improvement of bio-analytical detection strategies for 
deoxynivalenol (DON) in cereals, especially in wheat.  
First of all, there was a need for an alternative sampling method for cereals because of the 
heterogeneous distribution of mycotoxins within a bulk lot, which is the main cause of 
uncertainty of the test result. As an alternative for wheat grains, wheat dust was chosen 
characterized by its small particle size and production during the (un)loading of grain cereals 
and during harvesting. Wheat dust can be considered as a homogeneous and representative 
sample as it is continuously generated and sampled through the entire grain movement 
process. Another advantage of wheat dust is that no grinding step is needed prior to extraction 
and this makes it less time-consuming as normal wheat grain sample preparation.  
During this research, wheat dust generated by a laboratory scale model, was characterized in 
terms of particle size and content (organic, inorganic and water fraction) and a mineral 
content of more than 10 000 µg/g was observed for Fe, K and P, independent of the wheat 
dust origin. The interference of these minerals on the detection results is dependent on the 
analytical method used (chromatographic versus immunochemical method) and the type and 
volume of the extraction solvent used prior to detection.  
As wheat dust is easy to sample, this sampling method can be coupled to an immunochemical 
detection method for on-site DON measurement. Therefore anti-DON monoclonal antibodies 
are needed. The described and commercially available anti-DON monoclonal antibodies show 
high cross-reactivity against the acetylated derivatives 3-acetyldeoxynivalenol (3-ADON) and 
15-acetyldeoxynivalenol (15-ADON). These modified forms (like all other modified 
mycotoxins) are not included in legislation even though their toxicity is equal or even higher 
(for 15-ADON) than DON. 
A strategy was set up for the synthesis of DON-immunogens using different procedures and 
making different linkers with varying length and chemical structure between DON and the 
carrier protein to be able to lower cross-reactivity of the monoclonal antibodies. By using the 
hybridoma technology, Balb/C female mice (ethical approval according to ECD 10/08) were 
injected with the different DON immunogens to obtain antibody producing B-cells which 
were fused in vitro with myeloma cells to form hybridomas. Homologous and heterologous 
enzyme-linked immunosorbent assay (ELISA) hybridoma screening was performed whereby 
three anti-DON monoclonal antibody producing hybridomas were selected. The 13H1, 10H10 
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and 2A9 derived monoclonal antibodies were characterized in terms of sensitivity (IC50) and 
cross-reactivity towards chemically related trichothecenes using direct/indirect ELISA and/or 
surface plasmon resonance (SPR) detection. Direct ELISA results showed that the 13H1 
antibody could recognize DON and its analogues in the order of HT-2 toxin > 15-ADON > 
DON, with IC50 ranging from 1.14 to 2.13 µg/mL. The monoclonal antibody 2A9 proved to be 
very specific and sensitive to 3-ADON, with IC50 of 0.38 ng/mL. The 10H10 antibody on the 
other hand showed affinity for DON, 3-ADON and 15-ADON, with IC50 values of 22, 15 and 
34 ng/mL, respectively. Therefore the 10H10 antibody can be considered as a broad-specific 
antibody, measuring total DON (DON, 3-ADON and 15-ADON) contamination. Compared to 
the commercially available anti-DON monoclonal antibodies, this is the first antibody which 
can determine DON, 3ADON and 15-ADON with a similar sensitivity. This is a very good 
monoclonal antibody from a researcher’s point of view having knowledge about occurrence 
and toxicological data of 3-ADON and 15-ADON, not taking into account current legislation.  
Using an indirect ELISA format for the characterization of the 10H10 antibody decreased the 
sensitivity to 15-ADON with 92%. SPR characterization of the 10H10 antibody resulted in a 
10 times higher DON and 3-ADON sensitivity compared to indirect ELISA using the same 
coating antigen. So, depending on the used ELISA/SPR format, different characterization 
results were obtained. By using the combination of the indirect ELISA format with the 10H10 
antibody and the direct ELISA with the 2A9 antibody, the single DON contamination can be 
determined.  
As the developed DON immunogen synthesis strategy, combined with the hybridoma 
technology, did not deliver specific anti-DON monoclonal antibodies, recombinant antibody 
technology was used starting from the obtained 10H10 and 2A9 hybridoma. The single-chain 
variable fragment (scFv) synthesis and production in E. coli strains was optimized using 
different PCR (e.g. concentration of MgCl or MgSO4, type of polymerase enzyme) and cell 
culturing (e.g. different growth media, temperature, isopropyl--D-1-thiogalactopyranoside 
(IPTG) concentration) conditions. Indirect ELISA experiments gave absorbance values of 
around 0.6, revealing no decrease in ruggedness of the antibody structure and DON affinity. 
Based on the amino acid sequence of the scFv, modeling and docking experiments proved 
energetically enhanced DON-scFv interactions. 
As no regulatory limits exist for mycotoxins in grain dust, a correlation was needed between 
the DON level in wheat dust versus the DON level in the corresponding wheat. Therefore, a 
liquid chromatography-tandem mass spectrometry method in electrospray positive mode (LC-
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ESI
+
-MS/MS) was developed and validated for the determination of DON in wheat dust. An 
extraction was performed with acetonitrile/water/acetic acid (79/20/1, v/v/v), followed by an 
additional hexane defatting step resulting in cleaner extracts and therefore increasing the 
sensitivity. The method was validated in terms of linearity, apparent recovery, limit of 
detection, limit of quantitation, precision and accuracy based on the Commission Decision 
2002/657/EC of 12 August 2002 concerning the performance of analytical methods and the 
interpretation of results.  
To determine the suitability of wheat dust in the measurement of the DON contamination 
level, an experimental field trial was set up during the growing season 2011-2012. The 
influence of maize-wheat rotation, tillage method and wheat variety (Azzerti, Homeros, 
Sahara, Mulan and Tabasco) on the DON content of wheat grain and the corresponding wheat 
dust, was investigated. For Azzerti and Homeros, known as susceptible wheat varieties, no 
significant difference in DON level for both wheat and wheat dust was noticed between 
tillage (i.e. ploughing) and no tillage. This is in contrast with the moderately resistant varieties 
Mulan, Sahara and Tabasco, where lower DON contents were observed with tillage as soil 
treatment. It can be concluded that the derived results are in accordance with the wheat 
variety resistance to Fusarium infection. 
The data derived from the experimental field trial, together with LC-MS/MS results of an 
extra batch of wheat and wheat dust samples, gave rise to a scatterplot revealing a correlation 
between the DON content in wheat versus the DON content in wheat dust. For wheat samples 
with a DON contamination lower than 1 250 µg/kg (limit for human consumption), wheat 
dust showed a 13-fold accumulation of DON compared to wheat. With higher DON 
contaminated wheat, a sigmoidal relation of the DON content between wheat and wheat dust 
was observed.  
As the MycoHunt system was based on immunoassay technology, the suitability of the 
developed 10H10 anti-DON monoclonal antibodies was tested. Therefore, a water-based 
extraction and a direct ELISA method was successfully developed and validated for the 
determination of DON in wheat and wheat dust. For the optimization of sample preparation 
conditions, blank wheat and wheat dust samples were spiked with DON at different 
concentration levels and evaluated in terms of recovery by a common ELISA procedure. A 
small survey was executed on raw wheat material and their corresponding dust samples (n = 
16). A sigmoidal correlation between the DON concentration in wheat dust versus the DON 
concentration in wheat was observed (r = 0.928). When not considering the data points with a 
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DON concentration in wheat lower than 200 µg/kg (< LOD), a linear correlation (r = 0.889) 
was found. The slope of the trend line described a value of 5.023 which corresponds to a 5-
fold accumulation of DON on small particles and is different to the slope (13.192) found after 
LC-MS/MS analysis of wheat and their corresponding wheat dust samples. As limited wheat 
and corresponding wheat dust samples were obtained and only at a concentration level in 
wheat lower than 1 200 µg/kg, the uncertainty of the slope corresponding to the linear curve is 
high. Also, no conclusion can be taken about whether to use the linear or logarithmic curve.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 6: General conclusions and future perspectives 
171 
 
FUTURE PERSPECTIVES 
Mycotoxins have already been known for many centuries, still multiple questions are left 
unanswered. Emerging technologies in sampling, sample preparation and especially 
mycotoxin analysis has led and is still leading to the disclosure of novel information e.g. the 
identification of masked mycotoxin forms and mycotoxin risk assessment after human and 
animal exposure.  
 
Sampling and sample preparation 
From the available literature and information obtained during the PhD-dissertation it became 
clear that there is really a need for alternative sampling procedures due to the very 
heterogeneous distribution of mycotoxins in agricultural commodities and products intended 
for human and animal consumption. As the mycotoxin concentration of a sample is 
determined as an estimation of the true mycotoxin concentration in the bulk lot, it is difficult 
to determine with 100% certainty the true contamination of the bulk lot. The problem of 
heterogeneity could be solved by the collection of incremental samples, the sampling of large 
amounts of cereals or using a smaller particle size of the starting material. As an ideal 
alternative for cereal grain sampling, grain dust was selected during this research (Chapter 2). 
This matrix is characterized by its readily availability without need for grinding (particle size 
< 50 µm) and could therefore be used for on-site mycotoxin measurement. For the 
determination of DON in wheat dust, a sample preparation method was developed prior to 
LC-MS/MS analysis and ELISA screening. In the future, this method could be extrapolated to 
other mycotoxins and other grain dust sources if the mycotoxin contamination occurs at the 
outer layers of the cereal. This could be the beginning of a more precise determination of the 
mycotoxin contamination level.  
 
Analytical methods 
Chromatographic methods 
The need for multi-mycotoxin analyses is constantly rising and the technology of choice is 
LC-MS/MS. Further improvements of the LC-MS/MS instrumentation and its availability at a 
lower price will further contribute to LC-MS/MS, becoming the major tool in multi-
contaminant analysis. Nevertheless this analytical technique is targeted and it pre-supposes a 
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knowledge of which mycotoxins might be present. The introduction and application of high 
resolution mass spectrometers such as time-of-flight and orbitrap offer new opportunities in 
mycotoxin research. This emerging method used for the untargeted screening of masked 
mycotoxins, has already led to the identification of new conjugates such as fusarenon X-
glucoside, nivalenol-3-glucoside, T-2-3-glucoside, HT-2-3-glucoside and palmitoyl 
conjugates of zearalenone, DON and T-2 [Nakagawa et al., 2012; Busman et al., 2011; 
Chakrabarti and Ghosal, 1986]. Nowadays, this type of mass spectrometry is used in 
metabolomic studies. During metabolomics, conjugates or metabolites are identified revealing 
new detoxification routes of the fungus and unravelling new metabolization patterns of 
mycotoxins in biological fluids.  
 
Immunochemical methods 
Up to now, immunochemical methods are still important to monitor mycotoxin food and feed 
contamination even though the impact of cross-reactivity remains an unsolved problem. 
Hybridoma technology remains the method of choice for the production of antigen specific 
monoclonal antibodies. Over the past decade, the detailed knowledge of antibody structure 
and function has enabled antibody phage display of immune libraries to emerge as a powerful 
in vitro alternative to hybridoma methods for creating antibodies. The main advantage of 
phage display technology is the large diversity of variant antibodies (> 10
10
 members) that can 
be screened for its selectivity and affinity towards the target antigen. Another advantage 
includes the ability to perform antibody engineering based on the antibody encoding DNA 
sequence thereby improving the antibody characteristics (e.g. affinity, specificity).   
During the PhD-dissertation both antibody developing methods, hybridoma and recombinant 
technology, were used to prepare anti-DON antibodies. As described in Chapter 3, a broad-
selective monoclonal antibody 10H10 to DON and its masked forms (3-ADON, 15-ADON 
and DON-3G) derived from traditional hybridoma technology, was picked out by 
heterologous ELISA. The achievement of a selective 3-ADON antibody (2A9) opened 
perspectives for the development of specific anti-DON antibodies. Out of the 10H10 and 2A9 
hybridoma, recombinant scFv antibodies were synthesized. Indirect ELISA results revealed 
no loss in affinity towards their target antigen.  
To be able to characterize the scFv in terms of specificity, the production of the soluble 
recombinant antibody should be upgraded. Different causes of low scFv levels together with 
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possible solutions are presented in literature. A high amount of inclusion bodies compared to 
soluble anti-DON scFv is described by Choi et al. (2003), who solved this problem by the 
coexpression of molecular chaperones DnaK-DnaJ-GrpE in the phage-transfected E. coli 
strains. In addition, expression of the GroEL-GroES molecular chaperone complex may 
corporate with DnaK-DnaJ-GrpE in a synergistic way to increase soluble production of some 
proteins. Another possibility to increase scFv production is the transfer of the gene sequence 
encoding the scFv from the pComb3XSS phagemid to a pET expression system known to 
speed up recombinant antibody production. As the ends of the gene sequence need to be 
compatible with restriction sites at the cloning vector and no similar restriction sites are 
present (except the sfiI restriction site) on the pComb3XSS and pET expression systems, the 
NdeI and XhoI restriction sites should be incorporated using the sense primers 5’-
GCAACTCATATGCAGGTGAAGCTGCAGCAGTCT-3’ (VH), 5’-TCCGGCGGTGGTGG 
CAGCGGTGGCGGCGGTTCTCAGGCTGTTGTGACTCAGGAA-3’ (VL) and the reverse 
primers 5’-ACCGCTGCCACCACCGCCGGAGCCACCGCCACCTGAGGAGACGGTGAC 
CGTGGT-3’ (VH), 5’-CATTCTCTCGAGACCTAGGACA GTGACCTTGGT-3’ (VL).  
Another point to consider is the loss of recombinant antibody during immobilized metal 
chelate chromatography (IMAC) purification. As the protein retention is based on the 
availability of the hexahistidine (HIS) tag, the recovery of the recombinant protein is 
dependent on the amino acid sequence and consequent protein folding. Several researchers 
describe the multi-position interactions between the immobilized metal ions and protein 
residues during proper IMAC purification conditions.  None of them however could elucidate 
the exact interaction mechanism so far.  
Total characterization of the 10H10 and 2A9 scFv recombinant antibodies can reveal changes 
in specificity compared to the monoclonal antibodies. The amino acid sequence differences 
between the complementary determining regions (CDRs) of both 10H10 and 2A9 scFv give 
an idea about the origin of their respective broad-selective and 3-ADON specific character. 
Altering these amino acids by performing in vitro mutagenesis studies followed by modeling 
and docking experiments, can therefore deliver specific antibodies against DON. Using 
antibody engineering, could even lead to the first specific antibody against the masked 
deoxynivalenol-3-glucoside (DON-3G).  
Nowadays, hybridoma and recombinant technology is widely discouraged due to the animal 
pain and distress. Therefore promising alternatives to animal-based antibodies are developed 
including aptamers, molecular imprinted polymers (MIPS) and recombinant antibodies out of 
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naive or synthetic libraries, which can be created without using animals or animal tissue. 
However, to be able to synthesize and select the antibody substitutes, mycotoxin reference 
standards are needed. At the moment, masked mycotoxin reference standards are lacking. 
Promising techniques using detached leaves of maize and wheat obtaining large quantities in 
terms of mg of masked mycotoxins, have been described [De Boevre et al., 2014].  
 
Mycotoxin risk assessment 
Risk assessment is an important tool to quantify the true exposure of mycotoxins and their 
masked forms through food and feed. Current mycotoxin exposure assessments are based on 
calculations combining mycotoxin occurrence data in food or feed with consumption data. As 
some important information is lacking, risk assessors often have to make estimates and 
consequently all risk assessments are uncertain to some degree. As an example, the mycotoxin 
exposure through inhalation is not taken into account. According to the data presented in 
Chapter 2, the mycotoxin content in dust is a multiple of the amount present in the 
corresponding wheat grain. As no mycotoxin absorption data are available after inhalation, 
the contribution to risk exposure can not be determined. Moreover, inter-individual and inter-
species variation in kinetics (absorption, distribution, metabolization and excretion) exist, 
which further decrease the accuracy of the risk analysis.  
Therefore, the determination of mycotoxin metabolization products or biomarkers can provide 
a more accurate measure at individual level. As at the moment only a few biomarkers have 
been validated for some mycotoxins, future research need to focus on the untargeted 
screening of new valuable biomarkers by the use of high resolution mass spectrometry. The 
biomarker approach can be used in several biological matrices like blood, urine, faeces, liver, 
kidney and breast milk by applying chromatographic or immunochemical analytical methods. 
This highlights the need for specific antibodies or antibody substitutes against these 
mycotoxin metabolization products and makes us return to the above mentioned suited 
recombinant antibody technology.  
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The manuscript entitled “Bio-analytical detection strategies for deoxynivalenol in wheat dust” 
describes different biotechnological and analytical approaches for the detection of the 
mycotoxin deoxynivalenol (DON) in wheat dust transferable to other mycotoxins and other 
cereals.  
In the general introduction presented in Chapter 1 an overview of mycotoxins is shown 
together with the food and feed matrices where the mycotoxin contamination and related 
fungal infection can occur. To understand the awareness of the Flemish population (including 
food consumers and producers) concerning mycotoxin contamination of food and feed, a 
questionnaire was developed and distributed online at the Agriflanders Fair for and by 
Flemish agriculture (2013). Out of the results, it became clear that more information should 
be provided concerning mould growth, production of mycotoxins by moulds, their toxic 
effects on organisms, exposure pathways and how to deal with mouldy food or feed, to 
increase the awareness of mycotoxin contamination of food and feed. 
Further on, the principle and characteristics of existing analytical and immunochemical 
methods are presented specific to DON detection. A detailed explanation is given about the 
use of  traditional hybridoma and recombinant technology to prepare anti-DON antibodies. 
In Chapter 2, an alternative sampling method for grain cereals, namely “dust sampling”, is 
described. Dust is created during the transport through closed systems such as the (un)loading 
of a truck and is produced during this research by a laboratory dust collection facility. 
Characterized by its small size, homogeneous mycotoxin distribution and readily availability 
for mycotoxin analysis, it forms the ideal alternative for grain sampling.  
Combined with the sampling of wheat dust, a liquid chromatography-tandem mass 
spectrometry method in electrospray positive mode (LC-ESI
+
-MS/MS) was successfully 
developed and validated for the determination of DON in wheat dust. An extraction was 
performed with acetonitrile/water/acetic acid (79/20/1, v/v/v), followed by an additional 
hexane defatting step. After filtration, the extract was evaporated and the residue was 
redissolved in mobile phase for injection. The method was validated in terms of linearity, 
apparent recovery, limit of detection (LOD), limit of quantitation (LOQ), precision and 
accuracy based on the Commission Decision 2002/657/EC of 12 August 2002 concerning the 
performance of analytical methods and the interpretation of results. Due to a high 
contamination level of wheat dust compared to wheat, LOD and LOQ levels were obtained of 
358 µg/kg
 
and 717 µg/kg, respectively.  
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An experimental field trial set up in the growing season 2011-2012, was designed to obtain 
quantitative data on the occurrence of DON in wheat grain and the corresponding wheat dust. 
The influence of maize-wheat rotation, tillage method and wheat variety (Azzerti, Homeros, 
Sahara, Mulan and Tabasco) on Fusarium head blight (FHB) infection determined by DON 
analysis was investigated. First of all, an important influence of maize-wheat rotation was 
observed as a six times higher DON content was found in wheat sown after maize. For the 
susceptible wheat varieties Azzerti and Homeros no significant difference in DON level for 
both wheat and wheat dust was noticed between tillage (i.e. ploughing) and no tillage. This 
was in contrast to the moderately resistant varieties Mulan, Sahara and Tabasco, where lower 
DON contents were observed using tillage.  
The accumulation of DON in wheat dust was confirmed and a linear and sigmoidal 
relationship between the DON content in wheat dust versus wheat grain was determined. For 
wheat samples with a DON contamination lower than 1 250 µg/kg (limit for human 
consumption), wheat dust showed a 13-fold accumulation of DON compared to wheat. At 
higher DON contamination levels, a sigmoidal relation (y = 5 935 ln(x) – 28 423) of the DON 
content between wheat and wheat dust was observed.  
As wheat dust is readily available in contrast to grain cereals where adequate grinding needs 
to be performed prior to sample preparation, it forms an ideal basis for the development of a 
DON immunochemical screening method. As for this purpose antibodies are needed, 
monoclonal antibodies were developed using traditional hybridoma technology and this forms 
the basis of Chapter 3. A DON immunogen synthesis strategy was set up using different 
procedures and making different linkers with varying length and chemical structure between 
DON and the carrier protein. Balb/C female mice (ethical approval according to ECD 10/08) 
were subjected to an injection with the different DON immunogens to obtain antibody 
producing B-cells which were in vitro fused with myeloma cells using traditional hybridoma 
technology. For the hybridoma screening and selection, homologous and heterologous 
enzyme-linked immunosorbent assay (ELISA) was performed whereby three anti-DON 
monoclonal antibody producing hybridomas were selected. The 13H1, 10H10 and 2A9 
derived monoclonal antibodies were characterized in terms of sensitivity and cross-reactivity 
towards chemically related trichothecenes using direct/indirect ELISA and/or surface plasmon 
resonance (SPR) detection. The 13H1 antibody derived using deoxynivalenol-cyanuric 
chloride-bovine serum albumin (DON-CC-BSA) immunization could recognize DON and its 
analogues in the order of HT-2 toxin > 15-acetyldeoxynivalenol (15-ADON) > DON, with a 
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sensitivity of 1.14 µg/mL, 1.62 µg/mL and 2.13 µg/mL, respectively. Whereas the 10H10 
antibody derived from a deoxynivalenol-bovine serum albumin (DON-BSA) immunized 
mouse manifested relatively close sensitivities to DON, 3-acetyldeoxynivalenol (3-ADON), 
15-ADON and deoxynivalenol-3-glucoside (DON-3G), with sensitivity values of 22, 15, 34 
and 72 ng/mL, respectively. Using an indirect ELISA format for the characterization of the 
10H10 antibody, decreased the cross-reactivity to 15-ADON from 65% till 9%. SPR 
characterization of the 10H10 antibody resulted in a 10 times better DON and 3-ADON 
sensitivity compared to indirect ELISA using the same coating antigen. Another DON-BSA 
immunized mouse gave rise to the third monoclonal antibody 2A9 which showed to be very 
specific and sensitive to 3-ADON, with a sensitivity value of 0.38 ng/mL.  
In Chapter 4, the broad-specific anti-DON monoclonal antibody 10H10 was used to develop a 
direct ELISA method to determine DON contamination in wheat and wheat dust. As DON is 
a polar molecule and organic solvents can lead to protein denaturation, water was used as 
extraction solvent. A small survey was executed on raw wheat material and their 
corresponding dust samples (n = 16) using the optimized and validated extraction and ELISA 
procedure. A sigmoidal correlation between the DON concentration in wheat dust versus the 
DON concentration in wheat was observed (r = 0.928). When not considering the data points 
with a DON concentration in wheat lower than 200 µg/kg (< LOD), a linear correlation (r = 
0.889) was found. As limited wheat and corresponding wheat dust samples were obtained and 
only at a concentration level in wheat lower than 1 200 µg/kg, the uncertainty of the slope 
corresponding to the linear curve is high. Also, no conclusion can be taken about whether to 
use the linear or logarithmic curve.  
European legislation concerning DON contamination does not include the acetylated DON 
derivatives (3-ADON and 15-ADON) or other masked mycotoxins even though their 
toxicological importance is of concern. Until now, no specific anti-DON monoclonal 
antibodies were developed using the hybridoma technology. Therefore recombinant 
technology was used to synthesize single-chain variable fragment (scFv) antibodies out of 
hybridoma 10H10 and 2A9 and is described in detail in Chapter 5. Optimized conditions for 
culturing and expression of pComb3XSS transformed E. coli bacterial cells were selected 
based on a developed indirect ELISA procedure. High spectrophotometrically detected 
absorbance values revealed the ruggedness of the antibody structure after removing its 
constant domains. The amino acid sequence of the 10H10 scFv was determined and a 
distinction was made between the complementarity determining regions (CDRs) and 
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framework regions of variable heavy (VH) and variable light (VL) chain. Using the sequencing 
information, modeling and docking experiments were performed. A model scFv was found in 
the Swiss Model databank with 61.92% identity compared to the 10H10 scFv. Using this 
model, an assessment of DON-scFv possible and energetically enhanced interactions/clusters 
was performed.  
The knowledge gathered through the complete PhD research gives rise to the formulation of 
general conclusions and future perspectives presented in Chapter 6, revealing further bio-
analytical detection development and enhancement procedures.  
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Het doctoraatsproefschrift getiteld “Bio-analytical detection strategies for deoxynivalenol in 
wheat dust” beschrijft verschillende biotechnologische en analytische procedures voor de 
detectie van het mycotoxine deoxynivalenol (DON) in tarwestof en is eveneens bruikbaar 
voor de detectie van andere mycotoxines in verscheidene graansoorten.  
In de algemene inleiding voorgesteld in Hoofdstuk 1, wordt een overzicht weergegeven van 
de verschillende mycotoxines met de voedsel- en voedermatrices waarin ze voorkomen en de 
gerelateerde schimmelinfectie. Om een beeld te kunnen vormen betreffende het bewustzijn 
van de Vlaamse populatie (inclusief consument en producent) inzake mycotoxine 
contaminatie van voedsel en voeder, werd een enquête opgesteld en online ingevuld op de 
Vlaamse land- en tuinbouwbeurs Agriflanders (2013). Uit de resultaten bleek dat de mensen 
meer geïnformeerd moeten worden in verband met de schimmelgroei, productie van 
mycotoxines door schimmels, de toxische effecten op mens en dier, de blootstellingswegen en 
wat er te doen valt met beschimmeld voedsel of voeder. Op deze manier kan de kennis en het 
bewustzijn in verband met mycotoxine contaminatie van voedsel en voeder uitgebreid worden.  
Verder in dit hoofdstuk worden de principes en kenmerken van bestaande analytische en 
immunochemische methodes voor de detectie van DON voorgesteld. Een gedetailleerde uitleg 
wordt gegeven in verband met het gebruik van de traditionele en recombinante technologie 
voor de aanmaak van anti-DON antilichamen. 
In Hoofstuk 2 wordt een alternatieve methode voor staalname van granen, namelijk de 
staalname van graanstof, voorgesteld en beschreven. Dit stof wordt geproduceerd tijdens het 
transport van granen doorheen smalle systemen zoals bij het laden of lossen van een 
vrachtwagen of schip. Tijdens dit onderzoek werd gebruik gemaakt van een speciaal 
ontwikkelde laboratoriumconstructie voor de productie en collectie van graanstof. Door de 
kleine diameter van de stofpartikels, de homogene mycotoxine distributie en de onmiddellijke 
beschikbaarheid voor mycotoxine analyse, vormt het een ideaal alternatief voor de staalname 
van graan.  
Gecombineerd met de staalname van tarwestof, werd een vloeistof chromatography-tandem 
massaspectrometrische methode gebruik makend van de positieve electrospray-ionisatie (LC-
ESI
+
-MS/MS) succesvol ontwikkeld en gevalideerd voor de bepaling van DON in tarwestof. 
Een extractie werd uitgevoerd met acetonitrile/water/azijnzuur (79/20/1, v/v/v), gevolgd door 
een hexaanontvetting. Na filtratie werd het extract uitgedampt en het residu heropgelost in 
mobiele fase voor injectie. De methode werd gevalideerd inzake lineariteit, relatieve 
terugvinding, detectielimiet (LOD), kwantificatielimiet (LOQ), precisie en accuraatheid, 
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gebaseerd op Verordering Nr. 2002/657/EC inzake de performantie van analytische methodes 
en de interpretatie van resultaten. Omwille van de hoge contaminatie van tarwestof in 
vergelijking met tarwe, werden LOD- en LOQ-waarden bekomen van respectievelijk 358 
µg/kg en 717 µg/kg. 
Een experimentele veldtest werd opgesteld in het landbouwseizoen 2011-2012 voor het 
verkrijgen van quantitatieve data in verband met het voorkomen van DON in tarwe en het 
corresponderende tarwestof. Hierbij werd de invloed van maïs-tarwe wisselbouw, de 
akkerbewerkingsmethode en de tarwevariëteit (Azzerti, Homeros, Sahara, Mulan and Tabasco) 
op de Fusarium head blight (FHB) infectie nagegaan door bepaling van de DON-concentratie. 
Eerst en vooral werd een belangrijke invloed van de maïs-tarwe wisselbouw geobserveerd, 
aangezien een zes maal hogere DON-concentratie gevonden werd bij tarwe afkomstig van een 
akker waar voorheen maïs werd gezaaid. Voor de vatbare tarwevariëteiten Azzerti en 
Homeros werd geen significant verschil in DON-niveau geobserveerd bij het al dan niet 
bewerken van akkers voor zowel tarwe als tarwestof. Dit staat in tegenstelling tot de 
gemiddeld resistente variëteiten Mulan, Sahara en Tabasco waar een lagere DON-concentratie 
werd aangetroffen door het ploegen van de akker.  
De accumulatie van DON in tarwestof werd bevestigd en een lineair en sigmoïdaal verband 
tussen de DON-concentratie in tarwestof versus tarwe werd bepaald. Voor tarwestalen met 
een DON-contaminatie lager dan 1 250 µg/kg (limiet voor humane consumptie), werd een 13 
maal hogere DON-concentratie geobserveerd voor tarwestof ten opzichte van tarwe. Bij 
hogere DON-contaminaties bleek een sigmoïdale verhouding (y = 5 935 ln(x) – 28 423) 
tussen de DON concentratie in tarwe en tarwestof beter.  
Aangezien tarwestof onmiddellijk beschikbaar is, in tegenstelling tot graankorrels die eerst 
vermalen moeten worden voor staalvoorbereiding, vormt dit een ideale basis voor de 
ontwikkeling van een DON-immunochemische screeningsmethode. Voor deze 
screeningsmethode zijn antilichamen nodig en deze monoclonale antilichamen werden 
ontwikkeld, gebruik makend van de klassieke hybridomatechnologie en dit vormt de basis van 
Hoofdstuk 3. Een DON-immunogen synthesestrategie werd ontwikkeld door gebruik te maken 
van verschillende procedures en verschillende verbindingen met variërende lengte en 
chemische structuur tussen DON en het carrier proteïne. Balb/C vrouwelijke muizen (Ethisch 
goedgekeurd volgens ECD 10/08) werden onderworpen aan een injectie met de verschillende 
DON-immunogenen om de B-cellen aan te sporen tot productie van antilichamen. Deze B-
cellen werden in vitro versmolten met myelomacellen volgens de klassieke 
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hybridomatechnologie. Voor de hybridoma screening en selectie werden zowel homologe als 
heterologe enzyme-linked immunosorbent assay (ELISA) uitgevoerd, resulterend in de 
selectie van drie anti-DON monoclonale antilichaam-producerende hybridomas. De 13H1, 
10H10 en 2A9 bekomen monoclonale antilichamen werden gekarakteriseerd naar 
gevoeligheid en kruisreactiviteit ten opzichte van chemisch gerelateerde trichothecenen door 
middel van directe/indirecte ELISA en/of surface plasmon resonance (SPR) detectie. Het 
13H1 antilichaam afkomstig van deoxynivalenol-cyanuric chloride-bovine serum albumin 
(DON-CC-BSA) immunizatie kon DON en zijn analogen herkennen in de volgorde HT-2 
toxine > 15-acetyldeoxynivalenol (15-ADON) > DON, met een gevoeligheid van 
respectievelijk 1.14 µg/mL, 1.62 µg/mL en 2.13 µg/mL. Daarentegen werd het 10H10 
antilichaam bekomen via een deoxynivalenol-bovine serum albumin (DON-BSA) 
geïmmuniseerde muis, gekarakteriseerd door een gevoeligheid tegenover DON, 3-
acetyldeoxynivalenol (3-ADON), 15-ADON en DON-3-glucoside (DON-3G) met waarden 
van 22, 15, 34 en 72 ng/mL respectievelijk. Het gebruik van indirect ELISA voor de 
karakterisatie van het 10H10 antilichaam, deed de kruisreactiviteit ten opzichte van 15-
ADON dalen van 65% tot 9%. SPR-karakterisatie van het 10H10-antilichaam resulteerde in 
een 10 maal betere gevoeligheid voor DON en 3-ADON ten opzichte van indirect ELISA, 
gebruik makend van hetzelfde coating antigen. Een tweede DON-BSA geïmmuniseerde muis 
gaf aanleiding tot een derde monoclonaal antilichaam 2A9 dat een enorm grote specificiteit en 
gevoeligheid (0.38 ng/mL) vertoonde ten opzichte van 3-ADON.  
In Hoofdstuk 4 wordt het breed-specifiek anti-DON monoclonaal antilichaam 10H10 verder 
gebruikt voor het ontwikkelen van een directe ELISA-methode om de DON-contaminatie te 
bepalen in tarwe en tarwestof. Aangezien DON een polaire molecule is en organische 
solventen bovendien kunnen leiden tot denaturatie van proteïnen, werd water gebruikt als 
extractiesolvent. Een klein onderzoek werd uitgevoerd op tarwegranen en het 
corresponderend stof (n = 16), gebruik makend van de geoptimaliseerde extractie en ELISA 
procedure. Een sigmoïdale verhouding tussen de DON concentratie in tarwestof en tarwe 
werd gevonden (r = 0.928). Na het verwijderen van de datapunten overeenkomstig met een 
DON concentratie in tarwe lager dan 200 µg/kg (< LOD), werd een lineaire verhouding 
gevonden (r = 0.889). Door het beperkt aantal tarwe en overeenkomstige tarwestof stalen, is 
de onzekerheid van de lineaire regressie groot. Ook kan geen keuze gemaakt worden tussen 
de lineaire of logaritmische curve.  
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In de Europese wetgeving betreffende DON-contaminatie zijn de acetylderivaten 3-ADON en 
15-ADON of andere gemaskeerde mycotoxines niet opgenomen, ook al zijn deze van 
toxicologisch belang. Tot nu toe werden geen specifieke anti-DON-antilichamen ontwikkeld 
door gebruik te maken van de klassieke hybridomatechnologie. Daarom werd de 
recombinante technologie gebruikt om single-chain variable fragment (scFv) antilichamen te 
synthetiseren, gebruik makend van de 10H10 en 2A9 hybridoma en dit is in detail beschreven 
in Hoofdstuk 5. Geoptimaliseerde condities voor het in cultuur en tot expressie brengen van 
pComb3XSS getransformeerde E. coli cellen werden geselecteerd gebaseerd op een 
ontwikkelde indirecte ELISA-procedure. Hoge spectrofotometrisch gedetecteerde 
absorptiewaarden onthulden de sterkte van de antilichaamstructuur na het verwijderen van 
zijn constante domeinen. De aminozuursequentie van het 10H10 scFv werd bepaald en een 
onderscheid werd gemaakt tussen de complementarity determining regions (CDR) and 
framework regions van de variabele zware (VH) en variabele lichte (VL) keten. Gebruik 
makend van deze sequentie-informatie werden modeling en docking experimenten uitgevoerd. 
Een model scFv werd gevonden in de Swiss Model databank met  61.92% gelijkenis ten 
opzichte van het 10H10 scFv. Door gebruik te maken van dit scFv-model werd een 
inschatting gemaakt van de DON-scFv mogelijke en energetisch gunstige interacties/clusters. 
De verzamelde kennis doorheen het complete doctoraatsonderzoek heeft geleid tot het 
formuleren van een algemene conclusie en toekomstperspectieven waarin verder te 
ontwikkelen en te optimaliseren bio-analytische technieken worden voorgesteld. Dit staat 
uitgebreid beschreven in Hoofdstuk 6. 
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Appendix A: Questions and potential answers on the survey about the awareness of mycotoxin contamination of food and feed 
Question 1: In some cases food (for human consumption) can be unsuitable or even dangerous to eat. How could this occur according to 
you? 
 Possible Impossible I do not know 
By the presence of bacteria such as Salmonella  ○ ○ ○ 
By the presence of viruses such as Norovirus ○ ○ ○ 
By the presence of moulds such as Aspergillus  ○ ○ ○ 
Because the food is rancid  ○ ○ ○ 
Because of chemical substances such as pesticides  ○ ○ ○ 
Because of harmful substances produced by nature such as 
endotoxins 
○ ○ ○ 
Because the expiration date has been exceeded  ○ ○ ○ 
Because it does not smell good or look good anymore ○ ○ ○ 
 
Question 2: In some cases feed (for animal consumption) can be unsuitable or even dangerous to eat. How could this occur according to 
you? 
 Possible Impossible I do not know 
By the presence of bacteria such as Salmonella  ○ ○ ○ 
By the presence of viruses such as Norovirus ○ ○ ○ 
By the presence of moulds such as Aspergillus  ○ ○ ○ 
Because the feed is rancid  ○ ○ ○ 
2
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Because of chemical substances such as pesticides  ○ ○ ○ 
Because of harmful substances produced by nature such as 
endotoxins 
○ ○ ○ 
Because the expiration date has been exceeded  ○ ○ ○ 
Because it does not smell good or look good anymore ○ ○ ○ 
 
Question 3: Mycotoxins are harmful substances produced by nature. Which of the following statements are correct or incorrect in your 
opinion?  
 Correct Incorrect I don not know 
Mycotoxins are produced by certain toxic plants ○ ○ ○ 
Mycotoxins are produced by certain bacteria such as 
Salmonella 
○ ○ ○ 
Mycotoxins are produced by certain moulds such as 
Aspergillus 
○ ○ ○ 
Mycotoxins are produced by certain viruses such as 
Norovirus 
○ ○ ○ 
Mycotoxins are induced by burning food during 
preparation as well as during barbecuing 
○ ○ ○ 
Mycotoxins are the consequence of pollution ○ ○ ○ 
Mycotoxins are toxic to plants ○ ○ ○ 
Mycotoxins are toxic to insects and animals living in water ○ ○ ○ 
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Mycotoxins are toxic to humans ○ ○ ○ 
Mycotoxins are toxic to animals ○ ○ ○ 
Mycotoxins are visually detectable  ○ ○ ○ 
All moulds produce harmful toxins ○ ○ ○ 
Mycotoxins can cause anomalies in newborns (animals 
and humans) 
○ ○ ○ 
Mycotoxins are inhalable  ○ ○ ○ 
 
Question 4: In some cases, food is not suitable to be eaten anymore because of the presence of moulds. Popularly one often says “there is 
growing hair on top of it”. In which products mould growth can occur in your opinion?  
 Yes No I do not know 
Fresh meat or fish ○ ○ ○ 
Fresh vegetables or fruits ○ ○ ○ 
Dairy products such as cheese ○ ○ ○ 
Water or soft drinks ○ ○ ○ 
Beer or wine ○ ○ ○ 
Coffee or tea ○ ○ ○ 
Dry biscuits or sweets ○ ○ ○ 
Breakfast cereals or pasta ○ ○ ○ 
Bread or other products from the bakery ○ ○ ○ 
Prepared meals ○ ○ ○ 
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Frozen products ○ ○ ○ 
Preserved food ○ ○ ○ 
Products kept in fridge ○ ○ ○ 
Sauces such as mayonnaise or ketchup ○ ○ ○ 
Animal feed such as feed pellets or maize pulp ○ ○ ○ 
 
Question 5: In case you find out a product is mouldy, what can you do?  
 Totally 
Disagree 
Disagree Neutral Agree Totally 
agree 
I do not 
know 
If I remove the mouldy part I can still eat the remaining of the 
product 
○ ○ ○ ○ ○ ○ 
Moulds are not really harmful so I can just eat the product  ○ ○ ○ ○ ○ ○ 
If I wash the product thoroughly I can still eat it  ○ ○ ○ ○ ○ ○ 
If I heat up the product I can still eat it ○ ○ ○ ○ ○ ○ 
If the product is mouldy I have to throw it away completely  ○ ○ ○ ○ ○ ○ 
It is always clearly visible whether a product is mouldy or not ○ ○ ○ ○ ○ ○ 
 
Question 6: Who has to supervise that no moulds or mycotoxins are present in food or feed? Please put in order; ranging from most 
important (1) to less important (4). 
The government and food inspection 
The producers of food or feed 
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I have to check this myself 
The shops, store chains or the wholesalers who sell the food or feed products 
 
Question 7: Who has to supervise that our food or feed does not contain moulds or harmful substances such as mycotoxins? How do you 
feel about following statements? 
 Totally 
Disagree 
Disagree Neutral Agree Totally 
agree 
I don’t 
know 
The government or producers have to test food (for human 
consumption) on the presence of moulds 
○ ○ ○ ○ ○ ○ 
The government or producers have to test feed (for animals) on 
the presence of moulds 
○ ○ ○ ○ ○ ○ 
The government or producers have to test food (for human 
consumption) on the presence of mycotoxins as they do for 
pesticides 
○ ○ ○ ○ ○ ○ 
The government or producers have to test feed (for animals) on 
the presence of mycotoxins as they do for pesticides 
○ ○ ○ ○ ○ ○ 
I can check myself if there are moulds present ○ ○ ○ ○ ○ ○ 
I can check myself if there are mycotoxins present ○ ○ ○ ○ ○ ○ 
I am willing to pay more for a qualitatively good product that is 
tested on the presence of moulds or mycotoxins  
○ ○ ○ ○ ○ ○ 
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Finally, we would like to ask you a few more questions to be able to process the results as good as possible.   
 What is your gender? 
Male  
Female   
 In which year were you born?  
 Which is your highest obtained degree? 
Primary school or no education 
Lower secondary school 
Higher secondary school 
University college 
University 
Post-university 
 Which is your profession? 
Self-employed/free profession 
Employee 
Executive 
Labourer 
(Early) Retiree 
Student 
Job seeker 
Housewife/-husband 
Teacher 
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Other 
 In which sector are you working? 
Agriculture 
Food 
Medical sector 
Chemical sector 
Technological sector 
Construction sector 
ICT 
Education 
Government 
Other 
None 
 How is your marital status? 
Single 
In a relationship but not living together 
Married/living together 
Widow/widower 
 Do you have children? 
Yes 
No 
 If yes, how many? 
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